""	"response_component"	"curation_date"	"cohort"	"age_min"	"age_max"	"age_units"	"number_subjects"	"tissue_type"	"tissue_type_term_id"	"method"	"response_component_original"	"is_model"	"response_behavior_type"	"response_behavior"	"comparison"	"baseline_time_event"	"time_point"	"time_point_units"	"exposure_material_id"	"exposure_process"	"disease_name"	"disease_stage"	"publication_reference_id"	"publication_date"	"publication_reference_url"	"signature_source"	"comments"	"response_component_id"	"proterm_and_extra"	"pro_ontology_id"	"fully_qualified_response_component"	"response_comp_orig_cnt"	"response_comp_cnt"	"row_key"
"subject"	""	""	""	""	""	""	""	""	"cell_subset"	""	""	""	""	""	""	""	""	""	"pathogen"	""	""	""	""	""	""	""	""	"cell_subset"	""	""	""	""	""	""
"evidence"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"
"role"	"observed"	"background"	"observed"	"observed"	"observed"	"observed"	"observed"	"background"	"tissue"	"background"	"observed"	"background"	"background"	"measured"	"background"	"background"	"observed"	"observed"	"pathogen"	"background"	"background"	"observed"	"background"	"background"	"reference"	"background"	"background"	"cell_biomarker"	"observed"	"observed"	"observed"	"observed"	"observed"	"background"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"descriptive text on Dashboard"	"response component name"	"curation date YYYY-MM-DD"	"cohort - any characteristics of the population(s) studied, plus whether the result was taken from a subgroup of the broader cohort tested"	"age_min - age of youngest subject including both cases and controls"	"age_max - age of oldest subject including both case and controls"	"age units"	"number of subjects - count of case plus control subjects used in the measurement."	"tissue type"	"tissue (Cell Ontology)"	"method - primary experimental method used to measure the response"	"response component (original curated cell type)"	"signature was derived from a computational model"	"response behavior type"	"response behavior (direction, correlation type etc.)"	"comparison (affected vs control, correlated variable, time vs baseline event etc.)"	"baseline time event"	"time point relative to baseline event at which response was measured"	"time point units"	"exposure material (NCBI taxid)"	"exposure process - method by which immune exposureÂ  occurred"	"disease name"	"disease stage - reported disease stage(s) of affected subjects"	"publication reference (PMID)"	"print publication date or posted date (YYYY-MM-DD)"	"publication URL"	"signature source - figure, table or text section"	"comments and additional details"	"response component"	"response component protein ontology and extra terms"	"response component marker protein ontology ID"	"response component (fully qualified)"	"response component (original) count"	"response component count"	"row key"
""	"plasmablast (CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123-, CD19-lo, CD27-hi, CD38-hi, HLA-DR+); effector CD8-positive, alpha-beta T cell (CD3+, CD38-hi, HLA-DR++)"	"2021-03-31"	"Atlanta"	"23"	"94"	"years"	"36"	"peripheral blood mononuclear cell"	"CL:2000001"	"phospho-CyTOF"	"plasmablasts (CD3-, CD20-, CD56-, HLA-DR+, CD14-, CD16-, CD11c-, CD123-, CD19lo, CD27hi, and CD38hi); effector cd8 T cells(CD3+, CD8+, CD38hi, and HLA-DRhi)"	"N"	"cell-type frequency"	"up"	"pooled moderate, severe, ICU, and convalescent COVID-19 vs healthy"	"onset of symptoms"	"various"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"moderate, severe, ICU, convalescent (pooled)"	"32788292"	"2020-09-04"	"https://pubmed.ncbi.nlm.nih.gov/32788292/"	"Fig 1B"	"HLA-DR+/++ is noted specifically for these two cell types"	"CL:0000980; CL:0001050"	"(CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123-, CD19-lo, CD27-hi, CD38-hi, HLA-DR+); (CD3+, CD38-hi, HLA-DR++)"	"PR:000001020, PR:P11836, PR:000001024, PR:000001889, PR:000001483, PR:000001013, PR:000001865, PR:000001002, PR:000001963, PR:000001408, PR:000002015; PR:000001020, PR:000001408, PR:000002015"	"plasmablast (CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123-, CD19-lo, CD27-hi, CD38-hi, HLA-DR+); effector CD8-positive, alpha-beta T cell (CD3+, CD38-hi, HLA-DR++)"	"2"	"2"	"32788292_1_10"
""	"plasmablast (CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123-, CD19-lo, CD27-hi, CD38-hi, HLA-DR+); effector CD8-positive, alpha-beta T cell (CD3+, CD38-hi, HLA-DR++)"	"2021-03-31"	"Hong Kong"	"18"	"80"	"years"	"99"	"peripheral blood mononuclear cell"	"CL:2000001"	"phospho-CyTOF"	"plasmablasts (CD3-, CD20-, CD56-, HLA-DR+, CD14-, CD16-, CD11c-, CD123-, CD19lo, CD27hi, and CD38hi); effector cd8 T cells(CD3+, CD8+, CD38hi, and HLA-DRhi)"	"N"	"cell-type frequency"	"up"	"pooled moderate, severe, ICU, and convalescent COVID-19 vs healthy"	"onset of symptoms"	"various"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"moderate, severe, ICU, convalescent (pooled)"	"32788292"	"2020-09-04"	"https://pubmed.ncbi.nlm.nih.gov/32788292/"	"Fig 1B"	"HLA-DR+/++ is noted specifically for these two cell types"	"CL:0000980; CL:0001050"	"(CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123-, CD19-lo, CD27-hi, CD38-hi, HLA-DR+); (CD3+, CD38-hi, HLA-DR++)"	"PR:000001020, PR:P11836, PR:000001024, PR:000001889, PR:000001483, PR:000001013, PR:000001865, PR:000001002, PR:000001963, PR:000001408, PR:000002015; PR:000001020, PR:000001408, PR:000002015"	"plasmablast (CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123-, CD19-lo, CD27-hi, CD38-hi, HLA-DR+); effector CD8-positive, alpha-beta T cell (CD3+, CD38-hi, HLA-DR++)"	"2"	"2"	"32788292_2_11"
""	"plasmacytoid dendritic cell (CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123+, HLA-DR+)"	"2021-03-31"	"Atlanta"	"23"	"94"	"years"	"36"	"peripheral blood mononuclear cell"	"CL:2000001"	"phospho-CyTOF"	"plasmacytoid dendric cell  (CD3-, CD20-, CD56-, HLA-DR+, CD14-, CD16-, CD11c- and CD123+)"	"N"	"cell-type frequency"	"down"	"pooled moderate, severe, ICU, and convalescent COVID-19 vs healthy"	"onset of symptoms"	"various"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"moderate, severe, ICU, convalescent (pooled)"	"32788292"	"2020-09-04"	"https://pubmed.ncbi.nlm.nih.gov/32788292/"	"Fig 1C"	""	"CL:0000784"	"(CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123+, HLA-DR+)"	"PR:000001020, PR:P11836, PR:000001024, PR:000001889, PR:000001483, PR:000001013, PR:000001865, PR:000002015"	"plasmacytoid dendritic cell (CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123+, HLA-DR+)"	"1"	"1"	"32788292_3_12"
""	"plasmacytoid dendritic cell (CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123+, HLA-DR+)"	"2021-03-31"	"Hong Kong"	"18"	"80"	"years"	"99"	"peripheral blood mononuclear cell"	"CL:2000001"	"phospho-CyTOF"	"plasmacytoid dendric cell  (CD3-, CD20-, CD56-, HLA-DR+, CD14-, CD16-, CD11c- and CD123+)"	"N"	"cell-type frequency"	"down"	"pooled moderate, severe, ICU, and convalescent COVID-19 vs healthy"	"onset of symptoms"	"various"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"moderate, severe, ICU, convalescent (pooled)"	"32788292"	"2020-09-04"	"https://pubmed.ncbi.nlm.nih.gov/32788292/"	"Fig 1C"	""	"CL:0000784"	"(CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123+, HLA-DR+)"	"PR:000001020, PR:P11836, PR:000001024, PR:000001889, PR:000001483, PR:000001013, PR:000001865, PR:000002015"	"plasmacytoid dendritic cell (CD3-, CD20-, CD56-, CD14-, CD16-, CD11c-, CD123+, HLA-DR+)"	"1"	"1"	"32788292_4_13"
""	"lymphocyte"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"lymphocytes (bound to BD TruCount beads)"	"N"	"cell-type frequency"	"negatively correlated"	"lymphocyte count vs disease severity"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Supp Fig. 1"	""	"CL:0000542"	""	""	"lymphocyte"	"1"	"1"	"32650275_1_84"
""	"natural killer cell (CD45+, CD19-, CD56-, CD3+); mature NK T cell (CD45+, CD19-, CD56-, CD3+); mature gamma-delta T cell (CD3+, CD45RA+); CD8-positive, alpha-beta T cell (CD45+, CD19-, CD56-, CD3+)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"NK cell (CD45+, CD19-, CD56+, CD3-); NK T cell (CD45+, CD19-, CD56+, CD3+); TCRgammadelta+ T cell (CD45+, CD3+, TCRgammadelta+); CD8 T cell (CD45+, CD19-, CD56-, CD3+, CD8+)"	"N"	"cell-type frequency"	"down"	"severe disease vs mild disease"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 1"	""	"CL:0000623; CL:0000814; CL:0000800; CL:0000625"	"(CD45+, CD19-, CD56-, CD3+); (CD3+, CD45RA+)"	"PR:000001006, PR:000001002, PR:000001024, PR:000001020; PR:000001020, PR:000001015"	"natural killer cell (CD45+, CD19-, CD56-, CD3+); mature NK T cell (CD45+, CD19-, CD56-, CD3+); mature gamma-delta T cell (CD3+, CD45RA+); CD8-positive, alpha-beta T cell (CD45+, CD19-, CD56-, CD3+)"	"4"	"4"	"32650275_2_85"
""	"B cell, CD19-positive (CD45+, CD3-); natural killer cell (CD45+, CD19-, CD56-, CD3+); mature NK T cell (CD45+, CD19-, CD56-, CD3+); mature gamma-delta T cell (CD3+, CD45RA+); CD8-positive, alpha-beta T cell (CD45+, CD19-, CD56-, CD3+); CD4-positive, alpha-beta T cell (CD45+, CD19-, CD3+); CD4-positive, CD25-positive, alpha-beta regulatory T cell (CD45+, CD19-, CD3+, CD4+, CD25+, CD127low)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"B cell (CD45+, CD19+, CD3-); NK cell (CD45+, CD19-, CD56+, CD3-); NK T cell (CD45+, CD19-, CD56+, CD3+); TCRgammadelta+ T cell (CD45+, CD3+, TCRgammadelta+); Vgamma9- T cell (CD45+, CD3+, TCRgammadelta+, Vgamma9-); Vgamma9+ T cell (CD45+, CD3+, TCRgammadelta+, Vgamma9+); CD8 T cell (CD45+, CD19-, CD56-, CD3+, CD8+); CD4 Tcell (CD45+, CD19-, CD3+, CD4+); T reg cell (CD45+, CD19-, CD3+, CD4+, CD25+, CD127low)"	"N"	"cell-type frequency"	"down"	"severe disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 1"	""	"CL:0001201; CL:0000623; CL:0000814; CL:0000800; CL:0000625; CL:0000624; CL:0000792"	"(CD45+, CD3-); (CD45+, CD19-, CD56-, CD3+); (CD3+, CD45RA+); (CD45+, CD19-, CD3+); (CD45+, CD19-, CD3+, CD4+, CD25+, CD127low)"	"PR:000001006, PR:000001020; PR:000001006, PR:000001002, PR:000001024, PR:000001020; PR:000001020, PR:000001015; PR:000001006, PR:000001002, PR:000001020; PR:000001006, PR:000001002, PR:000001020, PR:000001004, PR:000001380, PR:000001869"	"B cell, CD19-positive (CD45+, CD3-); natural killer cell (CD45+, CD19-, CD56-, CD3+); mature NK T cell (CD45+, CD19-, CD56-, CD3+); mature gamma-delta T cell (CD3+, CD45RA+); CD8-positive, alpha-beta T cell (CD45+, CD19-, CD56-, CD3+); CD4-positive, alpha-beta T cell (CD45+, CD19-, CD3+); CD4-positive, CD25-positive, alpha-beta regulatory T cell (CD45+, CD19-, CD3+, CD4+, CD25+, CD127low)"	"9"	"9"	"32650275_3_86"
""	"B cell, CD19-positive (CD45+, CD3-); CD4-positive, CD25-positive, alpha-beta regulatory T cell (CD45+, CD19-, CD3+, CD4+, CD25+, CD127low)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"B cell (CD45+, CD19+, CD3-); T reg cell (CD45+, CD19-, CD3+, CD4+, CD25+, CD127low)"	"N"	"cell-type frequency"	"down"	"mild disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig.1"	""	"CL:0001201; CL:0000792"	"(CD45+, CD3-); (CD45+, CD19-, CD3+, CD4+, CD25+, CD127low)"	"PR:000001006, PR:000001020; PR:000001006, PR:000001002, PR:000001020, PR:000001004, PR:000001380, PR:000001869"	"B cell, CD19-positive (CD45+, CD3-); CD4-positive, CD25-positive, alpha-beta regulatory T cell (CD45+, CD19-, CD3+, CD4+, CD25+, CD127low)"	"2"	"2"	"32650275_4_87"
""	"effector memory CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L-)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"conventional CD4 effector/effector memory T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L-)"	"N"	"cell-type frequency"	"down"	"severe disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 2A, Supp Fig. 3A"	""	"CL:0000905"	"(CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L-)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001004, PR:000001380, PR:000001869, PR:000001015, PR:000001318"	"effector memory CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L-)"	"1"	"1"	"32650275_5_88"
""	"CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"conventional CD4 terminally differentiated T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-)"	"N"	"cell-type frequency"	"up"	"severe disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 2A, Supp Fig. 3A"	""	"CL:0000624"	"(CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001004, PR:000001380, PR:000001869, PR:000001015, PR:000001318"	"CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-)"	"1"	"1"	"32650275_6_89"
""	"CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-); central memory CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L+)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"conventional CD4 terminally differentiated T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-); conventional CD4 T central memory cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L+)"	"N"	"cell-type frequency"	"up"	"mild disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 2A, Supp Fig. 3A"	""	"CL:0000624; CL:0000904"	"(CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-); (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L+)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001004, PR:000001380, PR:000001869, PR:000001015, PR:000001318"	"CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-); central memory CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L+)"	"2"	"2"	"32650275_7_90"
""	"naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+); effector memory CD8-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD45RA+, CD62L+)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"CD8 naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+); CD8 effector/effector memory T cell (CD3+, CD56-, CD19-, CD8+, CD45RA-, CD62L-)"	"N"	"cell-type frequency"	"up"	"severe disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 2B, Supp Fig. 3B"	""	"CL:0000898; CL:0000913"	"(CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+); (CD3+, CD56-, CD19-, CD45RA+, CD62L+)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001084, PR:000001015, PR:000001318; PR:000001020, PR:000001024, PR:000001002, PR:000001015, PR:000001318"	"naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+); effector memory CD8-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD45RA+, CD62L+)"	"2"	"2"	"32650275_8_91"
""	"CD8-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+); central memory CD8-positive, alpha-beta T cell"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"CD8 terminally differentiated T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L-); CD8 central memory T cell (CD3+, CD56-, CD19-, CD8+, CD45RA-, CD62L+)"	"N"	"cell-type frequency"	"down"	"severe disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 2B, Supp Fig. 3B"	""	"CL:0000625; CL:0000907"	"(CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+); "	"PR:000001020, PR:000001024, PR:000001002, PR:000001084, PR:000001015, PR:000001318; "	"CD8-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+); central memory CD8-positive, alpha-beta T cell"	"2"	"2"	"32650275_9_92"
""	"effector memory CD8-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD45RA+, CD62L+)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"CD8 effector/effector memory T cell (CD3+, CD56-, CD19-, CD8+, CD45RA-, CD62L-)"	"N"	"cell-type frequency"	"up"	"mild disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 2B, Supp Fig. 3B"	""	"CL:0000913"	"(CD3+, CD56-, CD19-, CD45RA+, CD62L+)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001015, PR:000001318"	"effector memory CD8-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD45RA+, CD62L+)"	"1"	"1"	"32650275_10_93"
""	"naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"CD8 naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"N"	"cell-type frequency"	"down"	"mild disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 2B, Supp Fig. 3B"	""	"CL:0000898"	"(CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001084, PR:000001015, PR:000001318"	"naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"1"	"1"	"32650275_11_94"
""	"naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"CD8 naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"N"	"cell-type frequency"	"up"	"severe disease vs mild disease"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 2B, Supp Fig. 3B"	""	"CL:0000898"	"(CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001084, PR:000001015, PR:000001318"	"naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"1"	"1"	"32650275_12_95"
""	"effector memory CD8-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD45RA+, CD62L+)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"CD8 effector/effector memory T cell (CD3+, CD56-, CD19-, CD8+, CD45RA-, CD62L-)"	"N"	"cell-type frequency"	"down"	"severe disease vs mild disease"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 2B, Supp Fig. 3B"	""	"CL:0000913"	"(CD3+, CD56-, CD19-, CD45RA+, CD62L+)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001015, PR:000001318"	"effector memory CD8-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD45RA+, CD62L+)"	"1"	"1"	"32650275_13_96"
""	"mature gamma-delta T cell (CD3+, CD45RA+, CD62L+)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"TCRgammadelta naive T cell (CD3+, TCRgammadelta+, CD45RA+, CD62L+)"	"N"	"cell-type frequency"	"up"	"mild disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Figs. 3A, 3B"	""	"CL:0000800"	"(CD3+, CD45RA+, CD62L+)"	"PR:000001020, PR:000001015, PR:000001318"	"mature gamma-delta T cell (CD3+, CD45RA+, CD62L+)"	"1"	"1"	"32650275_14_97"
""	"mature gamma-delta T cell (CD3+, CD45RA-, CD62L-); mature gamma-delta T cell (CD3+, CD45RA-, CD62L+); mature gamma-delta T cell (CD3+, CD45RA+, CD62L-)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"TCRgammadelta effector/effector memory T cell (CD3+, TCRgammadelta+, CD45RA-, CD62L-); TCRgammadelta central memory T cell (CD3+, CD3+, TCRgammadelta+, CD45RA-, CD62L+); TCRgammadelta terminally differentiated T cell (CD3+, CD3+, TCRgammadelta+, CD45RA+, CD62L-)"	"N"	"cell-type frequency"	"down"	"severe disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Figs. 3A, 3B"	""	"CL:0000800"	"(CD3+, CD45RA-, CD62L-); (CD3+, CD45RA-, CD62L+); (CD3+, CD45RA+, CD62L-)"	"PR:000001020, PR:000001015, PR:000001318"	"mature gamma-delta T cell (CD3+, CD45RA-, CD62L-); mature gamma-delta T cell (CD3+, CD45RA-, CD62L+); mature gamma-delta T cell (CD3+, CD45RA+, CD62L-)"	"3"	"3"	"32650275_15_98"
""	"mature gamma-delta T cell (CD3+, CD45RA-, CD62L-)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"TCRgammadelta effector/effector memory T cell (CD3+, TCRgammadelta+, CD45RA-, CD62L-)"	"N"	"cell-type frequency"	"down"	"mild disease vs healthy control"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Figs. 3A, 3B"	""	"CL:0000800"	"(CD3+, CD45RA-, CD62L-)"	"PR:000001020, PR:000001015, PR:000001318"	"mature gamma-delta T cell (CD3+, CD45RA-, CD62L-)"	"1"	"1"	"32650275_16_99"
""	"mature gamma-delta T cell (CD3+, CD45RA-, CD62L+)"	"2021-08-03"	"Germany"	"19"	"91"	"years"	"90"	"blood"	"UBERON:0000178"	"flow cytometry"	"TCRgammadelta central memory T cell (CD3+, CD3+, TCRgammadelta+, CD45RA-, CD62L+)"	"N"	"cell-type frequency"	"down"	"severe disease vs mild disease"	"onset of symptoms"	"first measure at 2 to 32"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 3B"	""	"CL:0000800"	"(CD3+, CD45RA-, CD62L+)"	"PR:000001020, PR:000001015, PR:000001318"	"mature gamma-delta T cell (CD3+, CD45RA-, CD62L+)"	"1"	"1"	"32650275_17_100"
""	"naive T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-)"	"2021-08-03"	"Germany"	"19"	"85"	"years"	"7"	"blood"	"UBERON:0000178"	"flow cytometry"	"conventional CD4 naive T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-)"	"N"	"cell-type frequency"	"down"	"convalescing vs pooled mild or severe disease"	"onset of symptoms"	"convalescence at 7 to 38"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 4A"	""	"CL:0000898"	"(CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001004, PR:000001380, PR:000001869, PR:000001015, PR:000001318"	"naive T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA+, CD62L-)"	"1"	"1"	"32650275_18_101"
""	"effector memory CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L-); central memory CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L+)"	"2021-08-03"	"Germany"	"19"	"85"	"years"	"7"	"blood"	"UBERON:0000178"	"flow cytometry"	"conventional CD4 effector/effector memory T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L-); conventional CD4 T central memory cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L+)"	"N"	"cell-type frequency"	"up"	"convalescing vs pooled mild or severe disease"	"onset of symptoms"	"convalescence at 7 to 38"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 4A"	""	"CL:0000905; CL:0000904"	"(CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L-); (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L+)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001004, PR:000001380, PR:000001869, PR:000001015, PR:000001318"	"effector memory CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L-); central memory CD4-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD4+, CD25low, CD127hi, CD45RA-, CD62L+)"	"2"	"2"	"32650275_19_102"
""	"naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"2021-08-03"	"Germany"	"19"	"85"	"years"	"7"	"blood"	"UBERON:0000178"	"flow cytometry"	"CD8 naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"N"	"cell-type frequency"	"down"	"convalescing vs pooled mild or severe disease"	"onset of symptoms"	"convalescence at 7 to 38"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 4B"	""	"CL:0000898"	"(CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"PR:000001020, PR:000001024, PR:000001002, PR:000001084, PR:000001015, PR:000001318"	"naive T cell (CD3+, CD56-, CD19-, CD8+, CD45RA+, CD62L+)"	"1"	"1"	"32650275_20_103"
""	"effector memory CD8-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD45RA+, CD62L+); central memory CD8-positive, alpha-beta T cell"	"2021-08-03"	"Germany"	"19"	"85"	"years"	"7"	"blood"	"UBERON:0000178"	"flow cytometry"	"CD8 effector/effector memory T cell (CD3+, CD56-, CD19-, CD8+, CD45RA-, CD62L-); CD8 central memory T cell (CD3+, CD56-, CD19-, CD8+, CD45RA-, CD62L+)"	"N"	"cell-type frequency"	"up"	"convalescing vs pooled mild or severe disease"	"onset of symptoms"	"convalescence at 7 to 38"	"days"	"2697049"	"occurrence of infectious disease"	"COVID-19"	"mild, severe"	"32650275"	"2020-07-07"	"https://www.sciencedirect.com/science/article/pii/S2352396420302607?via%3Dihub"	"Fig. 4B"	""	"CL:0000913; CL:0000907"	"(CD3+, CD56-, CD19-, CD45RA+, CD62L+); "	"PR:000001020, PR:000001024, PR:000001002, PR:000001015, PR:000001318; "	"effector memory CD8-positive, alpha-beta T cell (CD3+, CD56-, CD19-, CD45RA+, CD62L+); central memory CD8-positive, alpha-beta T cell"	"2"	"2"	"32650275_21_104"
""	"natural killer cell; natural killer cell (CD56+-)"	"2021-02-14"	"COVID-19 patients and healthy controls (Stockholm, Sweden)"	"18"	"78"	"years"	"27"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"NK cell phenotyping"	"Natural Killer cells; CD56dim Natural Killer cells"	""	"cell-type frequency"	"down"	"moderate COVID-19 patients (N=10) vs healthy controls (N=17)"	"time of admission"	"0 to 8"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig 1C"	"\"COVID-19 patients were sampled 5 to 24 days after symptom debut and 0 to 8 days after being admitted to the hospital. Patients classified as having moderate COVID-19 disease had oxygen saturation of 90 to 94% or were receiving 0.5 to 3 liters/min..."	"CL:0000623; CL_0000623"	"; (CD56+-)"	"; PR:000001024"	"natural killer cell; natural killer cell (CD56+-)"	"2"	"2"	"32826343_1_105"
""	"natural killer cell; natural killer cell (CD56++); natural killer cell (CD56+-)"	"2021-02-14"	"COVID-19 patients and healthy controls (Stockholm, Sweden)"	"18"	"78"	"years"	"33"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"NK cell phenotyping"	"Natural Killer cells; CD56bright Natural Killer cells; CD56dim Natural Killer cells"	""	"cell-type frequency"	"down"	"moderate COVID-19 patients (N=10) vs healthy controls (N=17)"	"time of admission"	"0 to 8"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig 1C"	"\"COVID-19 patients were sampled 5 to 24 days after symptom debut and 0 to 8 days after being admitted to the hospital. Patients with severe COVID-19 disease were treated in an ICU or a high dependency unit, requiring either noninvasive or mechanic..."	"CL:0000623; CL_0000623"	"; (CD56++); (CD56+-)"	"; PR:000001024"	"natural killer cell; natural killer cell (CD56++); natural killer cell (CD56+-)"	"3"	"3"	"32826343_2_106"
""	"natural killer cell (NKG2C+,CD57+,CD56+-)"	"2021-02-14"	"COVID-19 patients and healthy controls (Stockholm, Sweden)"	"18"	"78"	"years"	"9"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"NKG2C+ CD57+ CD56dim Natural Killer cells"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of admission"	"0 to 5"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig 3B"	""	"CL_0000623"	"(NKG2C+,CD57+,CD56+-)"	"PR:000002024,PR:000001440,PR:000001024"	"natural killer cell (NKG2C+,CD57+,CD56+-)"	"1"	"1"	"32826343_3_120"
""	"natural killer cell (NKG2C-,CD57-,CD56+-)"	"2021-02-14"	"COVID-19 patients and healthy controls (Stockholm, Sweden)"	"18"	"78"	"years"	"6"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"NKG2C- CD57- CD56dim Natural Killer cells"	""	"cell-type frequency"	"down"	"moderate COVID-19 patients vs healthy patients"	"time of admission"	"0 to 5"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig 3C"	""	"CL_0000623"	"(NKG2C-,CD57-,CD56+-)"	"PR:000002024,PR:000001440,PR:000001024"	"natural killer cell (NKG2C-,CD57-,CD56+-)"	"1"	"1"	"32826343_4_121"
""	"natural killer cell (NKG2C-,CD57-,CD56+-)"	"2021-02-14"	"COVID-19 patients and healthy controls (Stockholm, Sweden)"	"18"	"78"	"years"	"9"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"NKG2C- CD57- CD56dim Natural Killer cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs healthy patients"	"time of admission"	"0 to 5"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig 3C"	""	"CL_0000623"	"(NKG2C-,CD57-,CD56+-)"	"PR:000002024,PR:000001440,PR:000001024"	"natural killer cell (NKG2C-,CD57-,CD56+-)"	"1"	"1"	"32826343_5_122"
""	"natural killer cell (CD56+-,NKG2C+,CD57+)"	"2021-08-24"	"COVID-19 patients  (Stockholm, Sweden)"	"18"	"78"	"years"	"27"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"Spearman's correlations; NPX"	"NKG2C+CD57+ CD56dim NK cells"	""	"cell-type frequency"	"positively correlated"	"soluble factor AREG"	"time of admission"	"0 to 5"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig 3L"	""	"CL_0000623"	"(CD56+-,NKG2C+,CD57+)"	"PR:000001024,PR:000002024,PR:000001440"	"natural killer cell (CD56+-,NKG2C+,CD57+)"	"1"	"1"	"32826343_6_127"
""	"natural killer cell (CD56+-,NKG2C+,CD57+)"	"2021-08-24"	"COVID-19 patients (Stockholm, Sweden)"	"18"	"78"	"years"	"27"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"Spearman's correlations; NPX"	"NKG2C+CD57+ CD56dim NK cells"	""	"cell-type frequency"	"negatively correlated"	"soluble factors: LTalpha, IFNgamma, IL-12beta"	"time of admission"	"0 to 5"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig 3L"	""	"CL_0000623"	"(CD56+-,NKG2C+,CD57+)"	"PR:000001024,PR:000002024,PR:000001440"	"natural killer cell (CD56+-,NKG2C+,CD57+)"	"1"	"1"	"32826343_7_128"
""	"natural killer cell (CD56++)"	"2021-02-14"	"COVID-19 patients (Stockholm, Sweden)"	"18"	"78"	"years"	"25"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"Spearman's correlations; MFI"	"CD56bright natural killer cells"	""	"cell-type frequency"	"positively correlated"	"granzyme B (MFI) expression on CD56bright NK cells"	"time of admission"	"0 to 8"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig 5E"	""	"CL_0000623"	"(CD56++)"	"PR:000001024"	"natural killer cell (CD56++)"	"1"	"1"	"32826343_8_133"
""	"natural killer cell (CD25+,CD56++); natural killer cell (CD56++,PRF1+); natural killer cell (CD56+-,PRF1+); natural killer cell (GZMB+,CD56++)"	"2021-02-14"	"COVID-19 patients (Stockholm, Sweden)"	"18"	"78"	"years"	"25"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"NK cell phenotyping; percentage & MFI; Spearman's correlation"	"CD25 CD56bright NK cells; perforin CD56bright NK cells; perforin CD56dim NK cells; Granzyme B CD56bright NK cells"	""	"cell-type frequency"	"positively correlated"	"perforin (MFI) on CD56bright NK cells"	"time of admission"	"0 to 8"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig S7B"	""	"CL_0000623"	"(CD25+,CD56++); (CD56++,PRF1+); (CD56+-,PRF1+); (GZMB+,CD56++)"	"PR:000001380,PR:000001024; PR:000001024,PR:000003466; PR:000003499,PR:000001024"	"natural killer cell (CD25+,CD56++); natural killer cell (CD56++,PRF1+); natural killer cell (CD56+-,PRF1+); natural killer cell (GZMB+,CD56++)"	"4"	"4"	"32826343_9_148"
""	"natural killer cell (TIGIT+,CD56+-)"	"2021-02-14"	"COVID-19 patients (Stockholm, Sweden)"	"18"	"78"	"years"	"25"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"NK cell phenotyping; MFI; Spearman's correlation"	"TIGIT CD56dim NK cells"	""	"cell-type frequency"	"negatively correlated"	"perforin (MFI) on CD56bright NK cells"	"time of admission"	"0 to 8"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig S7B"	""	"CL_0000623"	"(TIGIT+,CD56+-)"	"PR:000033769,PR:000001024"	"natural killer cell (TIGIT+,CD56+-)"	"1"	"1"	"32826343_10_149"
""	"natural killer cell (GZMB+,CD56+-); natural killer cell (CD25+,CD56+); natural killer cell (GZMB+,CD56++); natural killer cell (CD25+,CD56++); natural killer cell (KSP37+,CD56++)"	"2021-02-14"	"COVID-19 patients (Stockholm, Sweden)"	"18"	"78"	"years"	"25"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"NK cell phenotyping; MFI; Spearman's correlation"	"Granzyme B CD56dim NK cells; CD25 CD56dim NK cells; Granzyme B CD56bright NK cells; CD25 CD56bright NK cells; Ksp37 CD56bright NK cells"	""	"cell-type frequency"	"positively correlated"	"Granzyme B (MFI) on CD56bright NK cells"	"time of admission"	"0 to 8"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32826343"	"2020-08-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665314/"	"Fig S7C"	""	"CL_0000623"	"(GZMB+,CD56+-); (CD25+,CD56+); (GZMB+,CD56++); (CD25+,CD56++); (KSP37+,CD56++)"	"PR:000003499,PR:000001024; PR:000001380,PR:000001024; PR:000007502,PR:000001024"	"natural killer cell (GZMB+,CD56+-); natural killer cell (CD25+,CD56+); natural killer cell (GZMB+,CD56++); natural killer cell (CD25+,CD56++); natural killer cell (KSP37+,CD56++)"	"5"	"5"	"32826343_11_150"
""	"alpha-beta t cell (CD3+); monocyte (CD68+); monocyte (CD163+)"	"2021-02-19"	"COVID-19 patients and non-COVID-19 controls (Basel, Switzerland)"	"53"	"104"	"years"	"33"	"formalin-fixed and paraffin-embedded (FFPE) lung tissue"	"UBERON:0002048"	"Immunohistochemical analyses"	"CD3+ T cells; CD68+ monocytes; CD163+ monocytes"	""	"cell-type frequency"	"up"	"cluster 2 (ISG low) vs controls"	"death"	"11 to 67"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33033248"	"2020-10-08"	"https://www.nature.com/articles/s41467-020-18854-2"	"Fig 3c"	""	"CL_0000789; CL_0000576"	"(CD3+); (CD68+); (CD163+)"	"PR:000001020; PR:000002064; PR:000001925"	"alpha-beta t cell (CD3+); monocyte (CD68+); monocyte (CD163+)"	"3"	"3"	"33033248_1_163"
""	"alpha-beta t cell (CD3+); monocyte (CD68+); monocyte (CD163+); CD8-positive, alpha-beta T cell"	"2021-02-19"	"COVID-19 patients and non-COVID-19 controls (Basel, Switzerland)"	"53"	"96"	"years"	"33"	"formalin-fixed and paraffin-embedded (FFPE) lung tissue"	"UBERON:0002048"	"Immunohistochemical analyses"	"CD3+ T cells; CD68+ monocytes; CD163+ monocytes; CD8+ T cells"	""	"cell-type frequency"	"up"	"cluster 2 (ISG low) vs cluster 1 (ISG high)"	"death"	"11 to 67"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33033248"	"2020-10-08"	"https://www.nature.com/articles/s41467-020-18854-2"	"Fig 3c"	""	"CL_0000789; CL_0000576; CL:0000625"	"(CD3+); (CD68+); (CD163+); "	"PR:000001020; PR:000002064; PR:000001925; "	"alpha-beta t cell (CD3+); monocyte (CD68+); monocyte (CD163+); CD8-positive, alpha-beta T cell"	"4"	"4"	"33033248_2_164"
""	"CD4-positive, alpha-beta T cell; b cell (CD20+); cd8-positive, alpha-beta t cell (PD1+)"	"2021-02-19"	"COVID-19 patients and non-COVID-19 controls (Basel, Switzerland)"	"53"	"96"	"years"	"33"	"formalin-fixed and paraffin-embedded (FFPE) lung tissue"	"UBERON:0002048"	"Immunohistochemical analyses; computational image analysis"	"CD4+ T cells; CD20+ B cells; CD8+ PD1+ T cells"	""	"cell-type frequency"	"up"	"cluster 2 (ISG low) vs cluster 1 (ISG high)"	"death"	"11 to 67"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33033248"	"2020-10-08"	"https://www.nature.com/articles/s41467-020-18854-2"	"Fig 4a"	""	"CL:0000624; CL_0000236; CL_0000625"	"; (CD20+); (PD1+)"	"; PR:000001289; PR:000001919"	"CD4-positive, alpha-beta T cell; b cell (CD20+); cd8-positive, alpha-beta t cell (PD1+)"	"3"	"3"	"33033248_3_165"
""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2021-02-15"	"COVID-19 infected patients and age/sex-matched healthy controls"	"18"	"94"	"years"	"135"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"phospho-CyTOF"	"plasmablasts of CD45 cells; effector CD8 T cells of CD8 T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=73) vs healthy controls (N=62)"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig 1b"	"-healthy: samples from asymptomatic adults prior to widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more tha..."	"CL_0000980; CL_0001050"	""	""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2"	"2"	"32788292_5_172"
""	"plasmacytoid dendritic cell, human"	"2021-02-15"	"COVID-19 infected patients and age/sex-matched healthy controls"	"18"	"94"	"years"	"135"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"phospho-CyTOF"	"pDCs (plasmacytoid dendritic cells)"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=73) vs healthy controls (N=62)"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig 1c"	"-healthy: samples from asymptomatic adults prior to widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more tha..."	"CL_0001058"	""	""	"plasmacytoid dendritic cell, human"	"1"	"1"	"32788292_6_173"
""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2021-02-15"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"plasmablasts of CD45 cells; effector CD8 T cells of CD8 T cells"	""	"cell-type frequency"	"up"	"patients receiving IFN-B1 treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S3."	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0000980; CL_0001050"	""	""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2"	"2"	"32788292_7_206"
""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2021-02-15"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"plasmablasts of CD45 cells; effector CD8 T cells of CD8 T cells"	""	"cell-type frequency"	"up"	"patients not on IFN-B1 treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S3."	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0000980; CL_0001050"	""	""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2"	"2"	"32788292_8_207"
""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"plasmablasts of CD45 cells; effector CD8 T cells of CD8 T cells"	""	"cell-type frequency"	"up"	"patients receiving corticosteroid treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S3."	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0000980; CL_0001050"	""	""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2"	"2"	"32788292_9_208"
""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2021-02-16"	"COVID-19 infected patients(from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"plasmablasts of CD45 cells; effector CD8 T cells of CD8 T cells"	""	"cell-type frequency"	"up"	"patients receiving vs  not receiving corticosteroid treatment"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S3."	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0000980; CL_0001050"	""	""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2"	"2"	"32788292_10_209"
""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"plasmablasts of CD45 cells; effector CD8 T cells of CD8 T cells"	""	"cell-type frequency"	"up"	"patients not receiving corticosteroid treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S3."	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0000980; CL_0001050"	""	""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2"	"2"	"32788292_11_210"
""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"plasmablasts of CD45 cells; effector CD8 T cells of CD8 T cells"	""	"cell-type frequency"	"up"	"patients receiving antiviral treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S3."	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0000980; CL_0001050"	""	""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2"	"2"	"32788292_12_211"
""	"effector cd8-positive, alpha-beta t cell"	"2021-02-16"	"COVID-19 infected patients(from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"effector CD8 T cells of CD8 T cells"	""	"cell-type frequency"	"up"	"patients receiving vs  not receiving antiviral treatment"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S3."	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0001050"	""	""	"effector cd8-positive, alpha-beta t cell"	"1"	"1"	"32788292_13_212"
""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"plasmablasts of CD45 cells; effector CD8 T cells of CD8 T cells"	""	"cell-type frequency"	"up"	"patients not receiving antiviral treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S3."	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0000980; CL_0001050"	""	""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2"	"2"	"32788292_14_213"
""	"plasmacytoid dendritic cell, human"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"pDCs (plasmacytoid dendritic cells) of CD45 cells"	""	"cell-type frequency"	"down"	"patients receiving IFN-B1 treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S4a"	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0001058"	""	""	"plasmacytoid dendritic cell, human"	"1"	"1"	"32788292_15_214"
""	"plasmacytoid dendritic cell, human"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"pDCs (plasmacytoid dendritic cells) of CD45 cells"	""	"cell-type frequency"	"down"	"patients not on IFN-B1 treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S4a"	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0001058"	""	""	"plasmacytoid dendritic cell, human"	"1"	"1"	"32788292_16_215"
""	"plasmacytoid dendritic cell, human"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"pDCs (plasmacytoid dendritic cells) of CD45 cells"	""	"cell-type frequency"	"down"	"patients receiving corticosteroid treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S4a"	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0001058"	""	""	"plasmacytoid dendritic cell, human"	"1"	"1"	"32788292_17_216"
""	"plasmacytoid dendritic cell, human"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"pDCs (plasmacytoid dendritic cells) of CD45 cells"	""	"cell-type frequency"	"down"	"patients not receiving corticosteroid treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S4a"	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0001058"	""	""	"plasmacytoid dendritic cell, human"	"1"	"1"	"32788292_18_217"
""	"plasmacytoid dendritic cell, human"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Hong Kong, China)"	"18"	"80"	"years"	""	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"ex-vivo stimulation of PBMCs; intracellular staining assay; flow cytometry"	"pDCs (plasmacytoid dendritic cells) of CD45 cells"	""	"cell-type frequency"	"down"	"patients receiving antiviral treatment vs healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S4a"	"-healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyngeal swabs\". convalescent defined as \"more than ..."	"CL_0001058"	""	""	"plasmacytoid dendritic cell, human"	"1"	"1"	"32788292_19_218"
""	"monocyte (IL1B+); monocyte (TNFA+); monocyte (IL6+); monocyte (IL6+,TNFA+)"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Atlanta, Georgia)"	"23"	"94"	"years"	"31"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry of peripheral blood leukocytes ex vivo stimulated with bacterial cocktail (Pam3CSK14, LPS, & Flagellin)"	"IL-1B CD14+ monocytes; TNF-alpha CD14+ monocytes; IL-6 CD14+ monocytes; IL-6+ TNF+ CD14+ monocytes"	""	"cell-type frequency"	"down"	"patients (N=14) vs healthy (N=17), in response to stimulation by bacterial cocktail (Pam3CSK4, LPS, & Flagellin)"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S5."	"-Shows % of CD14+ monocytes producing cytokines. healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyn..."	"CL_0000576"	"(IL1B+); (TNFA+); (IL6+); (IL6+,TNFA+)"	"PR:000001136; PR:000000134; PR:000001393; PR:000001393,PR:000000134"	"monocyte (IL1B+); monocyte (TNFA+); monocyte (IL6+); monocyte (IL6+,TNFA+)"	"4"	"4"	"32788292_21_233"
""	"monocyte (IL1B+); monocyte (TNFA+); monocyte (IL6+); monocyte (IL6+,TNFA+); monocyte (MCP1+)"	"2021-02-16"	"COVID-19 infected patients and age/sex-matched healthy controls (from Atlanta, Georgia)"	"23"	"94"	"years"	"31"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry of peripheral blood leukocytes ex vivo stimulated with viral cocktail (polyIC + R848)"	"IL-1B CD14+ monocytes; TNF-alpha CD14+ monocytes; IL-6 CD14+ monocytes; IL-6+ TNF+ CD14+ monocytes; MCP-1 CD14+ monocytes"	""	"cell-type frequency"	"down"	"patients (N=14) vs healthy (N=17), in response to stimulation by viral cocktail (polyIC + R848)"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S5."	"-Shows % of CD14+ monocytes producing cytokines. healthy: samples from asymptomatic adults before widespread SARS-CoV-2 circulation in the community. COVID-19 patients \"according to WHO guidance and positive SARS-CoV-2 RT-PCR testing by nasopharyn..."	"CL_0000576"	"(IL1B+); (TNFA+); (IL6+); (IL6+,TNFA+); (MCP1+)"	"PR:000001136; PR:000000134; PR:000001393; PR:000001393,PR:000000134; PR:000002122"	"monocyte (IL1B+); monocyte (TNFA+); monocyte (IL6+); monocyte (IL6+,TNFA+); monocyte (MCP1+)"	"5"	"5"	"32788292_22_234"
""	"plasmacytoid dendritic cell, human"	"2021-02-18"	"COVID-19 infected patients and age/sex-matched healthy controls"	"18"	"94"	"years"	"52"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"phospho CyTOF; hierarchical clustering"	"pDCs (plasmacytoid dendritic cells)"	""	"cell-type frequency"	"down"	"ICU, severe, & moderate patients vs convalescent patients and healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S20."	""	"CL_0001058"	""	""	"plasmacytoid dendritic cell, human"	"1"	"1"	"32788292_23_301"
""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2021-02-18"	"COVID-19 infected patients and age/sex-matched healthy controls"	"18"	"94"	"years"	"52"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"phospho CyTOF; hierarchical clustering"	"plasmablast; Effector_CD8_T_cells"	""	"cell-type frequency"	"up"	"ICU, severe, & moderate patients vs convalescent patients and healthy controls"	"time of clinical onset"	"various"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32788292"	"2020-08-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665312/"	"Fig S20."	""	"CL:0000980; CL_0001050"	""	""	"plasmablast; effector cd8-positive, alpha-beta t cell"	"2"	"2"	"32788292_24_302"
""	"plasmablast (CD19+,IGD-,CD38+,CD20-,CD71+)"	""	"COVID-19 patients and healthy controls (St Louis, Missouri)"	"22"	"89"	"years"	"37"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"CD45+ CD19+ IgD- CD71+ CD38+ CD20- plasmablasts"	""	"cell-type frequency"	"up"	"severe COVID-19 patients (N=22) vs healthy (N=15)"	"time of hospital admission"	"1"	"day"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33187979"	"2020-12-09"	"https://advances.sciencemag.org/content/6/50/eabe3024/"	"Fig 1B"	""	"CL_0000980"	"(CD19+,IGD-,CD38+,CD20-,CD71+)"	"PR:000001002,PR:000050170,PR:000001408,PR:000001289,PR:000001945"	"plasmablast (CD19+,IGD-,CD38+,CD20-,CD71+)"	"1"	"1"	"33187979_1_326"
""	"cd8-positive, alpha-beta t cell (CD45+,CD3+); cd4-positive, alpha-beta memory t cell (CD45+,CD3+); classical monocyte (CD45+,CD3-,CD19-,CD14++,CD16-); intermediate monocyte (CD45+,CD3-,CD19-,CD14++,CD16+); non-classical monocyte (CD45+,CD3-,CD19-,CD14+,CD16+)"	""	"COVID-19 patients and healthy controls (St Louis, Missouri)"	"22"	"89"	"years"	"37"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"CD45+ CD3+ CD8+ T cells; CD45+ CD3+ CD4+ T cells; CD45+ CD3- CD19- CD14++ CD16- classical monocytes; CD45+ CD3- CD19- CD14++ CD16+ intermediate monocytes; CD45+ CD3- CD19- CD14+ CD16+ non-classical monocytes"	""	"cell-type frequency"	"down"	"severe COVID-19 patients (N=22) vs healthy (N=15)"	"time of hospital admission"	"1"	"day"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33187979"	"2020-12-09"	"https://advances.sciencemag.org/content/6/50/eabe3024/"	"Fig 1A & C"	""	"CL_0000625; CL_0000897; CL_0000860; CL_0002393; CL_0000875"	"(CD45+,CD3+); (CD45+,CD3-,CD19-,CD14++,CD16-); (CD45+,CD3-,CD19-,CD14++,CD16+); (CD45+,CD3-,CD19-,CD14+,CD16+)"	"PR:000001006,PR:000001020; PR:000001006,PR:000001020,PR:000001002,PR:000001889,PR:000001483"	"cd8-positive, alpha-beta t cell (CD45+,CD3+); cd4-positive, alpha-beta memory t cell (CD45+,CD3+); classical monocyte (CD45+,CD3-,CD19-,CD14++,CD16-); intermediate monocyte (CD45+,CD3-,CD19-,CD14++,CD16+); non-classical monocyte (CD45+,CD3-,CD19-,CD14+,CD16+)"	"5"	"5"	"33187979_2_327"
""	"classical monocyte (CD45+,CD3-,CD19-,CD14++,CD16-); intermediate monocyte (CD45+,CD3-,CD19-,CD14++,CD16+); non-classical monocyte (CD45+,CD3-,CD19-,CD14+,CD16+)"	""	"COVID-19 patients and influenza patients (St Louis, Missouri)"	"18"	"89"	"years"	"45"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"CD45+ CD3- CD19- CD14++ CD16- classical monocytes; CD45+ CD3- CD19- CD14++ CD16+ intermediate monocytes; CD45+ CD3- CD19- CD14+ CD16+ non-classical monocytes"	""	"cell-type frequency"	"down"	"severe COVID-19 patients (N=22) vs severe influenza patients (N=23)"	"time of hospital admission"	"1"	"day"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33187979"	"2020-12-09"	"https://advances.sciencemag.org/content/6/50/eabe3024/"	"Fig 1C"	""	"CL_0000860; CL_0002393; CL_0000875"	"(CD45+,CD3-,CD19-,CD14++,CD16-); (CD45+,CD3-,CD19-,CD14++,CD16+); (CD45+,CD3-,CD19-,CD14+,CD16+)"	"PR:000001006,PR:000001020,PR:000001002,PR:000001889,PR:000001483"	"classical monocyte (CD45+,CD3-,CD19-,CD14++,CD16-); intermediate monocyte (CD45+,CD3-,CD19-,CD14++,CD16+); non-classical monocyte (CD45+,CD3-,CD19-,CD14+,CD16+)"	"3"	"3"	"33187979_3_329"
""	"CD8-positive, alpha-beta T cell; monocyte (CD16+); monocyte (CD14+); natural killer cell (CD56+,CD16-); natural killer cell (CD56+,CD16+)"	""	"Birmingham, Alabama"	"19"	"88"	"years"	"80"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"CD8+ T cells; CD16+ monocyte; CD14+ monocyte; CD56+ CD16- NK cells; CD56+ CD16+ NK cells"	""	"cell-type frequency"	"up"	"nonhospitalized COVID-19 patients vs hospitalized COVID-19 patients"	"time of symptom onset"	"4-43"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33119547"	"2020-10-29"	"https://www.jci.org/articles/view/140491"	"Fig 1C, 1F-I"	""	"CL:0000625; CL_0000576; CL_0000623"	"; (CD16+); (CD14+); (CD56+,CD16-); (CD56+,CD16+)"	"; PR:000001483; PR:000001889; PR:000001024,PR:000001483"	"CD8-positive, alpha-beta T cell; monocyte (CD16+); monocyte (CD14+); natural killer cell (CD56+,CD16-); natural killer cell (CD56+,CD16+)"	"5"	"5"	"33119547_1_343"
""	"b cell"	""	"Birmingham, Alabama"	"19"	"88"	"years"	"80"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"B cells"	""	"cell-type frequency"	"up"	"hospitalized COVID-19 patients vs nonhospitalized COVID-19 patients"	"time of symptom onset"	"4-43"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33119547"	"2020-10-29"	"https://www.jci.org/articles/view/140491"	"Fig 1D"	""	"CL_0000236"	""	""	"b cell"	"1"	"1"	"33119547_2_344"
""	"b cell; dendritic cell"	""	"Birmingham, Alabama"	"25"	"86"	"years"	"58"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"B cells; Dendritic Cells (DCs)"	""	"cell-type frequency"	"down"	"nonhospitalized COVID-19 patients vs healthy patients"	"time of symptom onset"	"19-40"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33119547"	"2020-10-29"	"https://www.jci.org/articles/view/140491"	"Fig 1D & 1K"	""	"CL_0000236; CL_0000451"	""	""	"b cell; dendritic cell"	"2"	"2"	"33119547_3_345"
""	"CD14-positive, CD16-positive monocyte"	""	"Birmingham, Alabama"	"19"	"88"	"years"	"58"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"CD14+ CD16+ monocytes"	""	"cell-type frequency"	"up"	"nonhospitalized COVID-19 patients vs healthy patients"	"time of symptom onset"	"19-40"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33119547"	"2020-10-29"	"https://www.jci.org/articles/view/140491"	"Fig 1J"	""	"CL:0002397"	""	""	"CD14-positive, CD16-positive monocyte"	"1"	"1"	"33119547_4_346"
""	"natural killer cell (CD56+,CD16+); monocyte (CD14+); dendritic cell"	""	"Birmingham, Alabama"	"19"	"88"	"years"	"60"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"CD56+ CD16+ NK cells; CD14+ monocyte; dendritic cells"	""	"cell-type frequency"	"down"	"hospitalized COVID-19 patients vs healthy patients"	"time of symptom onset"	"4-43"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33119547"	"2020-10-29"	"https://www.jci.org/articles/view/140491"	"Fig 1F, 1H, & 1K"	""	"CL_0000623; CL_0000576; CL_0000451"	"(CD56+,CD16+); (CD14+); "	"PR:000001024,PR:000001483; PR:000001889; "	"natural killer cell (CD56+,CD16+); monocyte (CD14+); dendritic cell"	"3"	"3"	"33119547_5_347"
""	"cd4-positive, alpha-beta memory t cell (CD38+)"	""	"Birmingham, Alabama"	"19"	"88"	"years"	"85"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"flow cytometry"	"CD38-expressing CD4+ T cells"	""	"cell-type frequency"	"down"	"hospitalized COVID-19 patients vs nonhospitalized COVID-19 patients"	"time of symptom onset"	"4-43"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33119547"	"2020-10-29"	"https://www.jci.org/articles/view/140491"	"Fig 2I"	""	"CL_0000897"	"(CD38+)"	"PR:000001408"	"cd4-positive, alpha-beta memory t cell (CD38+)"	"1"	"1"	"33119547_6_351"
""	"lymphocyte"	""	"Rome, Italy"	"unknown"	"unknown"	"years"	"8"	"Whole blood"	"UBERON:0000178"	"clinical laboratory test"	"lymphocytes"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs mild COVID-19 patients"	"time after hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32514047"	"2020-06-08"	"https://www.nature.com/articles/s41418-020-0572-6"	"Fig 1A & paragraph above Fig 1."	"Significant in cell count and percentage frequency. Severe defined as \"with fever, cough and ARDS [PaO2= (partial pressure of arterial oxygen)/FIO2 (Fraction of inspired oxygen) Rati0 < 300âmmHg].\" Mild defined as \"mild conjunctivitis, axillary te..."	"CL_0000542"	""	""	"lymphocyte"	"1"	"1"	"32514047_1_385"
""	"neutrophil"	""	"Rome, Italy"	"unknown"	"unknown"	"years"	"8"	"Whole blood"	"UBERON:0000178"	"clinical laboratory test"	"neutrophils"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs mild COVID-19 patients"	"time after hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32514047"	"2020-06-08"	"https://www.nature.com/articles/s41418-020-0572-6"	"Fig 1A & paragraph above Fig 1."	"Significant in only percentage frequency. Severe defined as \"with fever, cough and ARDS [PaO2 = (partial pressure of arterial oxygen)/FIO2 (Fraction of inspired oxygen) Ratio < 300âmmHg].\" Mild defined as \"mild conjunctivitis, axillary temperature..."	"CL_0000775"	""	""	"neutrophil"	"1"	"1"	"32514047_2_386"
""	"myeloid suppressor cell (polymorphonuclear)"	""	"Rome, Italy"	"unknown"	"unknown"	"years"	"18"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"PMN-MDSC (Myeloid-Derived Suppressor Cells)"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs mild COVID-19 patients"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32514047"	"2020-06-08"	"https://www.nature.com/articles/s41418-020-0572-6"	"Fig 4C"	"Severe defined as \"with fever, cough and ARDS [PaO2 = (partial pressure of arterial oxygen)/FIO2 (Fraction of inspired oxygen) Ratio < 300 mmHg].\" Mild defined as \"mild conjunctivitis, axillary temperature of 37.5 Â°C, or with no clinical sign\""	"CL_0000889"	"(polymorphonuclear)"	""	"myeloid suppressor cell (polymorphonuclear)"	"1"	"1"	"32514047_3_387"
""	"myeloid suppressor cell (polymorphonuclear)"	""	"Rome, Italy"	"unknown"	"unknown"	"years"	"17"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"PMN-MDSC (Myeloid-Derived Suppressor Cells)"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs healthy patients"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32514047"	"2020-06-08"	"https://www.nature.com/articles/s41418-020-0572-6"	"Fig 4C"	"Severe defined as \"with fever, cough and ARDS [PaO2 = (partial pressure of arterial oxygen)/FIO2 (Fraction of inspired oxygen) Ratio < 300 mmHg].\" Mild defined as \"mild conjunctivitis, axillary temperature of 37.5 Â°C, or with no clinical sign\""	"CL_0000889"	"(polymorphonuclear)"	""	"myeloid suppressor cell (polymorphonuclear)"	"1"	"1"	"32514047_4_388"
""	"myeloid suppressor cell (polymorphonuclear)"	""	"Rome, Italy"	"unknown"	"unknown"	"years"	"17"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"PMN-MDSC (Myeloid-Derived Suppressor Cells)"	""	"cell-type frequency"	"up"	"mild COVID-19 patients vs healthy patients"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32514047"	"2020-06-08"	"https://www.nature.com/articles/s41418-020-0572-6"	"Fig 4C"	"Severe defined as \"with fever, cough and ARDS [PaO2 = (partial pressure of arterial oxygen)/FIO2 (Fraction of inspired oxygen) Ratio < 300 mmHg].\" Mild defined as \"mild conjunctivitis, axillary temperature of 37.5 Â°C, or with no clinical sign\""	"CL_0000889"	"(polymorphonuclear)"	""	"myeloid suppressor cell (polymorphonuclear)"	"1"	"1"	"32514047_5_389"
""	"eosinophil; non-classical monocyte; neutrophil; classical monocyte; intermediate monocyte; b cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"207"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & ELISA"	"eosinophils; non-classical monocytes; neutrophils; classical monocytes; intermediate monocytes; B cells"	""	"cell-type frequency"	"up"	"moderate and severe COVID-19 patients vs healthy patients"	"time post-symptom onset"	"3 to 51"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 1B"	"Moderate was defined as: \"SARS-CoV-2 infection requiring hospitalization without supplementary oxygen (1); infection requiring non-invasive supplementary oxygen (<3 l/min to maintain SpO2 >92%) (2); and infection requiring non-invasive supplementa..."	"CL_0000771; CL_0000875; CL_0000775; CL_0000860; CL_0002393; CL_0000236"	""	""	"eosinophil; non-classical monocyte; neutrophil; classical monocyte; intermediate monocyte; b cell"	"6"	"6"	"32717743_1_390"
""	"conventional dendritic cell (type 1); conventional dendritic cell (type 2); plasmacytoid dendritic cell, human; CD8-positive, alpha-beta T cell; CD4-positive, alpha-beta T cell; mature nk t cell; natural killer cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"207"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & ELISA"	"type 1 dendritic cells; type 2 dendritic cells; plasmacytoid dendritic cells; CD8+ T cells; CD4+ T cells; natural killer T cells; natural killer cells"	""	"cell-type frequency"	"down"	"moderate and severe COVID-19 patients vs healthy patients"	"time post-symptom onset"	"3 to 51"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 1B"	"Moderate was defined as: \"SARS-CoV-2 infection requiring hospitalization without supplementary oxygen (1); infection requiring non-invasive supplementary oxygen (<3 l/min to maintain SpO2 >92%) (2); and infection requiring non-invasive supplementa..."	"CL_0000990; CL_0001058; CL:0000625; CL:0000624; CL_0000814; CL_0000623"	"(type 1); (type 2); "	""	"conventional dendritic cell (type 1); conventional dendritic cell (type 2); plasmacytoid dendritic cell, human; CD8-positive, alpha-beta T cell; CD4-positive, alpha-beta T cell; mature nk t cell; natural killer cell"	"7"	"7"	"32717743_2_391"
""	"eosinophil"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"157"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & ELISA"	"eosinophil"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time post-symptom onset"	"3 to 51"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 1C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as concentration of millions of cells epr millilitre of blood."	"CL:0000771"	""	""	"eosinophil"	"1"	"1"	"32717743_3_392"
""	"monocyte; neutrophil"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"157"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & ELISA"	"monocytes; neutrophils"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time post-symptom onset"	"3 to 51"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 1C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percent of live single cells."	"CL:0000576; CL_0000775"	""	""	"monocyte; neutrophil"	"2"	"2"	"32717743_4_393"
""	"t cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"157"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & ELISA"	"T cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time post-symptom onset"	"3 to 51"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 1C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percent of live single cells."	"CL_0000084"	""	""	"t cell"	"1"	"1"	"32717743_5_394"
""	"t cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"167"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & ELISA"	"T cells"	""	"cell-type frequency"	"down"	"moderate COVID-19 patients vs healthy patients"	"time post-symptom onset"	"3 to 51"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 1C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percent of live single cells and as concentration of millions of cells per millilitre of blood."	"CL_0000084"	""	""	"t cell"	"1"	"1"	"32717743_6_395"
""	"neutrophil; eosinophil"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"167"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & ELISA"	"neutrophils; eosinophils"	""	"cell-type frequency"	"up"	"moderate COVID-19 patients vs healthy patients"	"time post-symptom onset"	"3 to 51"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 1C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percent of live single cells and as concentration of millions of cells per millilitre of blood."	"CL_0000775; CL_0000771"	""	""	"neutrophil; eosinophil"	"2"	"2"	"32717743_7_396"
""	"monocyte"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"167"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & ELISA"	"monocytes"	""	"cell-type frequency"	"up"	"moderate COVID-19 patients vs healthy patients"	"time post-symptom onset"	"3 to 51"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 1C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percent of live single cells."	"CL:0000576"	""	""	"monocyte"	"1"	"1"	"32717743_8_397"
""	"monocyte; neutrophil; eosinophil"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"90"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & ELISA"	"monocytes; neutrophils; eosinophils"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs healthy patients"	"time post-symptom onset"	"3 to 51"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 1C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percent of live single cells and as concentration of millions of cells per millilitre of blood."	"CL:0000576; CL_0000775; CL_0000771"	""	""	"monocyte; neutrophil; eosinophil"	"3"	"3"	"32717743_9_398"
""	"t cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"90"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & ELISA"	"T cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs healthy patients"	"time post-symptom onset"	"3 to 51"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 1C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percent of live single cells and as concentration of millions of cells per millilitre of blood."	"CL_0000084"	""	""	"t cell"	"1"	"1"	"32717743_10_399"
""	"monocyte"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"157"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"monocytes"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time post-symptom onset"	"14"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 2D; 3rd Paragraph under \"Longitudinal immune...\" section"	"Moderate and severe defined in commments for Fig 1B of same publication. \"Correlation matrices...comparing cytokine concentrations in patients with moderate or severe disease during the late phase (>10 DfSO) of disease\""	"CL:0000576"	""	""	"monocyte"	"1"	"1"	"32717743_11_407"
""	"eosinophil"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"157"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"eosinophils"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time post-symptom onset"	"10 to 20"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Fig 2E; 4th Paragraph under \"Longitudinal immune...\" section"	"Moderate and severe defined in commments for Fig 1B of same publication. \"Correlation matrices...comparing cytokine concentrations in patients with moderate or severe disease during the late phase (>10 DfSO) of disease\""	"CL_0000771"	""	""	"eosinophil"	"1"	"1"	"32717743_12_408"
""	"non-classical monocyte; neutrophil (CD16++); neutrophil (CD16+)"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"155"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"non-conventional monocytes; CD16high neutrophils; CD16int neutrophils"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2A"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as concentration of millions of cells per mL of blood."	"CL_0000875; CL_0000775"	"; (CD16++); (CD16+)"	"; PR:000001483"	"non-classical monocyte; neutrophil (CD16++); neutrophil (CD16+)"	"3"	"3"	"32717743_13_419"
""	"cd8-positive, alpha-beta cytotoxic t cell; plasmacytoid dendritic cell, human"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"155"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8 cells; plasmacytoid dendritic cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2A"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as concentration of millions of cells per mL of blood."	"CL_0000794; CL_0001058"	""	""	"cd8-positive, alpha-beta cytotoxic t cell; plasmacytoid dendritic cell, human"	"2"	"2"	"32717743_14_420"
""	"intermediate monocyte; non-classical monocyte; neutrophil (CD16++); neutrophil (CD16+)"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"204"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"intermediate monocytes; non-conventional monocytes; CD16high neutrophils; CD16int neutrophils"	""	"cell-type frequency"	"up"	"moderate and severe COVID-19 patients vs healthy patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2A"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as concentration of millions of cells per mL of blood."	"CL_0002393; CL_0000875; CL_0000775"	"; (CD16++); (CD16+)"	"; PR:000001483"	"intermediate monocyte; non-classical monocyte; neutrophil (CD16++); neutrophil (CD16+)"	"4"	"4"	"32717743_15_421"
""	"cd8-positive, alpha-beta cytotoxic t cell; cd4-positive, alpha-beta memory t cell; plasmacytoid dendritic cell, human; conventional dendritic cell (type 1); conventional dendritic cell (type 2); mature nk t cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"204"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8 cells; CD4 cells; plasmacytoid dendritic cells; type 1 dendritic cells; type 2 dendritic cells; natural killer T cells"	""	"cell-type frequency"	"down"	"moderate and severe COVID-19 patients vs healthy patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2A"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as concentration of millions of cells per mL of blood."	"CL_0000794; CL_0000897; CL_0001058; CL_0000990; CL_0000814"	"; (type 1); (type 2)"	""	"cd8-positive, alpha-beta cytotoxic t cell; cd4-positive, alpha-beta memory t cell; plasmacytoid dendritic cell, human; conventional dendritic cell (type 1); conventional dendritic cell (type 2); mature nk t cell"	"6"	"6"	"32717743_16_422"
""	"natural killer cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"163"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"natural killer cells"	""	"cell-type frequency"	"down"	"moderate COVID-19 patients vs healthy patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2A"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as concentration of millions of cells per mL of blood."	"CL_0000623"	""	""	"natural killer cell"	"1"	"1"	"32717743_17_423"
""	"naive thymus-derived cd4-positive, alpha-beta t cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"155"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"naive CD4+ T cells"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2B"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL_0000895"	""	""	"naive thymus-derived cd4-positive, alpha-beta t cell"	"1"	"1"	"32717743_18_424"
""	"central memory cd4-positive, alpha-beta t cell; t follicular helper cell (CD4+)"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"155"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"Central memory CD4+ T cells; CD4+ Tfh cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2B"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL_0000904; CL_0002038"	"; (CD4+)"	"; PR:000001004"	"central memory cd4-positive, alpha-beta t cell; t follicular helper cell (CD4+)"	"2"	"2"	"32717743_19_425"
""	"central memory CD8-positive, alpha-beta T cell; effector memory cd8-positive, alpha-beta t cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"155"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ central memory T cells; effector memory CD8+ T cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2B"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL_0000907; CL_0000913"	""	""	"central memory CD8-positive, alpha-beta T cell; effector memory cd8-positive, alpha-beta t cell"	"2"	"2"	"32717743_20_426"
""	"effector cd4-positive, alpha-beta t cell (regulatory); t follicular helper cell (CD4+)"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"163"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ effector Treg cells; CD4+ Tfh cells"	""	"cell-type frequency"	"up"	"moderate COVID-19 patients vs healthy patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2B"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL_0001044; CL_0002038"	"(regulatory); (CD4+)"	"; PR:000001004"	"effector cd4-positive, alpha-beta t cell (regulatory); t follicular helper cell (CD4+)"	"3"	"2"	"32717743_21_427"
""	"naive thymus-derived CD8-positive, alpha-beta T cell; effector memory cd8-positive, alpha-beta t cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"163"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ naive T cells; effector memory CD8+ T cells"	""	"cell-type frequency"	"down"	"moderate COVID-19 patients vs healthy patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2B"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL_0000900; CL_0000913"	""	""	"naive thymus-derived CD8-positive, alpha-beta T cell; effector memory cd8-positive, alpha-beta t cell"	"2"	"2"	"32717743_22_428"
""	"effector cd4-positive, alpha-beta t cell (regulatory)"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"90"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ effector Treg cells"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs healthy patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2B"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL_0001044"	"(regulatory)"	""	"effector cd4-positive, alpha-beta t cell (regulatory)"	"1"	"1"	"32717743_23_429"
""	"central memory CD8-positive, alpha-beta T cell; effector memory cd8-positive, alpha-beta t cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"90"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ central memory T cells; effector memory CD8+ T cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs healthy patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2B"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL_0000907; CL_0000913"	""	""	"central memory CD8-positive, alpha-beta T cell; effector memory cd8-positive, alpha-beta t cell"	"2"	"2"	"32717743_24_430"
""	"activated cd4-positive, alpha-beta t cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"155"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ TCR cells"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL_0000896"	""	""	"activated cd4-positive, alpha-beta t cell"	"1"	"1"	"32717743_26_432"
""	"CD4-positive, alpha-beta T cell (IFNG+)"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"155"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"interferon-gamma+ CD4 T cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL:0000624"	"(IFNG+)"	"PR:000000017"	"CD4-positive, alpha-beta T cell (IFNG+)"	"1"	"1"	"32717743_27_433"
""	"activated cd4-positive, alpha-beta t cell; cd4-positive, alpha-beta memory t cell (IL17+)"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"204"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ TCR cells; CD4+ IL-17 cells"	""	"cell-type frequency"	"up"	"moderate and severe COVID-19 patients vs healthy patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL_0000896; CL_0000897"	"; (IL17+)"	"; PR:000001138"	"activated cd4-positive, alpha-beta t cell; cd4-positive, alpha-beta memory t cell (IL17+)"	"2"	"2"	"32717743_28_435"
""	"cd8-positive, alpha-beta cytotoxic t cell; activated cd8-positive, alpha-beta t cell"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"204"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ granzyme B cells; CD8+ TCR cells"	""	"cell-type frequency"	"up"	"moderate and severe COVID-19 patients vs healthy patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as percentage of parent population (CD4+ T cell or CD8+ T cell)."	"CL_0000794; CL_0000906"	""	""	"cd8-positive, alpha-beta cytotoxic t cell; activated cd8-positive, alpha-beta t cell"	"2"	"2"	"32717743_29_436"
""	"CD4-positive, alpha-beta T cell (IFNG+)"	""	"New Haven, Connecticut"	"20"	"100"	"years"	"90"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"interferon-gamma+ CD4 T cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs healthy patients"	"time of symptom onset"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32717743"	"2020-07-27"	"https://www.nature.com/articles/s41586-020-2588-y"	"Extended Data Fig 2C"	"Moderate and severe defined in commments for Fig 1B of same publication. Measured as concentration of millions of cells per mL of blood."	"CL:0000624"	"(IFNG+)"	"PR:000000017"	"CD4-positive, alpha-beta T cell (IFNG+)"	"1"	"1"	"32717743_30_439"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD45RA+,CCR7+); naive thymus-derived cd8-positive, alpha-beta t cell (CD45RA+,CCR7+)"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"naive CD4+ CD45RA+ CCR7+ T cells; naive CD8+ CD45RA+ CCR7+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"14"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2A ; 1st Paragraph under \"Kinetics...\" section"	"\"naÃ¯ve CD4+ and CD8+ (CD45RA+CCR7+) T cells was low on day 14 (24.2% and 6%, respectively) relative to that of five healthy donors (HD) (Median [IQR] (42.9% [35.3-49.8] and 29.5% [13.4-45], respectively) and remained so to the end of the follow-up\""	"CL_0000895; CL_0000900"	"(CD45RA+,CCR7+)"	"PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD45RA+,CCR7+); naive thymus-derived cd8-positive, alpha-beta t cell (CD45RA+,CCR7+)"	"2"	"2"	"32829467_1_453"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD45RA+,CCR7+); naive thymus-derived cd8-positive, alpha-beta t cell (CD45RA+,CCR7+)"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"naive CD4+ CD45RA+ CCR7+ T cells; naive CD8+ CD45RA+ CCR7+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"14 to 24"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2A ; 1st Paragraph under \"Kinetics...\" section"	"\"naÃ¯ve CD4+ and CD8+ (CD45RA+CCR7+) T cells was low on day 14...[relative to healthy donors] and remained so to the end of the follow-up\""	"CL_0000895; CL_0000900"	"(CD45RA+,CCR7+)"	"PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD45RA+,CCR7+); naive thymus-derived cd8-positive, alpha-beta t cell (CD45RA+,CCR7+)"	"2"	"2"	"32829467_2_454"
""	"effector memory CD4-positive, alpha-beta T cell (CCR7-,CD45RA-); effector memory cd8-positive, alpha-beta t cell (CCR7-,CD45RA-)"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ CCR7-CD45RA- effector memory T cells; CD8+ CCR7-CD45RA- effector memory T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"14"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2A; 1st Paragraph under \"Kinetics...\" section"	"\"CD4+ and CD8+ (CCR7-CD45RA-) effector memory T cells was high on day 14 (51.7 and 28.6%, respectively) relative to that of HD (28.2% [21.8-29.4] and 23.5% for CD4+ and CD8+ T cells, respectively) and peaked at day 24 (67.4% and 46.2%, respectively)\""	"CL_0000905; CL_0000913"	"(CCR7-,CD45RA-)"	"PR:000001203,PR:000001015"	"effector memory CD4-positive, alpha-beta T cell (CCR7-,CD45RA-); effector memory cd8-positive, alpha-beta t cell (CCR7-,CD45RA-)"	"2"	"2"	"32829467_3_455"
""	"effector memory CD4-positive, alpha-beta T cell (CCR7-,CD45RA-); effector memory cd8-positive, alpha-beta t cell (CCR7-,CD45RA-)"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ CCR7-CD45RA- effector memory T cells; CD8+ CCR7-CD45RA- effector memory T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"24"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2A; 1st Paragraph under \"Kinetics...\" section"	"\"CD4+ and CD8+ (CCR7-CD45RA-) effector memory T cells...peaked at day 24 (67.4% and 46.2%, respectively) [relative to healthy donors]\""	"CL_0000905; CL_0000913"	"(CCR7-,CD45RA-)"	"PR:000001203,PR:000001015"	"effector memory CD4-positive, alpha-beta T cell (CCR7-,CD45RA-); effector memory cd8-positive, alpha-beta t cell (CCR7-,CD45RA-)"	"2"	"2"	"32829467_4_456"
""	"activated cd8-positive, alpha-beta t cell"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"activated CD8+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"20"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2b; 2nd Paragraph under \"Kinetics...\" section"	"\"Activated CD8+ T cells peaked on day 20 (27.5% and 0.6% [0.4-0.8], for the COVID-19 patient and HD [Healthy Donors], respectively)\""	"CL_0000906"	""	""	"activated cd8-positive, alpha-beta t cell"	"1"	"1"	"32829467_5_457"
""	"exhausted t cell (CD4+,PD1+,CD57+); exhausted t cell (CD8+,PD1+,CD57+)"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"exhausted PD1+ CD57+ CD4+ T cells; exhausted PD1+ CD57+ CD8+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"14"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2c; 2nd Paragraph under \"Kinetics...\" section"	"\"frequency of exhausted and senescent CD4+ and CD8+ T cells (PD-1+CD57+) increased in the COVID-19 patient from day 14 (7.43 and 56.1%, respectively)\""	"CL_0011025"	"(CD4+,PD1+,CD57+); (CD8+,PD1+,CD57+)"	"PR:000001004,PR:000001919,PR:000001440; PR:000001084,PR:000001919,PR:000001440"	"exhausted t cell (CD4+,PD1+,CD57+); exhausted t cell (CD8+,PD1+,CD57+)"	"2"	"2"	"32829467_6_458"
""	"exhausted t cell (CD4+,PD1+,CD57+)"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"exhausted PD1+ CD57+ CD4+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"24"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2c; 2nd Paragraph under \"Kinetics...\" section"	"\"frequency of exhausted and senescent CD4+ and CD8+ T cells (PD-1+CD57+) increased in the COVID-19 patient... peaking on day 24 for CD4+ T cells (25.3%) and...were dramatically higher than in the HD (1.6% [0.6-6.3] and 18.4%, [14-36], respectively)\""	"CL_0011025"	"(CD4+,PD1+,CD57+)"	"PR:000001004,PR:000001919,PR:000001440"	"exhausted t cell (CD4+,PD1+,CD57+)"	"1"	"1"	"32829467_7_459"
""	"exhausted t cell (CD8+,PD1+,CD57+)"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"exhausted PD1+ CD57+ CD8+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"22"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2c; 2nd Paragraph under \"Kinetics...\" section"	"\"frequency of exhausted and senescent CD4+ and CD8+ T cells (PD-1+CD57+) increased in the COVID-19 patient... peaking on... day 22 for CD8+ T cells (68.3%) and were dramatically higher than in the HD (1.6% [0.6-6.3] and 18.4%, [14-36], respectively)\""	"CL_0011025"	"(CD8+,PD1+,CD57+)"	"PR:000001084,PR:000001919,PR:000001440"	"exhausted t cell (CD8+,PD1+,CD57+)"	"1"	"1"	"32829467_8_460"
""	"gamma-delta t cell"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"gamma delta CD3+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"14"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2d; 3rd Paragraph under \"Kinetics...\" section"	"\"frequency of gamma-delta T cells was markedly high on day 14 (92%), relative to that of the HD [Healthy Donors] (6.2% [4-8.9])\""	"CL_0000798"	""	""	"gamma-delta t cell"	"1"	"1"	"32829467_9_461"
""	"gamma-delta t cell"	""	"males in Paris, France"	"80"	"80"	"years"	"1"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"gamma delta CD3+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients: day 15 vs day 14"	"time post-symptom onset"	"15"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2d; 3rd Paragraph under \"Kinetics...\" section"	"\"frequency of gamma-delta T cells was markedly high on day 14 (92%), relative to that of the HD (6.2% [4-8.9]), lower on day 15 (38.8%)\""	"CL_0000798"	""	""	"gamma-delta t cell"	"1"	"1"	"32829467_10_462"
""	"gamma-delta t cell"	""	"males in Paris, France"	"80"	"80"	"years"	"1"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"gamma delta CD3+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients: day 24 vs day 15"	"time post-symptom onset"	"24"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2d; 3rd Paragraph under \"Kinetics...\" section"	"\"frequency of gamma-delta T cells was markedly high on day 14 (92%), relative to that of the HD (6.2% [4-8.9]), lower on day 15 (38.8%), and increased continuously from day 20 until day 24 (83.4%).\""	"CL_0000798"	""	""	"gamma-delta t cell"	"1"	"1"	"32829467_11_463"
""	"memory b cell (activated and CD19+,CD27+,CD21-); plasmablast (CD19+,CD38+,CD27+); b cell (exchausted and CD19+,CD27-,CD21-)"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"activated memory CD19+ CD27+ CD21- B cells; CD19+ CD38+ CD27+ plasmablasts/antibody-secreting cells (ASC); exhausted CD19+ CD27- CD21low/neg B cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"20"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2e; 4th Paragraph under \"Kinetics...\" section"	"\"frequency of activated memory (CD19+CD27+CD21-) B cells and plasmablasts/antibody-secreting cells (ASC) (CD19+CD38+CD27+) peaked on day 20 (24.1 and 34.3%, respectively) and was markedly higher than that in HD (2.6% [2.1-3.8] and 0.32% [0.25-0.75..."	"CL_0000787; CL_0000980; CL_0000236"	"(activated and CD19+,CD27+,CD21-); (CD19+,CD38+,CD27+); (exchausted and CD19+,CD27-,CD21-)"	"PR:000001002,PR:000001963,PR:000001338; PR:000001002,PR:000001408,PR:000001963"	"memory b cell (activated and CD19+,CD27+,CD21-); plasmablast (CD19+,CD38+,CD27+); b cell (exchausted and CD19+,CD27-,CD21-)"	"3"	"3"	"32829467_12_466"
""	"natural killer cell"	""	"males in Paris, France"	"80"	"80"	"years"	"1"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"differentiated Ki67+ CD56dim CD57+ NK cells"	""	"cell-type frequency"	"up"	"COVID-19 patients: day 16 vs day 14"	"time post-symptom onset"	"16"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2g; 5th Paragraph under \"Kinetics...\" section"	"\"high frequency of differentiated CD56dim CD57+ NK cells was cycling (Ki67+) on day 14 (15.6%), peaked on day 16 (60.3%)\""	"CL_0000623"	""	""	"natural killer cell"	"1"	"1"	"32829467_13_467"
""	"natural killer cell"	""	"males in Paris, France"	"80"	"80"	"years"	"1"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"differentiated Ki67+ CD56dim CD57+ NK cells"	""	"cell-type frequency"	"down"	"COVID-19 patients: day 24 vs day 16"	"time post-symptom onset"	"24"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2g; 5th Paragraph under \"Kinetics...\" section"	"\"frequency of differentiated CD56dim CD57+ NK cells ...peaked on day 16 (60.3%), and then continuously decreased to day 24 (7.37%)\""	"CL_0000623"	""	""	"natural killer cell"	"1"	"1"	"32829467_14_468"
""	"natural killer cell"	""	"males in Paris, France"	"80"	"80"	"years"	"1"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"NKG2A+ NK cells"	""	"cell-type frequency"	"up"	"COVID-19 patients: day 16 vs day 14"	"time post-symptom onset"	"16"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2h; 5th Paragraph under \"Kinetics...\" section"	"\"frequency of NK cells expressing the inhibitory marker NKG2A markedly increased from day 14 (8%) to day 16 (44.6%)\""	"CL_0000623"	""	""	"natural killer cell"	"1"	"1"	"32829467_15_469"
""	"natural killer cell"	""	"males in Paris, France"	"80"	"80"	"years"	"1"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"NKG2A+ NK cells"	""	"cell-type frequency"	"up"	"COVID-19 patients: day 20 vs day 16"	"time post-symptom onset"	"20"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2h; 5th Paragraph under \"Kinetics...\" section"	"\"frequency of NK cells expressing the inhibitory marker NKG2A ....day 16 (44.6%), peaked on day 20 (50.6%)\""	"CL_0000623"	""	""	"natural killer cell"	"1"	"1"	"32829467_16_470"
""	"natural killer cell"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"NKG2A+ NK cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"20"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2h; 5th Paragraph under \"Kinetics...\" section"	"\"frequency of NK cells expressing the inhibitory marker NKG2A ....peaked on day 20 (50.6%), and remained much higher than in HD (33% [27-41])\""	"CL_0000623"	""	""	"natural killer cell"	"1"	"1"	"32829467_17_471"
""	"cd14-positive, cd16-negative classical monocyte"	""	"males in Paris, France"	"80"	"80"	"years"	"1"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"classical CD14+ CD16- monocytes"	""	"cell-type frequency"	"down"	"COVID-19 patients: day 20 vs day 16"	"time post-symptom onset"	"20"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2i; 6th Paragraph under \"Kinetics...\" section"	"\"frequency of classical CD14+CD16- monocytes steadily decreased from day 16, through days 20.\"..73.2% for day 16, 29.8% for day 20"	"CL_0002057"	""	""	"cd14-positive, cd16-negative classical monocyte"	"1"	"1"	"32829467_18_472"
""	"cd14-positive, cd16-negative classical monocyte"	""	"males in Paris, France"	"80"	"80"	"years"	"1"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"classical CD14+ CD16- monocytes"	""	"cell-type frequency"	"down"	"COVID-19 patients: day 22 vs day 20"	"time post-symptom onset"	"22"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2i; 6th Paragraph under \"Kinetics...\" section"	"\"frequency of classical CD14+CD16- monocytes steadily decreased from day 16, through days 20 and 22, to day 24\" Day 20: 29.8%. Day 22: 12.2%"	"CL_0002057"	""	""	"cd14-positive, cd16-negative classical monocyte"	"1"	"1"	"32829467_19_473"
""	"cd14-positive, cd16-negative classical monocyte"	""	"males in Paris, France"	"80"	"80"	"years"	"1"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"classical CD14+ CD16- monocytes"	""	"cell-type frequency"	"down"	"COVID-19 patients: day 24 vs day 22"	"time post-symptom onset"	"24"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2i; 6th Paragraph under \"Kinetics...\" section"	"\"frequency of classical CD14+CD16- monocytes steadily decreased from day 16, through days 20 and 22, to day 24\". Day 22: 12.2%. Day 24: 5.7%"	"CL_0002057"	""	""	"cd14-positive, cd16-negative classical monocyte"	"1"	"1"	"32829467_20_474"
""	"cd14-positive, cd16-positive monocyte; non-classical monocyte (CD14-,CD16+)"	""	"males in Paris, France"	"21.5"	"80"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"intermediate CD16+ CD14+ monocytes; non-classical CD14- CD16+ monocytes"	""	"cell-type frequency"	"down"	"COVID-19 patients vs healthy controls"	"time post-symptom onset"	"15"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"chronic"	"32829467"	"2020-08-22"	"https://link.springer.com/article/10.1007/s10875-020-00839-x"	"Fig 2i; 6th Paragraph under \"Kinetics...\" section"	"\"frequency of intermediate CD16+CD14+ and non-classical CD14-CD16+ monocytes remained extremely low throughout the follow-up, with a nadir at day 15 (0.4 and 0.02% versus 4.4% [2.9-5.8] and 4% [3.3-5.1] for HD, respectively)\""	"CL_0002397; CL_0000875"	"; (CD14-,CD16+)"	"; PR:000001889,PR:000001483"	"cd14-positive, cd16-positive monocyte; non-classical monocyte (CD14-,CD16+)"	"2"	"2"	"32829467_21_475"
""	"blood cell (WBCs); monocyte; neutrophil"	""	"Caucasians in Sassari, Italy"	"59"	"90"	"years"	"60"	"Whole Blood"	"UBERON:0000178"	"clinical laboratory test"	"whole blood cells (WBCs); monocytes; neutrophils"	""	"cell-type frequency"	"down"	"COVID-19 pneumonia patients vs non-COVID-19 pneumonia patients"	"time since hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32794454"	"2020-07-31"	"https://jidc.org/index.php/journal/article/view/32794454/2297"	"Table 2."	"\"cases with COVID-19 and non-COVID-19 pneumonia were matched for age and gender\" \"COVID-19 patients were  more  often  smokers  (66%  vs.  20%,  p  =  0.0003)  and  more  likely  to  die  during  the  follow-up  (30%  vs.  3%, p = 0.006).\""	"CL_0000081; CL:0000576; CL_0000775"	"(WBCs); "	""	"blood cell (WBCs); monocyte; neutrophil"	"3"	"3"	"32794454_1_513"
""	"platelet"	""	"Caucasians in Sassari, Italy"	"59"	"90"	"years"	"60"	"Whole Blood"	"UBERON:0000178"	"clinical laboratory test"	"platelets"	""	"cell-type frequency"	"up"	"COVID-19 pneumonia patients vs non-COVID-19 pneumonia patients"	"time since hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32794454"	"2020-07-31"	"https://jidc.org/index.php/journal/article/view/32794454/2297"	"Table 2."	"-also had higher MPV values (Mean Platelet Volume). Lymphocyte-to-monocyte ratio (LMR) was higher in COVID-19 pneumonia patients vs non-COVID-19 pneumonia patients"	"CL_0000233"	""	""	"platelet"	"2"	"1"	"32794454_2_514"
""	"neutrophil"	""	"Caucasian COVID-19 Patients in Sassari, Italy"	"59"	"90"	"years"	"30"	"Whole Blood"	"UBERON:0000178"	"clinical laboratory test"	"neutrophils"	""	"cell-type frequency"	"up"	"COVID-19 pneumonia non-survivors vs COVID-19 pneumonia survivors"	"time of  hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32794454"	"2020-07-31"	"https://jidc.org/index.php/journal/article/view/32794454/2297"	"Table 3."	"-Neutrophil-to-Lymphocyte ratio (NLR) & derived NLR were significantly higher in non-survivors than in survivors"	"CL_0000775"	""	""	"neutrophil"	"2"	"1"	"32794454_3_517"
""	"platelet"	""	"Caucasian COVID-19 Patients in Sassari, Italy"	"59"	"90"	"years"	"30"	"Whole Blood"	"UBERON:0000178"	"clinical laboratory test"	"platelets"	""	"cell-type frequency"	"down"	"COVID-19 pneumonia non-survivors vs COVID-19 pneumonia survivors"	"time of  hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32794454"	"2020-07-31"	"https://jidc.org/index.php/journal/article/view/32794454/2297"	"Table 3."	"\"cases with COVID-19 and non-COVID-19 pneumonia were matched for age and gender\" \"COVID-19 patients were  more  often  smokers  (66%  vs.  20%,  p  =  0.0003)  and  more  likely  to  die  during  the  follow-up  (30%  vs.  3%, p = 0.006).\""	"CL_0000233"	""	""	"platelet"	"1"	"1"	"32794454_4_518"
""	"monocyte; cd14-positive, cd16-negative classical monocyte"	""	"Paris, France"	"52"	"77"	"years"	"45"	"peripheral venous blood"	"UBERON:0000178"	"flow cytometry"	"CD45 monocytes; CD45 classical (CD14Hi CD16-) monocytes"	""	"cell-type frequency"	"down"	"type 2 diabetes COVID-19 patients vs non-diabetes COVID-19 patients"	"COVID duration at inclusion"	"5 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Fig 1A-B; Appendix Fig S1B-C"	""	"CL_0000576; CL_0002057"	""	""	"monocyte; cd14-positive, cd16-negative classical monocyte"	"2"	"2"	"32816392_1_566"
""	"monocyte (large-size, as determined by forward scatter)"	""	"Paris, France"	"52"	"77"	"years"	"45"	"peripheral venous blood"	"UBERON:0000178"	"flow cytometry"	"large (FSC-Hi) monocytes"	""	"cell-type frequency"	"up"	"type 2 diabetes COVID-19 patients vs non-diabetes COVID-19 patients"	"COVID duration at inclusion"	"5 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Fig 2B"	""	"CL_0000576"	"(large-size, as determined by forward scatter)"	""	"monocyte (large-size, as determined by forward scatter)"	"1"	"1"	"32816392_2_569"
""	"cd14-positive, cd16-positive monocyte"	""	"Paris, France"	"52"	"77"	"years"	"45"	"peripheral venous blood"	"UBERON:0000178"	"flow cytometry"	"intermediate (CD14Hi CD16+) monocytes"	""	"cell-type frequency"	"up"	"All COVID-19 patients: conventional (FSC-Lo) monocytes vs large (FSC-Hi) monocytes"	"COVID duration at inclusion"	"5 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Fig 2D"	""	"CL_0002397"	""	""	"cd14-positive, cd16-positive monocyte"	"1"	"1"	"32816392_3_571"
""	"monocyte"	""	"Type 2 Diabetes COVID-19 Patients in Paris, France"	"54"	"77"	"years"	"30"	"peripheral venous blood"	"UBERON:0000178"	"flow cytometry"	"CD45 monocytes"	""	"cell-type frequency"	"down"	"type 2 diabetes ICU COVID-19 patients vs type 2 diabetes general ward COVID-19 patients"	"COVID duration at inclusion"	"7 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Fig 4B"	""	"CL_0000576"	""	""	"monocyte"	"1"	"1"	"32816392_4_582"
""	"monocyte (CD8+); cd14-positive, cd16-negative classical monocyte"	""	"Type 2 Diabetes COVID-19 Patients in Paris, France"	"54"	"77"	"years"	"30"	"peripheral venous blood"	"UBERON:0000178"	"phenotypic analysis"	"CD45 CD8+ monocytes; CD45 classical (CD14Hi CD16-) monocytes"	""	"cell-type frequency"	"down"	"type 2 diabetes ICU COVID-19 patients vs type 2 diabetes general ward COVID-19 patients"	"COVID duration at inclusion"	"7 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Fig 4C"	""	"CL_0000576; CL_0002057"	"(CD8+); "	"PR:000001084; "	"monocyte (CD8+); cd14-positive, cd16-negative classical monocyte"	"2"	"2"	"32816392_5_583"
""	"CD14-positive monocyte; cd8-positive, alpha-beta t cell"	""	"Type 2 Diabetes COVID-19 Patients in Paris, France"	"54"	"77"	"years"	"30"	"peripheral venous blood"	"UBERON:0000178"	"t-SNE mapping"	"CD14+ monocytes; CD8+ lymphocytes"	""	"cell-type frequency"	"down"	"type 2 diabetes ICU COVID-19 patients vs type 2 diabetes general ward COVID-19 patients"	"COVID duration at inclusion"	"7 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Fig 4D"	""	"CL:0001054; CL_0000625"	""	""	"CD14-positive monocyte; cd8-positive, alpha-beta t cell"	"2"	"2"	"32816392_6_584"
""	"monocyte"	""	"Paris, France"	"52"	"77"	"years"	"45"	"peripheral venous blood"	"UBERON:0000178"	"clinical laboratory test"	"monocytes"	""	"cell-type frequency"	"down"	"type 2 diabetes COVID-19 patients vs non-diabetes COVID-19 patients"	"time since admission to hospital"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Appendix Table S1"	""	"CL:0000576"	""	""	"monocyte"	"1"	"1"	"32816392_7_585"
""	"CD14-positive monocyte; cd14-positive, cd16-negative classical monocyte"	""	"Paris, France"	"52"	"77"	"years"	"45"	"peripheral venous blood"	"UBERON:0000178"	"flow cytometry"	"CD14+ monocytes; CD14Hi CD16- classical monocytes"	""	"cell-type frequency"	"down"	"type 2 diabetes COVID-19 patients vs non-diabetes COVID-19 patients"	"COVID duration at inclusion"	"5 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Appendix Table S2"	""	"CL:0001054; CL_0002057"	""	""	"CD14-positive monocyte; cd14-positive, cd16-negative classical monocyte"	"2"	"2"	"32816392_8_586"
""	"lymphocyte; b cell; cd8-positive, alpha-beta t cell; cd4-positive, alpha-beta t cell; double-positive, alpha-beta thymocyte (CD4+,CD8+); t cell (CD4-,CD8-)"	""	"Paris, France"	"52"	"77"	"years"	"45"	"peripheral venous blood"	"UBERON:0000178"	"flow cytometry"	"CD45 lymphocytes; CD45 B cells; CD45 CD8+ lymphocytes; CD45 CD4+ lymphocytes; CD45 CD4+ CD8+ lymphocytes; CD45 CD4- CD8- lymphocytes"	""	"cell-type frequency"	"down"	"non-diabetes COVID-19 patients vs type 2 diabetes non-COVID-19 patients"	"COVID duration at inclusion"	"5 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Appendix Fig S1B-C"	""	"CL_0000542; CL_0000236; CL_0000625; CL_0000624; CL_0000809; CL_0000084"	"; (CD4+,CD8+); (CD4-,CD8-)"	"; PR:000001004,PR:000001084"	"lymphocyte; b cell; cd8-positive, alpha-beta t cell; cd4-positive, alpha-beta t cell; double-positive, alpha-beta thymocyte (CD4+,CD8+); t cell (CD4-,CD8-)"	"6"	"6"	"32816392_9_587"
""	"granulocyte"	""	"Paris, France"	"52"	"77"	"years"	"45"	"peripheral venous blood"	"UBERON:0000178"	"flow cytometry"	"CD45 granulocytes"	""	"cell-type frequency"	"up"	"non-diabetes COVID-19 patients vs type 2 diabetes non-COVID-19 patients"	"COVID duration at inclusion"	"5 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Appendix Fig S1B"	""	"CL_0000094"	""	""	"granulocyte"	"1"	"1"	"32816392_10_588"
""	"lymphocyte; monocyte; b cell; cd8-positive, alpha-beta t cell; cd4-positive, alpha-beta t cell; double-positive, alpha-beta thymocyte (CD4+,CD8+); t cell (CD4-,CD8-)"	""	"Type 2 Diabetes Patients in Paris, France"	"54"	"77"	"years"	"60"	"peripheral venous blood"	"UBERON:0000178"	"flow cytometry"	"CD45 lymphocytes; CD45 monocytes; CD45 B cells; CD45 CD8+ lymphocytes; CD45 CD4+ lymphocytes; CD45 CD4+ CD8+ lymphocytes; CD45 CD4- CD8- lymphocytes"	""	"cell-type frequency"	"down"	"type 2 diabetes COVID-19 patients vs type 2 diabetes non-COVID-19 patients"	"COVID duration at inclusion"	"5 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Appendix Fig S1B-C"	""	"CL_0000542; CL_0000576; CL_0000236; CL_0000625; CL_0000624; CL_0000809; CL_0000084"	"; (CD4+,CD8+); (CD4-,CD8-)"	"; PR:000001004,PR:000001084"	"lymphocyte; monocyte; b cell; cd8-positive, alpha-beta t cell; cd4-positive, alpha-beta t cell; double-positive, alpha-beta thymocyte (CD4+,CD8+); t cell (CD4-,CD8-)"	"7"	"7"	"32816392_11_589"
""	"granulocyte"	""	"Type 2 Diabetes Patients in Paris, France"	"54"	"77"	"years"	"60"	"peripheral venous blood"	"UBERON:0000178"	"flow cytometry"	"CD45 granulocytes"	""	"cell-type frequency"	"up"	"type 2 diabetes COVID-19 patients vs type 2 diabetes non-COVID-19 patients"	"COVID duration at inclusion"	"5 to 17"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32816392"	"2020-09-11"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461002/"	"Appendix Fig S1B"	""	"CL_0000094"	""	""	"granulocyte"	"1"	"1"	"32816392_12_590"
""	"lymphocyte; basophil; eosinophil"	""	"Tartu, Estonia"	"23"	"92"	"years"	"134"	"plasma"	"UBERON:0001969"	"Legendplex assay; OLINK assay"	"lymphocytes; basophil; eosinophil"	""	"cell-type frequency"	"down"	"ICU COVID-19 patients vs healthy patients"	"early stage of disease"	"0 to 3"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33239683"	"2020-11-25"	"https://www.nature.com/articles/s41598-020-77525-w"	"Suppl Fig 1: D1, H1, I1"	"-measured in % of cell"	"CL_0000542; CL_0000767; CL:0000771"	""	""	"lymphocyte; basophil; eosinophil"	"3"	"3"	"33239683_1_632"
""	"neutrophil"	""	"Tartu, Estonia"	"23"	"92"	"years"	"134"	"plasma"	"UBERON:0001969"	"Olink multiplex inflammation panel"	"neutrophil"	""	"cell-type frequency"	"up"	"ICU COVID-19 patients vs healthy patients"	"early stage of disease"	"0 to 3"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33239683"	"2020-11-25"	"https://www.nature.com/articles/s41598-020-77525-w"	"Suppl Fig 1: E1, F1"	"-measured in % of cell, NLR stands for neutrophil:lymphocyte ratio"	"CL:0000775"	""	""	"neutrophil"	"2"	"1"	"33239683_2_633"
""	"neutrophil; blood cell"	""	"Tartu, Estonia"	"23"	"92"	"years"	"134"	"plasma"	"UBERON:0001969"	"Olink multiplex inflammation panel"	"neutrophil; whole blood cell (WBC)"	""	"cell-type frequency"	"up"	"ICU COVID-19 patients vs healthy patients"	"time since onset of symptoms"	"0 to 54"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33239683"	"2020-11-25"	"https://www.nature.com/articles/s41598-020-77525-w"	"Suppl Fig 1: E2, F2, G2"	"-measured in % of cell, NLR stands for neutrophil:lymphocyte ratio"	"CL:0000775; CL_0000081"	""	""	"neutrophil; blood cell"	"3"	"2"	"33239683_3_634"
""	"basophil; lymphocyte"	""	"Tartu, Estonia"	"23"	"92"	"years"	"134"	"plasma"	"UBERON:0001969"	"Olink multiplex inflammation panel"	"basophil; lymphocyte"	""	"cell-type frequency"	"down"	"ICU COVID-19 patients vs healthy patients"	"time since onset of symptoms"	"0 to 54"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33239683"	"2020-11-25"	"https://www.nature.com/articles/s41598-020-77525-w"	"Suppl Fig 1: D2, H2"	"-measured in % of cell"	"CL_0000767; CL:0000542"	""	""	"basophil; lymphocyte"	"2"	"2"	"33239683_4_635"
""	"neutrophil"	""	"Tartu, Estonia"	"21"	"92"	"years"	"144"	"plasma"	"UBERON:0001969"	"Olink multiplex inflammation panel"	"neutrophil"	""	"cell-type frequency"	"up"	"non-ICU COVID-19 patients vs healthy patients"	"time since onset of symptoms"	"0 to 44"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33239683"	"2020-11-25"	"https://www.nature.com/articles/s41598-020-77525-w"	"Suppl Fig 1: E2"	"-measured in % of cell"	"CL:0000775"	""	""	"neutrophil"	"1"	"1"	"33239683_5_636"
""	"blood cell"	""	"COVID-19 Patients in Tartu, Estonia"	"21"	"92"	"years"	"40"	"plasma"	"UBERON:0001969"	"Olink multiplex inflammation panel"	"whole blood cell (WBC)"	""	"cell-type frequency"	"up"	"ICU COVID-19 patients vs non-ICU COVID-19 patients"	"time since onset of symptoms"	"0 to 54"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33239683"	"2020-11-25"	"https://www.nature.com/articles/s41598-020-77525-w"	"Suppl Fig 1: G2"	"-measured in % of cell"	"CL_0000081"	""	""	"blood cell"	"1"	"1"	"33239683_6_637"
""	"basophil; eosinophil"	""	"Tartu, Estonia"	"21"	"92"	"years"	"144"	"plasma"	"UBERON:0001969"	"Olink multiplex inflammation panel"	"basophil; eosinophil"	""	"cell-type frequency"	"down"	"non-ICU COVID-19 patients vs healthy patients"	"early stage of disease"	"0 to 3"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33239683"	"2020-11-25"	"https://www.nature.com/articles/s41598-020-77525-w"	"Suppl Fig 1: H1, I1"	"-measured in % of cell"	"CL_0000767; CL:0000771"	""	""	"basophil; eosinophil"	"2"	"2"	"33239683_7_638"
""	"basophil"	""	"Tartu, Estonia"	"21"	"92"	"years"	"144"	"plasma"	"UBERON:0001969"	"Olink multiplex inflammation panel"	"basophil"	""	"cell-type frequency"	"down"	"non-ICU COVID-19 patients vs healthy patients"	"time since onset of symptoms"	"0 to 44"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33239683"	"2020-11-25"	"https://www.nature.com/articles/s41598-020-77525-w"	"Suppl Fig 1: H2"	"-measured in % of cell"	"CL_0000767"	""	""	"basophil"	"1"	"1"	"33239683_8_639"
""	"neutrophil; leukocyte"	""	"Wuxi, China"	"25"	"61"	"years"	"55"	"whole blood"	"UBERON:0000178"	"clinical laboratory test"	"neutrophil; white blood cell"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs mild and moderate COVID-19 patients"	"time of admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33013872"	"2020-08-18"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461898/"	"Table 2; 3rd paragraph under Results section \"Characteristics of...\""	"-ratio of neutrophils to lymphocytes \"Mild, moderate, and severe cases were defined by...: (1) epidemiological history, (2) fever or other respiratory symptoms, (3) frequency of typical CT image abnormalities of viral pneumonia, and (4) positive R..."	"CL:0000775; CL:0000738"	""	""	"neutrophil; leukocyte"	"2"	"2"	"33013872_1_736"
""	"monocyte; lymphocyte"	""	"Wuxi, China"	"25"	"61"	"years"	"55"	"whole blood"	"UBERON:0000178"	"clinical laboratory test"	"monocytes; lymphocytes"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs mild and moderate COVID-19 patients"	"time of admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33013872"	"2020-08-18"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461898/"	"Table 2; 3rd paragraph under Results section \"Characteristics of...\""	"-ratio of neutrophils to lymphocytes \"Mild, moderate, and severe cases were defined by...: (1) epidemiological history, (2) fever or other respiratory symptoms, (3) frequency of typical CT image abnormalities of viral pneumonia, and (4) positive R..."	"CL:0000576; CL_0000542"	""	""	"monocyte; lymphocyte"	"2"	"2"	"33013872_2_737"
""	"neutrophil"	""	"Wuxi, China"	"25"	"61"	"years"	"6"	"peripheral blood"	"UBERON:0000178"	"MCPcounter; dynamic changes"	"neutrophils"	""	"cell-type frequency"	"up"	"7-9 days vs 0 days"	"time since symptom onset"	"7 to 9"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33013872"	"2020-08-18"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461898/"	"2nd paragraph in Results section \"Principal Component Analysis...\"; Fig 2c"	"\"Mild, moderate, and severe cases were defined by...: (1) epidemiological history, (2) fever or other respiratory symptoms, (3) frequency of typical CT image abnormalities of viral pneumonia, and (4) positive RT-PCR result for SARS-CoV-2 RNA...mil..."	"CL_0000775"	""	""	"neutrophil"	"1"	"1"	"33013872_3_741"
""	"neutrophil"	""	"Wuxi, China"	"25"	"61"	"years"	"53"	"peripheral blood"	"UBERON:0000178"	"MCPcounter; dynamic changes"	"neutrophils"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs mild and moderate COVID-19 patients"	"time since symptom onset"	"7 to 9"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33013872"	"2020-08-18"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461898/"	"2nd paragraph in Results section \"Principal Component Analysis...\"; Fig 2c"	"\"Mild, moderate, and severe cases were defined by...: (1) epidemiological history, (2) fever or other respiratory symptoms, (3) frequency of typical CT image abnormalities of viral pneumonia, and (4) positive RT-PCR result for SARS-CoV-2 RNA...mil..."	"CL_0000775"	""	""	"neutrophil"	"1"	"1"	"33013872_4_742"
""	"monocyte; lymphocyte"	""	"Wuxi, China"	"25"	"61"	"years"	"55"	"peripheral blood"	"UBERON:0000178"	"MCPcounter; dynamic changes"	"monocytes; lymphocytes"	""	"cell-type frequency"	"down"	"19-27 days vs 0 days"	"time since symptom onset"	"19 to 27"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33013872"	"2020-08-18"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461898/"	"2nd paragraph in Results section \"Principal Component Analysis...\"; Fig 2c"	"\"Mild, moderate, and severe cases were defined by...: (1) epidemiological history, (2) fever or other respiratory symptoms, (3) frequency of typical CT image abnormalities of viral pneumonia, and (4) positive RT-PCR result for SARS-CoV-2 RNA...mil..."	"CL:0000576; CL_0000542"	""	""	"monocyte; lymphocyte"	"2"	"2"	"33013872_5_743"
""	"monocyte; lymphocyte"	""	"Wuxi, China"	"25"	"61"	"years"	"55"	"peripheral blood"	"UBERON:0000178"	"MCPcounter; dynamic changes"	"monocytes; lymphocytes"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs mild and moderate COVID-19 patients"	"time since symptom onset"	"19 to 27"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33013872"	"2020-08-18"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461898/"	"2nd paragraph in Results section \"Principal Component Analysis...\"; Fig 2c"	"\"Mild, moderate, and severe cases were defined by...: (1) epidemiological history, (2) fever or other respiratory symptoms, (3) frequency of typical CT image abnormalities of viral pneumonia, and (4) positive RT-PCR result for SARS-CoV-2 RNA...mil..."	"CL:0000576; CL_0000542"	""	""	"monocyte; lymphocyte"	"2"	"2"	"33013872_6_744"
""	"cytotoxic t cell; monocyte; myeloid dendritic cell; neutrophil"	""	"COVID-19 patients and healthy controls (New York, USA)"	"25"	"61"	"years"	"4"	"lung"	"UBERON:0002048"	"RNA-seq; MCPcounter score"	"cytotoxic lymphocytes; monocytic lineage; myeloid dendritic cells; neutrophils"	""	"cell-type frequency"	"up"	"biopsies of COVID-19 patients (N=2) vs controls (N=2)"	"death"	"few"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33013872"	"2020-08-18"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461898/"	"Fig 4C"	"\"Mild, moderate, and severe cases were defined by...: (1) epidemiological history, (2) fever or other respiratory symptoms, (3) frequency of typical CT image abnormalities of viral pneumonia, and (4) positive RT-PCR result for SARS-CoV-2 RNA...mil..."	"CL_0000910; CL_0000576; CL_0000782; CL_0000775"	""	""	"cytotoxic t cell; monocyte; myeloid dendritic cell; neutrophil"	"4"	"4"	"33013872_7_760"
""	"t cell; cd8-positive, alpha-beta t cell; natural killer cell; lymphocyte of b lineage"	""	"COVID-19 patients and healthy controls (New York, USA)"	"25"	"61"	"years"	"4"	"lung"	"UBERON:0002048"	"RNA-seq; MCPcounter score"	"T cells; CD8 T cells; NK cells; B lineage"	""	"cell-type frequency"	"down"	"biopsies of COVID-19 patients (N=2) vs controls (N=2)"	"death"	"few"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33013872"	"2020-08-18"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461898/"	"Fig 4C"	"\"Mild, moderate, and severe cases were defined by...: (1) epidemiological history, (2) fever or other respiratory symptoms, (3) frequency of typical CT image abnormalities of viral pneumonia, and (4) positive RT-PCR result for SARS-CoV-2 RNA...mil..."	"CL_0000084; CL_0000625; CL_0000623; CL_0000945"	""	""	"t cell; cd8-positive, alpha-beta t cell; natural killer cell; lymphocyte of b lineage"	"4"	"4"	"33013872_8_761"
""	"cytotoxic t cell; lymphocyte of b lineage; monocyte; myeloid dendritic cell; neutrophil"	""	"COVID-19 patients and healthy controls (Wuhan, China)"	"25"	"61"	"years"	"5"	"BALF"	"UBERON:0002048"	"RNA-seq; MCPcounter score"	"cytotoxic lymphocytes; B lineage; monocytic lineage; myeloid dendritic cells; neutrophils"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=2) vs controls (N=3)"	"time of diagnosis"	"standard treatment"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33013872"	"2020-08-18"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461898/"	"Fig 4C"	"\"Mild, moderate, and severe cases were defined by...: (1) epidemiological history, (2) fever or other respiratory symptoms, (3) frequency of typical CT image abnormalities of viral pneumonia, and (4) positive RT-PCR result for SARS-CoV-2 RNA...mil..."	"CL_0000910; CL_0000945; CL_0000576; CL_0000782; CL_0000775"	""	""	"cytotoxic t cell; lymphocyte of b lineage; monocyte; myeloid dendritic cell; neutrophil"	"5"	"5"	"33013872_9_762"
""	"t cell; cd8-positive, alpha-beta t cell"	""	"COVID-19 patients and healthy controls (Wuhan, China)"	"25"	"61"	"years"	"5"	"BALF"	"UBERON:0002048"	"RNA-seq; MCPcounter score"	"T cells; CD8 T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=2) vs controls (N=3)"	"time of diagnosis"	"standard treatment"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33013872"	"2020-08-18"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461898/"	"Fig 4C"	"\"Mild, moderate, and severe cases were defined by...: (1) epidemiological history, (2) fever or other respiratory symptoms, (3) frequency of typical CT image abnormalities of viral pneumonia, and (4) positive RT-PCR result for SARS-CoV-2 RNA...mil..."	"CL_0000084; CL_0000625"	""	""	"t cell; cd8-positive, alpha-beta t cell"	"2"	"2"	"33013872_10_763"
""	"lymphocyte"	""	"COVID-19 patients (Martin City, Slovakia)"	"45"	"94"	"years"	"13"	"blood"	"UBERON:0000178"	"flow cytometry"	"lymphocytes"	""	"cell-type frequency"	"up"	"(mild and moderate patients) vs (severe patients, requiring oxygen supplementation)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 3."	"\"Group A (including asymptomatic patients or patients with mild/moderate symptoms, who were hospitalized for another reason than COVID-19, did not have signs of pneumonia on chest X-ray and did not require supplementation of oxygen); Group B (incl..."	"CL_0000542"	""	""	"lymphocyte"	"1"	"1"	"33937096_1_765"
""	"lymphocyte"	""	"COVID-19 patients (Martin City, Slovakia)"	"50"	"94"	"years"	"6"	"blood"	"UBERON:0000178"	"flow cytometry"	"lymphocytes"	""	"cell-type frequency"	"up"	"(mild and moderate patients) vs (critically ill patients, requiring ICU stay)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 3."	"\"Group A (including asymptomatic patients or patients with mild/moderate symptoms, who were hospitalized for another reason than COVID-19, did not have signs of pneumonia on chest X-ray and did not require supplementation of oxygen)\" Group C \"crit..."	"CL_0000542"	""	""	"lymphocyte"	"1"	"1"	"33937096_2_766"
""	"lymphocyte"	""	"COVID-19 patients (Martin City, Slovakia)"	"50"	"94"	"years"	"7"	"blood"	"UBERON:0000178"	"flow cytometry"	"lymphocytes"	""	"cell-type frequency"	"up"	"(mild and moderate COVID-19 patients) vs (critically ill patients who died)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 3."	"\"Group A (including asymptomatic patients or patients with mild/moderate symptoms, who were hospitalized for another reason than COVID-19, did not have signs of pneumonia on chest X-ray and did not require supplementation of oxygen)\" Group D: dece..."	"CL_0000542"	""	""	"lymphocyte"	"1"	"1"	"33937096_3_767"
""	"lymphocyte"	""	"COVID-19 patients (Martin City, Slovakia)"	"45"	"94"	"years"	"14"	"blood"	"UBERON:0000178"	"flow cytometry"	"lymphocytes"	""	"cell-type frequency"	"up"	"(severe patients, requiring oxygen supplementation) vs (critically ill patients who died)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 3."	"\"Group B (including patients with severe symptoms, signs of bilateral pneumonia on chest X-ray and/or SpO2 below 93% on room air, thus requiring supplementation of oxygen)\" Group D: deceased COVID-19 patients"	"CL_0000542"	""	""	"lymphocyte"	"1"	"1"	"33937096_4_768"
""	"t cell; cd8-positive, alpha-beta t cell"	""	"COVID-19 patients (Martin City, Slovakia)"	"45"	"94"	"years"	"13"	"lymphocytes"	"CL:0000542"	"flow cytometry"	"CD3+ cells; CD3+ CD8+ cells"	""	"cell-type frequency"	"up"	"(mild and moderate patients) vs (severe patients, requiring oxygen supplementation)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 6A & 6C"	"\"Group A (including asymptomatic patients or patients with mild/moderate symptoms, who were hospitalized for another reason than COVID-19, did not have signs of pneumonia on chest X-ray and did not require supplementation of oxygen); Group B (incl..."	"CL_0000084; CL_0000625"	""	""	"t cell; cd8-positive, alpha-beta t cell"	"2"	"2"	"33937096_14_778"
""	"t cell; cd8-positive, alpha-beta t cell; b cell, cd19-positive"	""	"COVID-19 patients (Martin City, Slovakia)"	"50"	"94"	"years"	"6"	"lymphocytes"	"CL:0000542"	"flow cytometry"	"CD3+ cells; CD3+ CD8+ cells; CD19+ cells"	""	"cell-type frequency"	"up"	"(mild and moderate patients) vs (critically ill patients, requiring ICU stay)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 6A & 6C-D"	"\"Group A (including asymptomatic patients or patients with mild/moderate symptoms, who were hospitalized for another reason than COVID-19, did not have signs of pneumonia on chest X-ray and did not require supplementation of oxygen)\" Group C \"crit..."	"CL_0000084; CL_0000625; CL_0001201"	""	""	"t cell; cd8-positive, alpha-beta t cell; b cell, cd19-positive"	"3"	"3"	"33937096_15_779"
""	"t cell; cd4-positive, alpha-beta t cell; cd8-positive, alpha-beta t cell; b cell, cd19-positive"	""	"COVID-19 patients (Martin City, Slovakia)"	"50"	"94"	"years"	"7"	"lymphocytes"	"CL:0000542"	"flow cytometry"	"CD3+ cells; CD3+ CD4+ cells; CD3+ CD8+ cells; CD19+ cells"	""	"cell-type frequency"	"up"	"(mild and moderate COVID-19 patients) vs (critically ill patients who died)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 6"	"\"Group A (including asymptomatic patients or patients with mild/moderate symptoms, who were hospitalized for another reason than COVID-19, did not have signs of pneumonia on chest X-ray and did not require supplementation of oxygen)\" Group D: dece..."	"CL_0000084; CL_0000624; CL_0000625; CL_0001201"	""	""	"t cell; cd4-positive, alpha-beta t cell; cd8-positive, alpha-beta t cell; b cell, cd19-positive"	"4"	"4"	"33937096_16_780"
""	"t cell; cd8-positive, alpha-beta t cell; b cell, cd19-positive"	""	"COVID-19 patients (Martin City, Slovakia)"	"45"	"89"	"years"	"13"	"lymphocytes"	"CL:0000542"	"flow cytometry"	"CD3+ cells; CD3+ CD8+ cells; CD19+ cells"	""	"cell-type frequency"	"up"	"(severe patients, requiring oxygen supplementation) vs (critically ill patients, requiring ICU stay)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 6A & 6C-D"	"\"Group B (including patients with severe symptoms, signs of bilateral pneumonia on chest X-ray and/or SpO2 below 93% on room air, thus requiring supplementation of oxygen)\" Group C \"critically ill patients requiring intensive care unit stay and ei..."	"CL_0000084; CL_0000625; CL_0001201"	""	""	"t cell; cd8-positive, alpha-beta t cell; b cell, cd19-positive"	"3"	"3"	"33937096_17_781"
""	"t cell; cd8-positive, alpha-beta t cell; b cell, cd19-positive"	""	"COVID-19 patients (Martin City, Slovakia)"	"45"	"94"	"years"	"14"	"lymphocytes"	"CL:0000542"	"flow cytometry"	"CD3+ cells; CD3+ CD8+ cells; CD19+ cells"	""	"cell-type frequency"	"up"	"(severe patients, requiring oxygen supplementation) vs (critically ill patients who died)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 6A & 6C-D"	"\"Group B (including patients with severe symptoms, signs of bilateral pneumonia on chest X-ray and/or SpO2 below 93% on room air, thus requiring supplementation of oxygen)\" Group D: deceased COVID-19 patients"	"CL_0000084; CL_0000625; CL_0001201"	""	""	"t cell; cd8-positive, alpha-beta t cell; b cell, cd19-positive"	"3"	"3"	"33937096_18_782"
""	"t cell; cd4-positive, alpha-beta t cell"	""	"COVID-19 patients (Martin City, Slovakia)"	"45"	"89"	"years"	"13"	"lymphocytes"	"CL:0000542"	"flow cytometry"	"CD3+ cells; CD3+ CD4+ cells"	""	"cell-type frequency"	"up"	"severe (requiring oxygen supplementation) and critically ill (requiring ICU stay) surviving patients: recovery vs admission"	"time of hospital admission"	"various"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 7"	"\"Group B (including patients with severe symptoms, signs of bilateral pneumonia on chest X-ray and/or SpO2 below 93% on room air, thus requiring supplementation of oxygen)\" Group C \"critically ill patients requiring intensive care unit stay and ei..."	"CL_0000084; CL_0000624"	""	""	"t cell; cd4-positive, alpha-beta t cell"	"2"	"2"	"33937096_19_783"
""	"exhausted t cell (CD4+,PD1+); exhausted t cell (CD8+,PD1+)"	""	"COVID-19 patients (Martin City, Slovakia)"	"45"	"94"	"years"	"20"	"lymphocytes"	"CL:0000542"	"flow cytometry"	"PD-1+ CD3+ CD4+ cells; PD-1+ CD3+ CD8+ cells"	""	"cell-type frequency"	"up"	"patients who died vs patients who survived (including mild, severe, and critically ill)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 8A-B"	"\"Group A (including asymptomatic patients or patients with mild/moderate symptoms, who were hospitalized for another reason than COVID-19, did not have signs of pneumonia on chest X-ray and did not require supplementation of oxygen)...Group B (inc..."	"CL_0011025"	"(CD4+,PD1+); (CD8+,PD1+)"	"PR:000001004,PR:000001919; PR:000001084,PR:000001919"	"exhausted t cell (CD4+,PD1+); exhausted t cell (CD8+,PD1+)"	"2"	"2"	"33937096_20_784"
""	"exhausted t cell (CD4+,TIM3+); exhausted t cell (CD8+,TIM3+); cd8-positive, alpha-beta t cell (CD38+)"	""	"COVID-19 patients (Martin City, Slovakia)"	"45"	"89"	"years"	"13"	"lymphocytes"	"CL:0000542"	"flow cytometry"	"Tim-3+ CD3+ CD4+ cells; Tim-3+ CD3+ CD8+ cells; CD38+ CD3+ CD8+ cells"	""	"cell-type frequency"	"down"	"severe (requiring oxygen supplementation) and critically ill (requiring ICU stay) surviving patients: recovery vs admission"	"time of hospital admission"	"various"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 9; Fig 10C"	"\"Group B (including patients with severe symptoms, signs of bilateral pneumonia on chest X-ray and/or SpO2 below 93% on room air, thus requiring supplementation of oxygen)\" Group C \"critically ill patients requiring intensive care unit stay and ei..."	"CL_0011025; CL_0000625"	"(CD4+,TIM3+); (CD8+,TIM3+); (CD38+)"	"PR:000001004,PR:000008454; PR:000001084,PR:000008454; PR:000001408"	"exhausted t cell (CD4+,TIM3+); exhausted t cell (CD8+,TIM3+); cd8-positive, alpha-beta t cell (CD38+)"	"3"	"3"	"33937096_21_785"
""	"activated cd8-positive, alpha-beta t cell (CD38+,HLADRA+)"	""	"COVID-19 patients (Martin City, Slovakia)"	"45"	"94"	"years"	"20"	"lymphocytes"	"CL:0000542"	"flow cytometry"	"CD38+ HLA-DR+ CD3+ CD8+ cells"	""	"cell-type frequency"	"down"	"patients who died vs patients who survived (including mild, severe, and critically ill)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 10B"	"\"Group A (including asymptomatic patients or patients with mild/moderate symptoms, who were hospitalized for another reason than COVID-19, did not have signs of pneumonia on chest X-ray and did not require supplementation of oxygen)...Group B (inc..."	"CL_0000906"	"(CD38+,HLADRA+)"	"PR:000001408,PR:000002015"	"activated cd8-positive, alpha-beta t cell (CD38+,HLADRA+)"	"1"	"1"	"33937096_22_786"
""	"cd8-positive, alpha-beta t cell (CD38+)"	""	"COVID-19 patients (Martin City, Slovakia)"	"45"	"94"	"years"	"20"	"lymphocytes"	"CL:0000542"	"flow cytometry"	"CD38+ CD3+ CD8+ cells"	""	"cell-type frequency"	"up"	"patients who died vs patients who survived (including mild, severe, and critically ill)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33937096"	"2021-04-15"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082075/"	"Fig 10A"	"\"Group A (including asymptomatic patients or patients with mild/moderate symptoms, who were hospitalized for another reason than COVID-19, did not have signs of pneumonia on chest X-ray and did not require supplementation of oxygen)...Group B (inc..."	"CL_0000625"	"(CD38+)"	"PR:000001408"	"cd8-positive, alpha-beta t cell (CD38+)"	"1"	"1"	"33937096_23_787"
""	"t cell"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"53.73"	"73.51"	"years"	"17"	"Peripheral Blood Mononuclear Cells (PBMCs); Bronchoalveolar Lavage Fluid Mononuclear Cells (BALFMCs)"	"CL:2000001; NCIT:C13195"	"spectral flow cytometry; quantification of general immune cell populations"	"CD45+ T cells"	""	"cell-type frequency"	"up"	"Peripheral Blood Mononuclear Cells (PBMCs) vs Bronchoalveolar Lavage Fluid Mononuclear Cells (BALFMCs)"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 1E"	""	"CL_0000084"	""	""	"t cell"	"1"	"1"	"33846275_1_788"
""	"monocyte"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"53.73"	"73.51"	"years"	"17"	"Peripheral Blood Mononuclear Cells (PBMCs); Bronchoalveolar Lavage Fluid Mononuclear Cells (BALFMCs)"	"CL:2000001; NCIT:C13195"	"spectral flow cytometry; quantification of general immune cell populations"	"CD45+ monocytes"	""	"cell-type frequency"	"down"	"ICU COVID-19 patients: Peripheral Blood Mononuclear Cells (PBMCs) vs Bronchoalveolar Lavage Fluid Mononuclear Cells (BALFMCs)"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 1E"	""	"CL_0000576"	""	""	"monocyte"	"1"	"1"	"33846275_2_789"
""	"b cell"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"48.7"	"76.9"	"years"	"27"	"Peripheral Blood Mononuclear Cells (PBMCs); Bronchoalveolar Lavage Fluid Mononuclear Cells (BALFMCs)"	"CL:2000001; NCIT:C13195"	"spectral flow cytometry; quantification of general immune cell populations"	"CD45+ B cells"	""	"cell-type frequency"	"down"	"ICU COVID-19 patients' Peripheral Blood Mononuclear Cells (PBMCs) vs healthy's PBMCs"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 1E"	""	"CL_0000236"	""	""	"b cell"	"1"	"1"	"33846275_3_790"
""	"conventional dendritic cell"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"48.7"	"76.9"	"years"	"27"	"Peripheral Blood Mononuclear Cells (PBMCs); Bronchoalveolar Lavage Fluid Mononuclear Cells (BALFMCs)"	"CL:2000001; NCIT:C13195"	"spectral flow cytometry; quantification of general immune cell populations"	"CD45+ conventional dendritic cells (cDC)"	""	"cell-type frequency"	"up"	"ICU COVID-19 patients' Peripheral Blood Mononuclear Cells (PBMCs) vs healthy's PBMCs"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 1E"	""	"CL_0000990"	""	""	"conventional dendritic cell"	"1"	"1"	"33846275_4_791"
""	"intermediate monocyte"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"53.73"	"73.51"	"years"	"17"	"monocytes"	"CL:0000576"	"spectral flow cytometry; quantification of general immune cell populations"	"intermediate monocytes"	""	"cell-type frequency"	"down"	"ICU COVID-19 patients: Peripheral Blood Mononuclear Cells (PBMCs) vs Bronchoalveolar Lavage Fluid Mononuclear Cells (BALFMCs)"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 1G"	""	"CL_0002393"	""	""	"intermediate monocyte"	"1"	"1"	"33846275_5_792"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD45RA+,CD27+,CD28+,CD95-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7-)"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"48.7"	"76.9"	"years"	"27"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"spectral flow cytometry; T cell phenotyping"	"naive (CD45RA+ CD27+ CD28+ CD95-) CD4+ T cells; effector memory Ra+ (TEMRA) (CD45RA- CD27+ CD28+ CCR7-) CD4+ T cells"	""	"cell-type frequency"	"down"	"ICU COVID-19 patients' Peripheral Blood Mononuclear Cells (PBMCs) vs healthy's PBMCs"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 2A"	""	"CL_0000895; CL_0000905"	"(CD45RA+,CD27+,CD28+,CD95-); (CD45RA-,CD27+,CD28+,CCR7-)"	"PR:000001015,PR:000001963,PR:000001841,PR:000001962; PR:000001015,PR:000001963,PR:000001841,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD45RA+,CD27+,CD28+,CD95-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7-)"	"2"	"2"	"33846275_6_799"
""	"cd4-positive, cd25-positive, alpha-beta regulatory t cell (CD25+,CD127-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28-,CCR7-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7+); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7-)"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"48.7"	"76.9"	"years"	"27"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"spectral flow cytometry; T cell phenotyping"	"CD4+ T regulatory cells (Tregs) (CD25+ CD127-); effector memory-4 (EM4) (CD45RA- CD27- CD28- CCR7-) CD4+ T cells; effector memory-3 (EM3) (CD45RA- CD27- CD28+ CCR7-) CD4+ T cells; effector memory-2 (EM2) (CD45RA- CD27- CD28+ CCR7+) CD4+ T cells; effector memory-1 (EM1) (CD45RA- CD27+ CD28+ CCR7-) CD4+ T cells"	""	"cell-type frequency"	"up"	"ICU COVID-19 patients' Peripheral Blood Mononuclear Cells (PBMCs) vs healthy's PBMCs"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 2A"	""	"CL_0000792; CL_0000905"	"(CD25+,CD127-); (CD45RA-,CD27-,CD28-,CCR7-); (CD45RA-,CD27-,CD28+,CCR7-); (CD45RA-,CD27-,CD28+,CCR7+); (CD45RA-,CD27+,CD28+,CCR7-)"	"PR:000001380,PR:000001869; PR:000001015,PR:000001963,PR:000001841,PR:000001203"	"cd4-positive, cd25-positive, alpha-beta regulatory t cell (CD25+,CD127-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28-,CCR7-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7+); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7-)"	"5"	"5"	"33846275_7_800"
""	"effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28-,CCR7-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7+)"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"53.73"	"73.51"	"years"	"17"	"Peripheral Blood Mononuclear Cells (PBMCs); Bronchoalveolar Lavage Fluid (BALF)"	"CL:2000001; NCIT:C13195"	"spectral flow cytometry; T cell phenotyping"	"effector memory-4 (EM4) (CD45RA- CD27- CD28- CCR7-) CD4+ T cells; effector memory-3 (EM3) (CD45RA- CD27- CD28+ CCR7-) CD4+ T cells; effector memory-2 (EM2) (CD45RA- CD27- CD28+ CCR7+) CD4+ T cells"	""	"cell-type frequency"	"down"	"ICU COVID-19 patients: Peripheral Blood Mononuclear Cells (PBMCs) vs Bronchoalveolar Lavage Fluid (BALF)"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 2A"	""	"CL_0000905"	"(CD45RA-,CD27-,CD28-,CCR7-); (CD45RA-,CD27-,CD28+,CCR7-); (CD45RA-,CD27-,CD28+,CCR7+)"	"PR:000001015,PR:000001963,PR:000001841,PR:000001203"	"effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28-,CCR7-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7+)"	"3"	"3"	"33846275_8_801"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD45RA+,CD27+,CD28+,CD95-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7-); central memory cd4-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7+); cd4-positive, alpha-beta memory t cell (CD45RA+,CD27+,CD28+,CD95+)"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"53.73"	"73.51"	"years"	"17"	"Peripheral Blood Mononuclear Cells (PBMCs); Bronchoalveolar Lavage Fluid (BALF)"	"CL:2000001; NCIT:C13195"	"spectral flow cytometry; T cell phenotyping"	"naive (CD45RA+ CD27+ CD28+ CD95-) CD4+ T cells; effector memory Ra+ (TEMRA) (CD45RA- CD27+ CD28+ CCR7-) CD4+ T cells; central memory (CM) (CD45RA- CD27+ CD28+ CCR7+) CD4+ T cells; Stem cell-like memory (SCM) (CD45RA+ CD27+ CD28+ CD95+) CD4+ T cells; effector memory-1 (EM1) (CD45RA- CD27+ CD28+ CCR7-) CD4+ T cells"	""	"cell-type frequency"	"up"	"ICU COVID-19 patients: Peripheral Blood Mononuclear Cells (PBMCs) vs Bronchoalveolar Lavage Fluid (BALF)"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 2A"	""	"CL_0000895; CL_0000905; CL_0000904; CL_0000897"	"(CD45RA+,CD27+,CD28+,CD95-); (CD45RA-,CD27+,CD28+,CCR7-); (CD45RA-,CD27+,CD28+,CCR7+); (CD45RA+,CD27+,CD28+,CD95+)"	"PR:000001015,PR:000001963,PR:000001841,PR:000001962; PR:000001015,PR:000001963,PR:000001841,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD45RA+,CD27+,CD28+,CD95-); effector memory cd4-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7-); central memory cd4-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7+); cd4-positive, alpha-beta memory t cell (CD45RA+,CD27+,CD28+,CD95+)"	"5"	"5"	"33846275_9_802"
""	"naive thymus-derived cd8-positive, alpha-beta t cell (CD45RA+,CD27+,CD28+,CD95-); cd8-positive, alpha-beta memory t cell (CD45RA+,CD27+,CD28+,CD95+); central memory cd8-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7+)"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"48.7"	"76.9"	"years"	"27"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"spectral flow cytometry; T cell phenotyping"	"naive (CD45RA+ CD27+ CD28+ CD95-) CD8+ T cells; Stem cell-like memory (SCM) (CD45RA+ CD27+ CD28+ CD95+) CD8+ T cells; central memory (CM) (CD45RA- CD27+ CD28+ CCR7+) CD8+ T cells"	""	"cell-type frequency"	"down"	"ICU COVID-19 patients' Peripheral Blood Mononuclear Cells (PBMCs) vs healthy's PBMCs"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 2E"	""	"CL_0000900; CL_0000909; CL_0000907"	"(CD45RA+,CD27+,CD28+,CD95-); (CD45RA+,CD27+,CD28+,CD95+); (CD45RA-,CD27+,CD28+,CCR7+)"	"PR:000001015,PR:000001963,PR:000001841,PR:000001962; PR:000001015,PR:000001963,PR:000001841,PR:000001203"	"naive thymus-derived cd8-positive, alpha-beta t cell (CD45RA+,CD27+,CD28+,CD95-); cd8-positive, alpha-beta memory t cell (CD45RA+,CD27+,CD28+,CD95+); central memory cd8-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7+)"	"3"	"3"	"33846275_10_814"
""	"effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27-,CD28-,CCR7-); effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7-); effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7-)"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"48.7"	"76.9"	"years"	"27"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"spectral flow cytometry; T cell phenotyping"	"effector memory-4 (EM4) (CD45RA- CD27- CD28- CCR7-) CD8+ T cells; effector memory-3 (EM3) (CD45RA- CD27- CD28+ CCR7-) CD8+ T cells; effector memory-1 (EM1) (CD45RA- CD27+ CD28+ CCR7-) CD8+ T cells; effector memory Ra+ (TEMRA) (CD45RA- CD27+ CD28+ CCR7-) CD8+ T cells"	""	"cell-type frequency"	"up"	"ICU COVID-19 patients' Peripheral Blood Mononuclear Cells (PBMCs) vs healthy's PBMCs"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 2E"	""	"CL_0000913"	"(CD45RA-,CD27-,CD28-,CCR7-); (CD45RA-,CD27-,CD28+,CCR7-); (CD45RA-,CD27+,CD28+,CCR7-)"	"PR:000001015,PR:000001963,PR:000001841,PR:000001203"	"effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27-,CD28-,CCR7-); effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7-); effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7-)"	"4"	"4"	"33846275_11_815"
""	"effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27-,CD28-,CCR7-); effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7+)"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"53.73"	"73.51"	"years"	"17"	"Peripheral Blood Mononuclear Cells (PBMCs); Bronchoalveolar Lavage Fluid (BALF)"	"CL:2000001; NCIT:C13195"	"spectral flow cytometry; T cell phenotyping"	"effector memory-4 (EM4) (CD45RA- CD27- CD28- CCR7-) CD8+ T cells; effector memory-2 (EM2) (CD45RA- CD27- CD28+ CCR7+) CD8+ T cells"	""	"cell-type frequency"	"down"	"ICU COVID-19 patients: Peripheral Blood Mononuclear Cells (PBMCs) vs Bronchoalveolar Lavage Fluid (BALF)"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 2E"	""	"CL_0000913"	"(CD45RA-,CD27-,CD28-,CCR7-); (CD45RA-,CD27-,CD28+,CCR7+)"	"PR:000001015,PR:000001963,PR:000001841,PR:000001203"	"effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27-,CD28-,CCR7-); effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27-,CD28+,CCR7+)"	"2"	"2"	"33846275_12_816"
""	"naive thymus-derived cd8-positive, alpha-beta t cell (CD45RA+,CD27+,CD28+,CD95-); effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7-); central memory cd8-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7+); cd8-positive, alpha-beta memory t cell (CD45RA+,CD27+,CD28+,CD95+)"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"53.73"	"73.51"	"years"	"17"	"Peripheral Blood Mononuclear Cells (PBMCs); Bronchoalveolar Lavage Fluid (BALF)"	"CL:2000001; NCIT:C13195"	"spectral flow cytometry; T cell phenotyping"	"naive (CD45RA+ CD27+ CD28+ CD95-) CD8+ T cells; effector memory Ra+ (TEMRA) (CD45RA- CD27+ CD28+ CCR7-) CD8+ T cells; central memory (CM) (CD45RA- CD27+ CD28+ CCR7+) CD8+ T cells; Stem cell-like memory (SCM) (CD45RA+ CD27+ CD28+ CD95+) CD8+ T cells; effector memory-1 (EM1) (CD45RA- CD27+ CD28+ CCR7-) CD8+ T cells"	""	"cell-type frequency"	"up"	"ICU COVID-19 patients: Peripheral Blood Mononuclear Cells (PBMCs) vs Bronchoalveolar Lavage Fluid (BALF)"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 2E"	""	"CL_0000900; CL_0000913; CL_0000907; CL_0000909"	"(CD45RA+,CD27+,CD28+,CD95-); (CD45RA-,CD27+,CD28+,CCR7-); (CD45RA-,CD27+,CD28+,CCR7+); (CD45RA+,CD27+,CD28+,CD95+)"	"PR:000001015,PR:000001963,PR:000001841,PR:000001962; PR:000001015,PR:000001963,PR:000001841,PR:000001203"	"naive thymus-derived cd8-positive, alpha-beta t cell (CD45RA+,CD27+,CD28+,CD95-); effector memory cd8-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7-); central memory cd8-positive, alpha-beta t cell (CD45RA-,CD27+,CD28+,CCR7+); cd8-positive, alpha-beta memory t cell (CD45RA+,CD27+,CD28+,CD95+)"	"5"	"5"	"33846275_13_817"
""	"cd4-positive, cd25-positive, alpha-beta regulatory t cell (CD127-,CD25+)"	""	"ICU COVID-19 patients in Amsterdam, The Netherlands"	"53.73"	"73.51"	"years"	"17"	"Peripheral Blood Mononuclear Cells (PBMCs)"	"CL:2000001"	"manual gating; Spearman correlation"	"regulatory (CD127- CD25+) CD4+ T cells"	""	"cell-type frequency"	"negatively correlated"	"DN T cells (Double Negative) (percent (%) of T cells Bronchoalveolar Lavage Fluid Mononuclear Cells (BALFMCs))"	"time after ICU admission"	"1 to 31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33846275"	"2021-03-28"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050882/"	"Fig 3C"	""	"CL_0000792"	"(CD127-,CD25+)"	"PR:000001869,PR:000001380"	"cd4-positive, cd25-positive, alpha-beta regulatory t cell (CD127-,CD25+)"	"1"	"1"	"33846275_15_821"
""	"cd4-positive, alpha-beta t cell (TNFA+)"	"2021-06-07"	"SARS-CoV-2 convalescing patients (27d - 90d after symptom onset)"	"31"	"72"	"years"	"12"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry following ex-vivo stimulation with SARS-CoV-2 spike protein or IAV PR8"	"TNF-alpha+ CD4+ T cells"	""	"cell-type frequency"	"up"	"ex vivo stimulation with SARS-CoV-2 spike protein vs control"	"symptom onset"	"27 to 90"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33208459"	"2021-01-01"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750861/"	"Fig 1C"	""	"CL_0000624"	"(TNFA+)"	"PR:000000134"	"cd4-positive, alpha-beta t cell (TNFA+)"	"1"	"1"	"33208459_1_827"
""	"cd4-positive, alpha-beta t cell (IL2+)"	"2021-06-07"	"SARS-CoV-2 convalescing patients (27d - 90d after symptom onset)"	"31"	"72"	"years"	"13"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry following ex-vivo stimulation with SARS-CoV-2 spike protein or IAV PR8"	"IL-2+ CD4+ T cells"	""	"cell-type frequency"	"up"	"ex vivo stimulation with SARS-CoV-2 spike protein vs control"	"symptom onset"	"27 to 90"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33208459"	"2021-01-01"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750861/"	"Fig 1D"	""	"CL_0000624"	"(IL2+)"	"PR:000001379"	"cd4-positive, alpha-beta t cell (IL2+)"	"1"	"1"	"33208459_2_828"
""	"effector cd4-positive, alpha-beta t cell (IL2+)"	"2021-06-07"	"SARS-CoV-2 convalescing patients (27d - 90d after symptom onset)"	"31"	"72"	"years"	"10"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry following ex-vivo stimulation with SARS-CoV-2 spike protein"	"IL-2+ CD4+ effector T cells"	""	"cell-type frequency"	"up"	"ex vivo stimulation with 5Î¼g/mL vs 0Î¼g/mL of SARS-CoV-2 spike protein"	"symptom onset"	"27 to 90"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33208459"	"2021-01-01"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750861/"	"Suppl Fig 2A"	""	"CL_0001044"	"(IL2+)"	"PR:000001379"	"effector cd4-positive, alpha-beta t cell (IL2+)"	"1"	"1"	"33208459_3_829"
""	"cd4-positive, alpha-beta t cell (TNFA+,IL2+,IFNG+)"	"2021-06-07"	"SARS-CoV-2 convalescing patients (27d - 90d after symptom onset)"	"31"	"72"	"years"	"12 (SARS-CoV-2 spike protein); 13 (PR8 strain of IAV)"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry following ex-vivo stimulation with SARS-CoV-2 spike protein or IAV PR8"	"TNF-alpha+ IL-2+ IFN-gamma+ CD4+ T cell"	""	"cell-type frequency"	"up"	"ex vivo stimulation with SARS-CoV-2 spike protein vs PR8 strain of IAV"	"symptom onset"	"27 to 90"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33208459"	"2021-01-01"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750861/"	"Fig 2A"	""	"CL_0000624"	"(TNFA+,IL2+,IFNG+)"	"PR:000000134,PR:000001379,PR:000000017"	"cd4-positive, alpha-beta t cell (TNFA+,IL2+,IFNG+)"	"1"	"1"	"33208459_4_830"
""	"effector cd4-positive, alpha-beta t cell (TNFA+)"	"2021-09-06"	"SARS-CoV-2 convalescing patients (27d - 90d after symptom onset)"	"31"	"72"	"years"	"9"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry following ex-vivo stimulation with SARS-CoV-2 spike protein"	"TNF-alpha+ CD4+ effector T cells"	""	"cell-type frequency"	"down"	"central memory T cells vs naive T cells"	"symptom onset"	"27 to 90"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33208459"	"2021-01-01"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750861/"	"Fig 2C"	""	"CL_0001044"	"(TNFA+)"	"PR:000000134"	"effector cd4-positive, alpha-beta t cell (TNFA+)"	"1"	"1"	"33208459_6_832"
""	"activated CD4-positive, alpha-beta T cell (HLADRA+,4-1BB+)"	"2021-06-07"	"SARS-CoV-2 convalescing patients (27d - 90d after symptom onset)"	"31"	"72"	"years"	"9"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry following ex-vivo stimulation with SARS-CoV-2 spike protein, SARS-CoV-2 nucleocapsid protein, or IAV PR8"	"HLA-DR+ 4-1BB+ CD4+ T cell"	""	"cell-type frequency"	"up"	"ex vivo stimulation with SARS-CoV-2 spike protein vs control"	"symptom onset"	"27 to 90"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33208459"	"2021-01-01"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750861/"	"Fig 2D"	"cell type frequency of subsets of TNF-alpha+/CD4+ T cells determined after ex vivo incubation of SARS-CoV-2 convalescing patient PBMCs with SARS-CoV-2 spike protein"	"CL_0000896"	"(HLADRA+,4-1BB+)"	"PR:000002015,PR:000001965"	"activated CD4-positive, alpha-beta T cell (HLADRA+,4-1BB+)"	"1"	"1"	"33208459_7_833"
""	"cd4-positive, alpha-beta t cell (IFNG+,GZMB+)"	"2021-06-07"	"SARS-CoV-2 convalescing patients (27d - 90d after symptom onset)"	"31"	"72"	"years"	"13"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IFN-gamma & granzyme B-coproducing CD4+ T cells"	""	"cell-type frequency"	"positively correlated"	"cell type frequency of IL-2+ pTfh"	"symptom onset"	"27 to 90"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33208459"	"2021-01-01"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750861/"	"Fig 8C"	"ex vivo stimulation of PBMCs from SARS-CoV-2 convalescent patients using S-master peptides pool"	"CL_0000624"	"(IFNG+,GZMB+)"	"PR:000000017,PR:000003499"	"cd4-positive, alpha-beta t cell (IFNG+,GZMB+)"	"1"	"1"	"33208459_8_847"
""	"cd4-positive, cd25-positive, alpha-beta regulatory t cell (CD25+,CD127-)"	"2021-06-10"	"Munich, Germany"	"24"	"86"	"years"	"17"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ CD25+ CD127- CD3+ regulatory T cells"	""	"cell-type frequency"	"up"	"COVID severe vs COVID mild"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 1A"	""	"CL_0000792"	"(CD25+,CD127-)"	"PR:000001380,PR:000001869"	"cd4-positive, cd25-positive, alpha-beta regulatory t cell (CD25+,CD127-)"	"1"	"1"	"33546489_1_848"
""	"cd4-positive, cd25-positive, alpha-beta regulatory t cell (CD25+,CD127-)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"18"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ CD25+ CD127- CD3+ regulatory T cells"	""	"cell-type frequency"	"up"	"COVID severe vs healthy controls"	"time of symptom onset"	"7-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 1A"	""	"CL_0000792"	"(CD25+,CD127-)"	"PR:000001380,PR:000001869"	"cd4-positive, cd25-positive, alpha-beta regulatory t cell (CD25+,CD127-)"	"1"	"1"	"33546489_2_849"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD62L++,CD45RO+-)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"19"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD62L-hi CD45RO-low CD4+ naive T cells"	""	"cell-type frequency"	"down"	"COVID mild vs healthy controls"	"time of symptom onset"	"1-56"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 1C"	""	"CL_0000895"	"(CD62L++,CD45RO+-)"	"PR:000001318,PR:000001017"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD62L++,CD45RO+-)"	"1"	"1"	"33546489_3_850"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD62L++,CD45RO+-)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"18"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD62L-hi CD45RO-low CD4+ naive T cells"	""	"cell-type frequency"	"down"	"COVID severe vs healthy controls"	"time of symptom onset"	"7-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 1C"	""	"CL_0000895"	"(CD62L++,CD45RO+-)"	"PR:000001318,PR:000001017"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD62L++,CD45RO+-)"	"1"	"1"	"33546489_4_851"
""	"effector memory cd4-positive, alpha-beta t cell (CD62L+-,CD45RO++)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"19"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD62L-low CD45RO-hi CD4+ effector memory T cells"	""	"cell-type frequency"	"up"	"COVID mild vs healthy controls"	"time of symptom onset"	"1-56"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 1C"	""	"CL_0000905"	"(CD62L+-,CD45RO++)"	"PR:000001318,PR:000001017"	"effector memory cd4-positive, alpha-beta t cell (CD62L+-,CD45RO++)"	"1"	"1"	"33546489_5_852"
""	"effector memory cd4-positive, alpha-beta t cell (CD62L+-,CD45RO++)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"18"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD62L-low CD45RO-hi CD4+ effector memory T cells"	""	"cell-type frequency"	"up"	"COVID severe vs healthy controls"	"time of symptom onset"	"7-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 1C"	""	"CL_0000905"	"(CD62L+-,CD45RO++)"	"PR:000001318,PR:000001017"	"effector memory cd4-positive, alpha-beta t cell (CD62L+-,CD45RO++)"	"1"	"1"	"33546489_6_853"
""	"naive thymus-derived cd8-positive, alpha-beta t cell (CD62L++,CD45RO+-)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"19"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD62L-hi CD45RO-low CD8+ naive T cells"	""	"cell-type frequency"	"down"	"COVID mild vs healthy controls"	"time of symptom onset"	"1-56"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 1D"	""	"CL_0000900"	"(CD62L++,CD45RO+-)"	"PR:000001318,PR:000001017"	"naive thymus-derived cd8-positive, alpha-beta t cell (CD62L++,CD45RO+-)"	"1"	"1"	"33546489_7_854"
""	"naive thymus-derived cd8-positive, alpha-beta t cell (CD62L++,CD45RO+-)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"18"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD62L-hi CD45RO-low CD8+ naive T cells"	""	"cell-type frequency"	"down"	"COVID severe vs healthy controls"	"time of symptom onset"	"7-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 1D"	""	"CL_0000900"	"(CD62L++,CD45RO+-)"	"PR:000001318,PR:000001017"	"naive thymus-derived cd8-positive, alpha-beta t cell (CD62L++,CD45RO+-)"	"1"	"1"	"33546489_8_855"
""	"effector memory cd8-positive, alpha-beta t cell (CD62L+-,CD45RO++)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"18"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD62L-low CD45RO-hi CD8+ effector memory T cells"	""	"cell-type frequency"	"up"	"COVID severe vs healthy controls"	"time of symptom onset"	"7-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 1D"	""	"CL_0000913"	"(CD62L+-,CD45RO++)"	"PR:000001318,PR:000001017"	"effector memory cd8-positive, alpha-beta t cell (CD62L+-,CD45RO++)"	"1"	"1"	"33546489_9_856"
""	"effector memory cd8-positive, alpha-beta t cell (CD62L+-,CD45RO++)"	"2021-06-10"	"Munich, Germany"	"24"	"86"	"years"	"17"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD62L-low CD45RO-hi CD8+ effector memory T cells"	""	"cell-type frequency"	"up"	"COVID severe vs COVID mild"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 1D"	""	"CL_0000913"	"(CD62L+-,CD45RO++)"	"PR:000001318,PR:000001017"	"effector memory cd8-positive, alpha-beta t cell (CD62L+-,CD45RO++)"	"1"	"1"	"33546489_10_857"
""	"gamma-delta T cell (gammadelta2 and CD3+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"24"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ gammadelta2 T cells"	""	"cell-type frequency"	"down"	"COVID mild vs healthy controls"	"time of symptom onset"	"1-56"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 2B"	""	"CL_0000798"	"(gammadelta2 and CD3+)"	"PR:000001020"	"gamma-delta T cell (gammadelta2 and CD3+)"	"1"	"1"	"33546489_11_858"
""	"gamma-delta T cell (gammadelta2 and CD3+)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ gammadelta2 T cells"	""	"cell-type frequency"	"down"	"COVID severe vs healthy controls"	"time of symptom onset"	"7-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 2B"	""	"CL_0000798"	"(gammadelta2 and CD3+)"	"PR:000001020"	"gamma-delta T cell (gammadelta2 and CD3+)"	"1"	"1"	"33546489_12_859"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"64"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID patients vs healthy controls"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 2C"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	"1"	"1"	"33546489_13_860"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID mild vs healthy controls"	"time of symptom onset"	"1-56"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 2D"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	"1"	"1"	"33546489_14_861"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"43"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID severe vs healthy controls"	"time of symptom onset"	"7-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 2D"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	"1"	"1"	"33546489_15_862"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"39"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID mild, acute patients vs healthy controls"	"time of symptom onset"	"0-72"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 2D"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	"1"	"1"	"33546489_16_863"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID severe, acute patients vs healthy controls"	"time of symptom onset"	"0-72"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 2D"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining)"	"1"	"1"	"33546489_17_864"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and CD8+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"42"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+/MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID patients vs healthy controls"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 2E"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and CD8+)"	"PR:000001084"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and CD8+)"	"1"	"1"	"33546489_18_865"
""	"mucosal invariant t cell (Valpha7.2+ and CD8+,CD161+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"12"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+/CD161+/Valpha7.2+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID mild vs healthy controls"	"time of symptom onset"	"1-56"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig S2B"	""	"CL_0000940"	"(Valpha7.2+ and CD8+,CD161+)"	"PR:000001084,PR:000025670"	"mucosal invariant t cell (Valpha7.2+ and CD8+,CD161+)"	"1"	"1"	"33546489_19_866"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and CD8+)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"25"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+/MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID convalescent vs healthy controls"	"time of hospital admission"	"4-9"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig S2C"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and CD8+)"	"PR:000001084"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and CD8+)"	"1"	"1"	"33546489_20_867"
""	"mucosal invariant t cell (Valpha7.2+ and CD8+,CD161+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"12"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+/CD161+/Valpha7.2+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID acute (mild & severe) vs healthy controls"	"time of symptom onset"	"0-72"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig S2C"	""	"CL_0000940"	"(Valpha7.2+ and CD8+,CD161+)"	"PR:000001084,PR:000025670"	"mucosal invariant t cell (Valpha7.2+ and CD8+,CD161+)"	"1"	"1"	"33546489_21_868"
""	"mucosal invariant t cell (Valpha7.2+ and CD8+,CD161+)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"9"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+/CD161+/Valpha7.2+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID convalescent vs healthy controls"	"time of hospital admission"	"4-9"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig S2C"	""	"CL_0000940"	"(Valpha7.2+ and CD8+,CD161+)"	"PR:000001084,PR:000025670"	"mucosal invariant t cell (Valpha7.2+ and CD8+,CD161+)"	"1"	"1"	"33546489_22_869"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IL12R+); mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IL18R1+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IL-12R+/MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cell; IL18R+/MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"down"	"COVID patients vs healthy controls"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 2F"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and IL12R+); (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IL18R1+)"	"PR:000008980; PR:000001377"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IL12R+); mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IL18R1+)"	"2"	"2"	"33546489_23_870"
""	"mucosal invariant t cell (Valpha7.2+ and CD38+,CD161+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry of ex-vivo expression of surface activation markers on MAIT cells"	"CD38+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"up"	"COVID patients vs healthy controls"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 3A"	""	"CL_0000940"	"(Valpha7.2+ and CD38+,CD161+)"	"PR:000001408,PR:000025670"	"mucosal invariant t cell (Valpha7.2+ and CD38+,CD161+)"	"1"	"1"	"33546489_24_871"
""	"mucosal invariant t cell (Valpha7.2+ and CD69+,CD161+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"59"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry of ex-vivo expression of surface activation markers on MAIT cells"	"CD69+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"up"	"COVID patients vs healthy controls"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 3A"	""	"CL_0000940"	"(Valpha7.2+ and CD69+,CD161+)"	"PR:000001343,PR:000025670"	"mucosal invariant t cell (Valpha7.2+ and CD69+,CD161+)"	"1"	"1"	"33546489_25_872"
""	"mucosal invariant t cell (Valpha7.2+ and HLADRA+,CD161+); mucosal invariant t cell (Valpha7.2+ and CD161+,CTLA4+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"56"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry of ex-vivo expression of surface activation markers on MAIT cells"	"HLA-DR+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cell; CTLA-4+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"up"	"COVID patients vs healthy controls"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 3A"	""	"CL_0000940"	"(Valpha7.2+ and HLADRA+,CD161+); (Valpha7.2+ and CD161+,CTLA4+)"	"PR:000002015,PR:000025670; PR:000025670,PR:000001852"	"mucosal invariant t cell (Valpha7.2+ and HLADRA+,CD161+); mucosal invariant t cell (Valpha7.2+ and CD161+,CTLA4+)"	"2"	"2"	"33546489_26_873"
""	"mucosal invariant t cell (Valpha7.2+ and CD38+,CD161+); mucosal invariant t cell (Valpha7.2+ and CD69+,CD161+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"35"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry of ex-vivo expression of surface activation markers on MAIT cells"	"CD38+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cell; CD69+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"up"	"COVID mild vs healthy controls"	"time of symptom onset"	"1-56"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 3B"	""	"CL_0000940"	"(Valpha7.2+ and CD38+,CD161+); (Valpha7.2+ and CD69+,CD161+)"	"PR:000001408,PR:000025670; PR:000001343,PR:000025670"	"mucosal invariant t cell (Valpha7.2+ and CD38+,CD161+); mucosal invariant t cell (Valpha7.2+ and CD69+,CD161+)"	"2"	"2"	"33546489_27_875"
""	"mucosal invariant t cell (Valpha7.2+ and CD38+,CD161+); mucosal invariant t cell (Valpha7.2+ and CD69+,CD161+); mucosal invariant t cell (Valpha7.2+ and CD161+,CTLA4+)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"31"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry of ex-vivo expression of surface activation markers on MAIT cells"	"CD38+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cell; CD69+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cell; CTLA-4+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"up"	"COVID severe vs healthy controls"	"time of symptom onset"	"7-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 3B"	""	"CL_0000940"	"(Valpha7.2+ and CD38+,CD161+); (Valpha7.2+ and CD69+,CD161+); (Valpha7.2+ and CD161+,CTLA4+)"	"PR:000001408,PR:000025670; PR:000001343,PR:000025670; PR:000025670,PR:000001852"	"mucosal invariant t cell (Valpha7.2+ and CD38+,CD161+); mucosal invariant t cell (Valpha7.2+ and CD69+,CD161+); mucosal invariant t cell (Valpha7.2+ and CD161+,CTLA4+)"	"3"	"3"	"33546489_28_876"
""	"mucosal invariant t cell (Valpha7.2+ and CD38+,CD161+); mucosal invariant t cell (Valpha7.2+ and CD69+,CD161+)"	"2021-06-10"	"Munich, Germany"	"24"	"86"	"years"	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry of ex-vivo expression of surface activation markers on MAIT cells"	"CD38+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cells; CD69+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT)cells"	""	"cell-type frequency"	"down"	"COVID convalescent vs COVID acute (mild & severe)"	"time of symptom onset"	"0-9"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 3D"	""	"CL_0000940"	"(Valpha7.2+ and CD38+,CD161+); (Valpha7.2+ and CD69+,CD161+)"	"PR:000001408,PR:000025670; PR:000001343,PR:000025670"	"mucosal invariant t cell (Valpha7.2+ and CD38+,CD161+); mucosal invariant t cell (Valpha7.2+ and CD69+,CD161+)"	"2"	"2"	"33546489_29_878"
""	"mucosal invariant t cell (Valpha7.2+ and CD161+,CTLA4+)"	"2021-06-10"	"Munich, Germany"	"24"	"86"	"years"	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry of ex-vivo expression of surface activation markers on MAIT cells"	"CTLA-4+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"down"	"COVID severe, convalescent patients vs COVID severe, acute patients"	"time of symptom onset"	"0-9"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 3D"	""	"CL_0000940"	"(Valpha7.2+ and CD161+,CTLA4+)"	"PR:000025670,PR:000001852"	"mucosal invariant t cell (Valpha7.2+ and CD161+,CTLA4+)"	"1"	"1"	"33546489_30_879"
""	"mucosal invariant t cell (Valpha7.2+ and HLADRA+,CD161+)"	"2021-06-10"	"Munich, Germany"	"24"	"84"	"years"	"8"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry of ex-vivo expression of surface activation markers on MAIT cells"	"HLA-DR+ CD161+ Valpha7.2+ mucosal-associated invariant T (MAIT) cell"	""	"cell-type frequency"	"positively correlated"	"SAPS II score in convalescent COVID-19 patients"	"time of hospital admission"	"4-9"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 3E; Text (Results: Section 3.3)"	""	"CL_0000940"	"(Valpha7.2+ and HLADRA+,CD161+)"	"PR:000002015,PR:000025670"	"mucosal invariant t cell (Valpha7.2+ and HLADRA+,CD161+)"	"1"	"1"	"33546489_31_880"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IL17A+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"56"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry of ex-vivo expression of surface activation markers on MAIT cells"	"IL-17A+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT)cells"	""	"cell-type frequency"	"up"	"COVID patients vs healthy controls"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 3F"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and IL17A+)"	"PR:000001138"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IL17A+)"	"1"	"1"	"33546489_32_881"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and TNFA+); mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry of ex-vivo expression of surface activation markers on MAIT cells"	"TNFalpha+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells; GrzB+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"up"	"COVID patients vs healthy controls"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 3F"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and TNFA+); (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"PR:000000134; PR:000003499"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and TNFA+); mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"2"	"2"	"33546489_33_882"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and TNFA+); mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"2021-06-10"	"Munich, Germany"	"23"	"86"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"TNFalpha+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells; GrzB+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"up"	"COVID mild vs healthy controls"	"time of symptom onset"	"1-56"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig S3D"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and TNFA+); (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"PR:000000134; PR:000003499"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and TNFA+); mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"2"	"2"	"33546489_34_883"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+); mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and PRF1+)"	"2021-06-10"	"Munich, Germany"	"23"	"84"	"years"	"19"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"GrzB+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells; Perforin+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"up"	"COVID severe vs healthy controls"	"time of symptom onset"	"7-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig S3D"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+); (identified via MR1 5-OP-RU BV421-labeled tetramer staining and PRF1+)"	"PR:000003499; PR:000003466"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+); mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and PRF1+)"	"2"	"2"	"33546489_35_884"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and PRF1+)"	"2021-06-10"	"Munich, Germany"	"24"	"86"	"years"	"25"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"Perforin+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"up"	"COVID severe vs COVID mild"	"time of symptom onset"	"1-74"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig S3D"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and PRF1+)"	"PR:000003466"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and PRF1+)"	"1"	"1"	"33546489_36_885"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IFNG+)"	"2021-06-10"	"Munich, Germany"	"24"	"86"	"years"	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & co-culture with E.coli"	"IFNgamma+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"up"	"in-vitro stimulation of COVID-19 patients PBMCs through incubation with paraformaldehyde-fixed E.coli vs unstimulated COVID-19 patients PBMCs (control)"	"time of incubation"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 4A"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and IFNG+)"	"PR:000000017"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IFNG+)"	"1"	"1"	"33546489_37_886"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IFNG+)"	"2021-06-10"	"Munich, Germany"	"24"	"86"	"years"	"21"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & in-vitro stimulation with IL-12 and IL-18"	"IFNgamma+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"up"	"in-vitro stimulation of COVID-19 patients PBMCs through incubation with IL-12 and IL-18 vs unstimulated PBMCs (control)"	"time of incubation"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 4B, Fig S4A"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and IFNG+)"	"PR:000000017"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IFNG+)"	"1"	"1"	"33546489_38_887"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and PRF1+)"	"2021-06-10"	"Munich, Germany"	"24"	"86"	"years"	"21"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry & in-vitro stimulation with IL-12 and IL-18 & co-culture with E.coli"	"Perforin+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"down"	"in-vitro stimulation of COVID-19 patients PBMCs through incubation with IL-12 and IL-18 vs unstimulated patients PBMCs (control)"	"time of incubation"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig 4D"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and PRF1+)"	"PR:000003466"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and PRF1+)"	"1"	"1"	"33546489_39_888"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IFNG+)"	"2021-06-10"	"Munich, Germany"	"24"	"86"	"years"	"30"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IFNgamma+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"up"	"COVID severe vs COVID mild (response component for both groups measured after in-vitro stimulation of COVID-19 patients PBMCs through incubation with IL-12 and IL-18)"	"time of incubation"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig S4B"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and IFNG+)"	"PR:000000017"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and IFNG+)"	"1"	"1"	"33546489_40_889"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"2021-06-10"	"Munich, Germany"	"26"	"84"	"years"	"30"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"GrzB+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"up"	"COVID severe patients PBMCs after in-vitro stimulation through incubation with IL-12 and IL-18 vs unstimulated COVID severe patients PBMCs"	"time of incubation"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig S4C"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"PR:000003499"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"1"	"1"	"33546489_41_890"
""	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"2021-06-10"	"Munich, Germany"	"24"	"86"	"years"	"30"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"GrzB+ MR1 5-OP-RU+ mucosal-associated invariant T (MAIT) cells"	""	"cell-type frequency"	"up"	"COVID severe vs COVID mild (response component for both groups measured after in-vitro stimulation of COVID-19 patients PBMCs through incubation with IL-12 and IL-18)"	"time of incubation"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33546489"	"2021-02-03"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913667/"	"Fig S4C"	""	"CL_0000940"	"(identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"PR:000003499"	"mucosal invariant t cell (identified via MR1 5-OP-RU BV421-labeled tetramer staining and GZMB+)"	"1"	"1"	"33546489_42_891"
""	"lymphocyte"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"34"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"absolute lymphocytes"	""	"cell-type frequency"	"down"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Results: 1st paragraph"	""	"CL_0000542"	""	""	"lymphocyte"	"1"	"1"	"32632085_1_892"
""	"CD4-positive, alpha-beta T cell; naive thymus-derived cd4-positive, alpha-beta t cell (CCR7+,CD45RA+,CD28+,CD27+); central memory cd4-positive, alpha-beta t cell (CCR7-,CD45RA+,CD28+,CD27+-); effector memory cd4-positive, alpha-beta t cell (CCR7-,CD45RA-,CD28+-,CD27+-)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"34"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ T cells; (CCR7+ CD45RA+ CD28+ CD27+) naive CD4+ T cells; central memory (CCR7- CD45RA+ CD28+ CD27+-) CD4+ T cells; effector memory (CCR7- CD45RA- CD28+- CD27+-) CD4+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 1B"	"Significant changes are seen in the absolute value of CD4+ T cells, (CCR7+/CD45RA+/CD28+/CD27+) naive T cells, central memory (CCR7-/CD45RA+/CD28+/CD27+-) T cells and effector memory (CCR7-/CD45RA-/CD28+-/CD27+-) T cells"	"CL:0000624; CL_0000895; CL_0000904; CL_0000905"	"; (CCR7+,CD45RA+,CD28+,CD27+); (CCR7-,CD45RA+,CD28+,CD27+-); (CCR7-,CD45RA-,CD28+-,CD27+-)"	"; PR:000001203,PR:000001015,PR:000001841,PR:000001963"	"CD4-positive, alpha-beta T cell; naive thymus-derived cd4-positive, alpha-beta t cell (CCR7+,CD45RA+,CD28+,CD27+); central memory cd4-positive, alpha-beta t cell (CCR7-,CD45RA+,CD28+,CD27+-); effector memory cd4-positive, alpha-beta t cell (CCR7-,CD45RA-,CD28+-,CD27+-)"	"4"	"4"	"32632085_2_893"
""	"effector memory cd4-positive, alpha-beta t cell, terminally differentiated (CCR7-,CD45RA+,CD28-,CD27+-)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"34"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"terminal effector (CCR7- CD45RA+ CD28- CD27+-) CD4+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 1B"	"Significant changes are seen in the percentage of terminal effector (CCR7-/CD45RA+/CD28-/CD27+-) T cells."	"CL_0001087"	"(CCR7-,CD45RA+,CD28-,CD27+-)"	"PR:000001203,PR:000001015,PR:000001841,PR:000001963"	"effector memory cd4-positive, alpha-beta t cell, terminally differentiated (CCR7-,CD45RA+,CD28-,CD27+-)"	"1"	"1"	"32632085_3_894"
""	"activated cd4-positive, alpha-beta t cell (HLADRA+,CD38+); exhausted t cell (CD57+,PD1+); cd4-positive, alpha-beta t cell (PD1+); cd4-positive, cd25-positive, alpha-beta regulatory t cell (CD127-,CD25+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"34"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"activated (HLA-DR+ CD38+) CD4+ T cells; exhausted/senescent (CD57+ PD1+) CD4+ T cells; PD1+ CD4+ T cells; regulatory (CD127- CD25+) CD4+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 1C"	"Significant changes are seen in the percentage of activated (HLA-DR+/CD38+) T cells, exhaused/senescent (CD57+/PD1+) T cells, PD1+ T cells and regulatory (CD127-/CD25+) T cells."	"CL_0000896; CL_0011025; CL_0000624; CL_0000792"	"(HLADRA+,CD38+); (CD57+,PD1+); (PD1+); (CD127-,CD25+)"	"PR:000002015,PR:000001408; PR:000001440,PR:000001919; PR:000001919; PR:000001869,PR:000001380"	"activated cd4-positive, alpha-beta t cell (HLADRA+,CD38+); exhausted t cell (CD57+,PD1+); cd4-positive, alpha-beta t cell (PD1+); cd4-positive, cd25-positive, alpha-beta regulatory t cell (CD127-,CD25+)"	"4"	"4"	"32632085_4_895"
""	"naive regulatory t cell (CD4+); activated cd4-positive, alpha-beta t cell, human (central memory, regulatory); effector memory cd4-positive, alpha-beta t cell (PD1+); activated cd4-positive, alpha-beta t cell, human (central memory, regulatory and PD1+,HLADRA+,CD38+); central memory cd4-positive, alpha-beta t cell (CD38+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"34"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"naive CD4+ T regulatory cells; central memory CD4+ T regulatory cells; PD1+ effector memory CD4+ T cells; PD1+ activated (HLA-DR+ CD38+) central memory CD4+ T cells; CD38+ central memory CD4+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 2C"	""	"CL_0002677; CL_0001043; CL_0000905; CL_0000904"	"(CD4+); (central memory, regulatory); (PD1+); (central memory, regulatory and PD1+,HLADRA+,CD38+); (CD38+)"	"PR:000001004; ; PR:000001919; PR:000001919,PR:000002015,PR:000001408; PR:000001408"	"naive regulatory t cell (CD4+); activated cd4-positive, alpha-beta t cell, human (central memory, regulatory); effector memory cd4-positive, alpha-beta t cell (PD1+); activated cd4-positive, alpha-beta t cell, human (central memory, regulatory and PD1+,HLADRA+,CD38+); central memory cd4-positive, alpha-beta t cell (CD38+)"	"5"	"5"	"32632085_5_896"
""	"cd4-positive, alpha-beta t cell (CCR6+); cd4-positive, alpha-beta t cell (CXCR3+); cd4-positive, alpha-beta t cell (CD161+,CCR6+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"13"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CCR6+ CD4+ T cells; CXCR3+ CD4+ T cells; CCR6+ CD161+ CD4+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 2E"	"Significant changes are seen in the percentage of all listed cell types."	"CL_0000624"	"(CCR6+); (CXCR3+); (CD161+,CCR6+)"	"PR:000001202; PR:000001207; PR:000025670,PR:000001202"	"cd4-positive, alpha-beta t cell (CCR6+); cd4-positive, alpha-beta t cell (CXCR3+); cd4-positive, alpha-beta t cell (CD161+,CCR6+)"	"3"	"3"	"32632085_6_897"
""	"cd4-positive, alpha-beta t cell (CXCR4+); CD4-positive, alpha-beta T cell (CCR4+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"13"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CXCR4+ CD4+ T cells; CCR4+ CD4+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 2E"	"Significant changes are seen in the percentage of all listed cell types."	"CL_0000624"	"(CXCR4+); (CCR4+)"	"PR:000001208; PR:000001200"	"cd4-positive, alpha-beta t cell (CXCR4+); CD4-positive, alpha-beta T cell (CCR4+)"	"2"	"2"	"32632085_7_898"
""	"CD8-positive, alpha-beta T cell; naive thymus-derived cd8-positive, alpha-beta t cell (CCR7+,CD45RA+,CD28+,CD27+); central memory CD8-positive, alpha-beta T cell (CCR7-,CD28+,CD27+-,CD45RA+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"34"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ T cells; naive (CCR7+ CD45RA+ CD28+ CD27+) CD8+ T cells; central memory (CCR7- CD45RA+ CD28+ CD27+-) CD8+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 3B"	"Significant changes are seen in the absolute value of CD8+ T cells, absolute value and percentage of naive (CCR7+/CD45RA+/CD28+/CD27+) T cells, absolute value and percentage of central memory (CCR7-/CD45RA+/CD28+/CD27+-) T cells."	"CL:0000625; CL_0000900; CL_0000907"	"; (CCR7+,CD45RA+,CD28+,CD27+); (CCR7-,CD28+,CD27+-,CD45RA+)"	"; PR:000001203,PR:000001015,PR:000001841,PR:000001963; PR:000001203,PR:000001841,PR:000001963,PR:000001015"	"CD8-positive, alpha-beta T cell; naive thymus-derived cd8-positive, alpha-beta t cell (CCR7+,CD45RA+,CD28+,CD27+); central memory CD8-positive, alpha-beta T cell (CCR7-,CD28+,CD27+-,CD45RA+)"	"3"	"3"	"32632085_8_899"
""	"effector memory CD8-positive, alpha-beta T cell, terminally differentiated (CCR7-,CD28-,CD27+-,CD45RA+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"34"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"terminal effector (CCR7- CD45RA+ CD28- CD27+-) CD8+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 3B"	"Significant changes are seen in the percentage of terminal effector (CCR7-/CD45RA+/CD28-/CD27+-) T cells."	"CL_0001062"	"(CCR7-,CD28-,CD27+-,CD45RA+)"	"PR:000001203,PR:000001841,PR:000001963,PR:000001015"	"effector memory CD8-positive, alpha-beta T cell, terminally differentiated (CCR7-,CD28-,CD27+-,CD45RA+)"	"1"	"1"	"32632085_9_900"
""	"activated CD8-positive, alpha-beta T cell (HLADRA+,CD38+); exhausted t cell (CD8+,PD1+,CD57+); CD8-positive, alpha-beta T cell (CD57+); cd8-positive, alpha-beta t cell (PD1+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"34"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"activated (HLA-DR+ CD38+) CD8+ T cells; exhausted PD1+ CD57+ CD8+ T cells; CD57+ CD8+ T cells; CD8+ PD1+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 3C"	"Significant changes are seen in the absolute value and percentage of activated (HLA-DR+/CD38+) T cells, percentage of CD57+/PD1+ T cells, percentage of CD57+ T cells, and percentage of PD1+ T cells."	"CL_0000906; CL_0011025; CL_0000625"	"(HLADRA+,CD38+); (CD8+,PD1+,CD57+); (CD57+); (PD1+)"	"PR:000002015,PR:000001408; PR:000001084,PR:000001919,PR:000001440; PR:000001440; PR:000001919"	"activated CD8-positive, alpha-beta T cell (HLADRA+,CD38+); exhausted t cell (CD8+,PD1+,CD57+); CD8-positive, alpha-beta T cell (CD57+); cd8-positive, alpha-beta t cell (PD1+)"	"4"	"4"	"32632085_10_901"
""	"effector CD8-positive, alpha-beta T cell (terminally differentiated and CD38+); effector memory CD8-positive, alpha-beta T cell (CD38+,CD57+); effector memory CD8-positive, alpha-beta T cell (activated and PD1+); effector memory CD8-positive, alpha-beta T cell (CD57+); effector CD8-positive, alpha-beta T cell (terminally differentiated and CD57+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD38+ terminal effector CD8+ T cells; CD38+/CD57+ effector memory CD8+ T cells; PD1+ activated effector memory CD8+ T cells; CD57+ effector memory CD8+ T cell; CD57+ terminal effector CD8+ T cell"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 4C"	""	"CL_0001050; CL_0000913"	"(terminally differentiated and CD38+); (CD38+,CD57+); (activated and PD1+); (CD57+); (terminally differentiated and CD57+)"	"PR:000001408; PR:000001408,PR:000001440; PR:000001919; PR:000001440"	"effector CD8-positive, alpha-beta T cell (terminally differentiated and CD38+); effector memory CD8-positive, alpha-beta T cell (CD38+,CD57+); effector memory CD8-positive, alpha-beta T cell (activated and PD1+); effector memory CD8-positive, alpha-beta T cell (CD57+); effector CD8-positive, alpha-beta T cell (terminally differentiated and CD57+)"	"5"	"5"	"32632085_11_902"
""	"central memory CD8-positive, alpha-beta T cell; naive thymus-derived CD8-positive, alpha-beta T cell"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ central memory T cells; CD8+ naive T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 4C"	""	"CL_0000907; CL_0000900"	""	""	"central memory CD8-positive, alpha-beta T cell; naive thymus-derived CD8-positive, alpha-beta T cell"	"2"	"2"	"32632085_12_903"
""	"CD8-positive, alpha-beta T cell (CCR4+); CD8-positive, alpha-beta T cell (CXCR4+); CD8-positive, alpha-beta T cell (GATA3+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"13"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CCR4+ CD8+ T cell; CXCR4+ CD8+ T cell; GATA3+ CD8+ T cell"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 4E"	"Significant changes are seen in the percentage of all listed cell types."	"CL_0000625"	"(CCR4+); (CXCR4+); (GATA3+)"	"PR:000001200; PR:000001208; PR:000001941"	"CD8-positive, alpha-beta T cell (CCR4+); CD8-positive, alpha-beta T cell (CXCR4+); CD8-positive, alpha-beta T cell (GATA3+)"	"3"	"3"	"32632085_13_904"
""	"CD8-positive, alpha-beta T cell (TBET+); CD8-positive, alpha-beta T cell (CXCR3+); CD8-positive, alpha-beta T cell (CXCR3+,TBET+); CD8-positive, alpha-beta T cell (CCR6+); CD8-positive, alpha-beta T cell (CD161++); CD8-positive, alpha-beta T cell (CCR6+,CD161+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"13"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"TBET+ CD8+ T cell; CXCR3+ CD8+ T cell; CXCR3+/TBET+ CD8+ T cell; CCR6+ CD8+ T cell; CD161high CD8+ T cell; CCR6+/CD161+ CD8+ T cell"	""	"cell-type frequency"	"down"	"COVID-19 patients vs healthy controls"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 4E"	"Significant changes are seen in the percentage of all listed cell types."	"CL_0000625"	"(TBET+); (CXCR3+); (CXCR3+,TBET+); (CCR6+); (CD161++); (CCR6+,CD161+)"	"PR:000001835; PR:000001207; PR:000001207,PR:000001835; PR:000001202; PR:000025670; PR:000001202,PR:000025670"	"CD8-positive, alpha-beta T cell (TBET+); CD8-positive, alpha-beta T cell (CXCR3+); CD8-positive, alpha-beta T cell (CXCR3+,TBET+); CD8-positive, alpha-beta T cell (CCR6+); CD8-positive, alpha-beta T cell (CD161++); CD8-positive, alpha-beta T cell (CCR6+,CD161+)"	"6"	"6"	"32632085_14_905"
""	"CD4-positive, alpha-beta T cell (IFNG+); cd4-positive, alpha-beta t cell (TNF+); CD4-positive, alpha-beta T cell (IL17A+); cd4-positive, alpha-beta t cell (IL2+); CD4-positive, alpha-beta T cell (CD107a+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"14"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IFN-gamma+ CD4+ T cells; TNF+ CD4+ T cells; IL-17A+ CD4+ T cells; IL-2+ CD4+ T cells; CD107a+ CD4+ T cells"	""	"cell-type frequency"	"up"	"PBMCs after stimulation with anti-CD3/CD28 (patient vs healthy controls)"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 8C"	"Significant changes are seen in the percentage of CD4+ T cells producing the given cytokine."	"CL_0000624"	"(IFNG+); (TNF+); (IL17A+); (IL2+); (CD107a+)"	"PR:000000017; PR:000000134; PR:000001138; PR:000001379; PR:000002060"	"CD4-positive, alpha-beta T cell (IFNG+); cd4-positive, alpha-beta t cell (TNF+); CD4-positive, alpha-beta T cell (IL17A+); cd4-positive, alpha-beta t cell (IL2+); CD4-positive, alpha-beta T cell (CD107a+)"	"5"	"5"	"32632085_15_907"
""	"CD8-positive, alpha-beta T cell (IL17A+); CD8-positive, alpha-beta T cell (IL2+); CD8-positive, alpha-beta T cell (CD107a+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"14"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IL-17A+ CD8+ T cells; IL-2+ CD8+ T cells; CD107a+ CD8+ T cells"	""	"cell-type frequency"	"up"	"PBMCs after stimulation with anti-CD3/CD28 (patient vs healthy controls)"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 8D"	"Significant changes are seen in the percentage of CD8+ T cells producing the given cytokine."	"CL_0000625"	"(IL17A+); (IL2+); (CD107a+)"	"PR:000001138; PR:000001379; PR:000002060"	"CD8-positive, alpha-beta T cell (IL17A+); CD8-positive, alpha-beta T cell (IL2+); CD8-positive, alpha-beta T cell (CD107a+)"	"3"	"3"	"32632085_16_908"
""	"cd4-positive, alpha-beta t cell (TNF+,IFNG+,CD107A+); cd4-positive, alpha-beta t cell (TNF+); CD4-positive, alpha-beta T cell (IL2+,IL17+)"	"2021-06-13"	"severe COVID-19 patients with pneumonia and healthy controls (Modena, Italy)"	"36"	"49"	"years"	"18"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"107+ IFN+ TNF+ CD4+ T cells; TNF+ CD4+ T cells; IL2+ IL17+ CD4+ T cells"	""	"cell-type frequency"	"up"	"PBMCs after stimulation with anti-CD3/CD28 (patient vs healthy controls)"	"time of symptom onset"	"0-19"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32632085"	"2020-07-06"	"https://www.nature.com/articles/s41467-020-17292-4"	"Fig 9B"	"Significant changes are seen in the percentage of CD4+ T cells producing the given cytokine."	"CL_0000624"	"(TNF+,IFNG+,CD107A+); (TNF+); (IL2+,IL17+)"	"PR:000000134,PR:000000017,PR:000002060; PR:000000134; PR:000001379,PR:000001138"	"cd4-positive, alpha-beta t cell (TNF+,IFNG+,CD107A+); cd4-positive, alpha-beta t cell (TNF+); CD4-positive, alpha-beta T cell (IL2+,IL17+)"	"3"	"3"	"32632085_17_909"
""	"neutrophil"	"2021-06-22"	"COVID-19 patients w/ mild/common disease in Beijing, China"	"29"	"78"	"years"	"11"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"clinical laboratory data"	"Neutrophils"	""	"cell-type frequency"	"up"	"COVID-19 patient with severe or critically severe disease (Group A) vs COVID-19 patients with mild or common disease (Group B)"	"time of admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32307550"	"2020-04-20"	"https://academic.oup.com/cid/article/71/16/2052/5822600/"	"Table 1"	""	"CL_0000775"	""	""	"neutrophil"	"1"	"1"	"32307550_1_913"
""	"t cell; CD4-positive, alpha-beta T cell; CD8-positive, alpha-beta T cell"	"2021-06-22"	"COVID-19 patients w/ mild/common disease in Beijing, China"	"46"	"78"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"CyTOF mass cytometry"	"T cells; CD4+ T cells; CD8+ T cells"	""	"cell-type frequency"	"down"	"samples at 0d from COVID-19 patients with severe or critically severe disease (Group A1) vs samples from normal control (Group NC)"	"time of admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32307550"	"2020-04-20"	"https://academic.oup.com/cid/article/71/16/2052/5822600/"	"Fig 4D, last half of Results section \"Potential Key Genes...\""	""	"CL_0000084; CL:0000624; CL:0000625"	""	""	"t cell; CD4-positive, alpha-beta T cell; CD8-positive, alpha-beta T cell"	"3"	"3"	"32307550_2_933"
""	"t cell; CD8-positive, alpha-beta T cell"	"2021-06-22"	"COVID-19 patients w/ mild/common disease in Beijing, China"	"46"	"78"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"CyTOF mass cytometry"	"T cells; CD8+ T cells"	""	"cell-type frequency"	"down"	"samples at 5d from COVID-19 patients with severe or critically severe disease (Group A2) vs samples from normal control (Group NC)"	"time of admission"	"5"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32307550"	"2020-04-20"	"https://academic.oup.com/cid/article/71/16/2052/5822600/"	"Fig 4D, last half of Results section \"Potential Key Genes...\""	""	"CL_0000084; CL:0000625"	""	""	"t cell; CD8-positive, alpha-beta T cell"	"2"	"2"	"32307550_3_934"
""	"t cell; CD8-positive, alpha-beta T cell"	"2021-06-22"	"COVID-19 patients w/ mild/common disease in Beijing, China"	"29"	"65"	"years"	"5"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"CyTOF mass cytometry"	"T cells; CD8+ T cells"	""	"cell-type frequency"	"down"	"samples at 0d from COVID-19 patients with mild or common disease (Group B1) vs samples from normal controls (Group NC)"	"time of admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32307550"	"2020-04-20"	"https://academic.oup.com/cid/article/71/16/2052/5822600/"	"Fig 4D, last half of Results section \"Potential Key Genes...\""	""	"CL_0000084; CL:0000625"	""	""	"t cell; CD8-positive, alpha-beta T cell"	"2"	"2"	"32307550_4_935"
""	"monocyte"	""	"London, UK"	""	""	""	"78"	"Serum/Plasma"	"UBERON:0001977; UBERON:0001969"	"RT-qPCR"	"monocytes"	""	"cell-type frequency"	"negatively correlated"	"SARS-CoV-2-RNAemia in COVID-19 ICU patients"	"time of ICU admission"	"0-24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"34099652"	"2021-06-07"	"https://www.nature.com/articles/s41467-021-23494-1/"	"Fig 2C"	""	"CL:0000576"	""	""	"monocyte"	"1"	"1"	"34099652_1_939"
""	"leukocyte; neutrophil"	"2021-07-07"	"Wuhan, China"	"42.8"	"66"	"years"	"21"	"Whole Blood"	"UBERON:0000178"	"clinical laboratory data"	"white blood cells; neutrophils"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32217835"	"2020-03-27"	"https://www.jci.org/articles/view/137244"	"Table 2"	""	"CL_0000738; CL_0000775"	""	""	"leukocyte; neutrophil"	"2"	"2"	"32217835_1_968"
""	"lymphocyte"	"2021-07-07"	"Wuhan, China"	"42.8"	"66"	"years"	"21"	"Whole Blood"	"UBERON:0000178"	"clinical laboratory data"	"lymphocyte"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32217835"	"2020-03-27"	"https://www.jci.org/articles/view/137244"	"Table 2"	""	"CL:0000542"	""	""	"lymphocyte"	"1"	"1"	"32217835_2_969"
""	"T cell; CD4-positive, alpha-beta T cell; CD8-positive, alpha-beta T cell"	"2021-07-07"	"Wuhan, China"	"42.8"	"66"	"years"	"14"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"Total T Lymphocytes; CD4+ T cells; CD8+ T cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32217835"	"2020-03-27"	"https://www.jci.org/articles/view/137244"	"Fig 3A-B, Table 3"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000084; CL:0000624; CL:0000625"	""	""	"T cell; CD4-positive, alpha-beta T cell; CD8-positive, alpha-beta T cell"	"3"	"3"	"32217835_3_973"
""	"T cell"	"2021-07-07"	"Wuhan, China"	"42.8"	"66"	"years"	"21"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"Total T Lymphocytes"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32217835"	"2020-03-27"	"https://www.jci.org/articles/view/137244"	"Table 3"	"Significant changes were observed in the frequency (%) of the given cell(s)."	"CL_0000084"	""	""	"T cell"	"1"	"1"	"32217835_4_974"
""	"B cell"	"2021-07-07"	"Wuhan, China"	"42.8"	"66"	"years"	"21"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"Total B Lymphocytes"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32217835"	"2020-03-27"	"https://www.jci.org/articles/view/137244"	"Table 3"	"Significant changes were observed in the frequency (%) of the given cell(s)."	"CL_0000236"	""	""	"B cell"	"1"	"1"	"32217835_5_975"
""	"regulatory T cell (CD45RA+)"	"2021-07-07"	"Wuhan, China"	"42.8"	"66"	"years"	"21"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD45RA+ Treg cells"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs moderate COVID-19 patients"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32217835"	"2020-03-27"	"https://www.jci.org/articles/view/137244"	"Table 3"	"Significant changes were observed in the frequency (%) of the given cell(s) within Treg cells"	"CL_0000815"	"(CD45RA+)"	"PR:000001015"	"regulatory T cell (CD45RA+)"	"1"	"1"	"32217835_6_976"
""	"leukocyte"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused either by bacterial infection (with sepsis) or by SARS-CoV-2 (Athens, Greece)"	"48.9"	"91.6"	"years"	"74"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"clinical laboratory test"	"white blood cells"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with no respiratory failure vs bacterial CAP patients with no respiratory failure"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Table 1"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000738"	""	""	"leukocyte"	"1"	"1"	"32320677_1_977"
""	"leukocyte"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused either by bacterial infection (with sepsis) or by SARS-CoV-2 (Athens, Greece)"	"57"	"86.6"	"years"	"84"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"clinical laboratory test"	"white blood cells"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with severe respiratory failure vs bacterial CAP patients with severe respiratory failure"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Table 1"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000738"	""	""	"leukocyte"	"1"	"1"	"32320677_2_978"
""	"neutrophil"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"47"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"Neutrophils"	""	"cell-type frequency"	"up"	"SARS-CoV-2 CAP patients with immune dysregulation vs SARS-CoV-2 CAP patients with intermediate immune activation"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 1E"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000775"	""	""	"neutrophil"	"1"	"1"	"32320677_3_993"
""	"monocyte"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"33"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"Monocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with macrophage-activation syndrome vs SARS-CoV-2 CAP patients with intermediate immune activation"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 1F"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000576"	""	""	"monocyte"	"1"	"1"	"32320677_4_994"
""	"monocyte"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"Monocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with macrophage-activation syndrome vs SARS-CoV-2 CAP patients with immune dysregulation"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 1F"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000576"	""	""	"monocyte"	"1"	"1"	"32320677_5_995"
""	"natural killer cell (CD3+,CD4+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection and healthy controls (Athens, Greece)"	"48.9"	"78.6"	"years"	"19"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD4+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with intermediate immune activation vs healthy controls"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2A"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD4+,CD45+)"	"PR:000001020,PR:000001004,PR:000001006"	"natural killer cell (CD3+,CD4+,CD45+)"	"1"	"1"	"32320677_6_996"
""	"natural killer cell (CD3+,CD8+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection and healthy controls (Athens, Greece)"	"48.9"	"78.6"	"years"	"19"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD8+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with intermediate immune activation vs healthy controls"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2B"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD8+,CD45+)"	"PR:000001020,PR:000001084,PR:000001006"	"natural killer cell (CD3+,CD8+,CD45+)"	"1"	"1"	"32320677_7_997"
""	"natural killer cell (CD19+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection and healthy controls (Athens, Greece)"	"48.9"	"78.6"	"years"	"19"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD19+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with intermediate immune activation vs healthy controls"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2E"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD19+,CD45+)"	"PR:000001002,PR:000001006"	"natural killer cell (CD19+,CD45+)"	"1"	"1"	"32320677_8_998"
""	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection and healthy controls (Athens, Greece)"	"48.9"	"78.6"	"years"	"19"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD16+ CD56+ CD45+ lymphocytes"	""	"cell-type frequency"	"up"	"SARS-CoV-2 CAP patients with intermediate immune activation vs healthy controls"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2D"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3-,CD16+,CD56+,CD45+)"	"PR:000001020,PR:000001483,PR:000001024,PR:000001006"	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"1"	"1"	"32320677_9_999"
""	"natural killer cell (CD3+,CD4+,CD45+); natural killer cell (CD3+,CD8+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection and healthy controls (Athens, Greece)"	"48.9"	"78.6"	"years"	"24"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD4+ CD45+ lymphocytes; CD3+ CD8+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with immune dysregulation vs healthy controls"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2A"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD4+,CD45+); (CD3+,CD8+,CD45+)"	"PR:000001020,PR:000001004,PR:000001006; PR:000001020,PR:000001084,PR:000001006"	"natural killer cell (CD3+,CD4+,CD45+); natural killer cell (CD3+,CD8+,CD45+)"	"2"	"2"	"32320677_10_1000"
""	"natural killer cell (CD3+,CD4+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection and healthy controls (Athens, Greece)"	"48.9"	"78.6"	"years"	"13"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD4+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with macrophage-activation syndrome vs healthy controls"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2A"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD4+,CD45+)"	"PR:000001020,PR:000001004,PR:000001006"	"natural killer cell (CD3+,CD4+,CD45+)"	"1"	"1"	"32320677_11_1001"
""	"natural killer cell (CD3+,CD8+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection and healthy controls (Athens, Greece)"	"48.9"	"78.6"	"years"	"13"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD8+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with macrophage-activation syndrome vs healthy controls"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2B"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD8+,CD45+)"	"PR:000001020,PR:000001084,PR:000001006"	"natural killer cell (CD3+,CD8+,CD45+)"	"1"	"1"	"32320677_12_1002"
""	"natural killer cell (CD19+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection and healthy controls (Athens, Greece)"	"48.9"	"78.6"	"years"	"13"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD19+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with macrophage-activation syndrome vs healthy controls"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2E"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD19+,CD45+)"	"PR:000001002,PR:000001006"	"natural killer cell (CD19+,CD45+)"	"1"	"1"	"32320677_13_1003"
""	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"48.9"	"78.6"	"years"	"24"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD16+ CD56+ CD45+ lymphocytes"	""	"cell-type frequency"	"up"	"SARS-CoV-2 CAP patients with macrophage-activation syndrome vs 2009 H1N1 CAP patients"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2D"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3-,CD16+,CD56+,CD45+)"	"PR:000001020,PR:000001483,PR:000001024,PR:000001006"	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"1"	"1"	"32320677_14_1004"
""	"natural killer cell (CD19+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"48.9"	"78.6"	"years"	"24"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD19+ CD45+ lymphocytes"	""	"cell-type frequency"	"up"	"SARS-CoV-2 CAP patients with macrophage-activation syndrome vs 2009 H1N1 CAP patients"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2E"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD19+,CD45+)"	"PR:000001002,PR:000001006"	"natural killer cell (CD19+,CD45+)"	"1"	"1"	"32320677_15_1005"
""	"natural killer cell (CD3+,CD4+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"48.9"	"78.6"	"years"	"45"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD4+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with immune dysregulation vs 2009 H1N1 CAP patients"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2A"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD4+,CD45+)"	"PR:000001020,PR:000001004,PR:000001006"	"natural killer cell (CD3+,CD4+,CD45+)"	"1"	"1"	"32320677_16_1006"
""	"natural killer cell (CD3+,CD8+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"48.9"	"78.6"	"years"	"45"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD8+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with immune dysregulation vs 2009 H1N1 CAP patients"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2B"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD8+,CD45+)"	"PR:000001020,PR:000001084,PR:000001006"	"natural killer cell (CD3+,CD8+,CD45+)"	"1"	"1"	"32320677_17_1007"
""	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"48.9"	"78.6"	"years"	"45"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD16+ CD56+ CD45+ lymphocytes"	""	"cell-type frequency"	"up"	"SARS-CoV-2 CAP patients with immune dysregulation vs 2009 H1N1 CAP patients"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2D"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3-,CD16+,CD56+,CD45+)"	"PR:000001020,PR:000001483,PR:000001024,PR:000001006"	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"1"	"1"	"32320677_18_1008"
""	"natural killer cell (CD19+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"48.9"	"78.6"	"years"	"45"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD19+ CD45+ lymphocytes"	""	"cell-type frequency"	"up"	"SARS-CoV-2 CAP patients with immune dysregulation vs 2009 H1N1 CAP patients"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2E"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD19+,CD45+)"	"PR:000001002,PR:000001006"	"natural killer cell (CD19+,CD45+)"	"1"	"1"	"32320677_19_1009"
""	"natural killer cell (CD3+,CD4+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"48.9"	"78.6"	"years"	"30"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD4+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with intermediate immune activation vs 2009 H1N1 CAP patients"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2A"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD4+,CD45+)"	"PR:000001020,PR:000001004,PR:000001006"	"natural killer cell (CD3+,CD4+,CD45+)"	"1"	"1"	"32320677_20_1010"
""	"natural killer cell (CD3+,CD4+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"23"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD4+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with immune dysregulation vs SARS-CoV-2 CAP patients with intermediate immune activation"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2A"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD4+,CD45+)"	"PR:000001020,PR:000001004,PR:000001006"	"natural killer cell (CD3+,CD4+,CD45+)"	"1"	"1"	"32320677_21_1011"
""	"natural killer cell (CD3+,CD8+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"23"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD8+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with immune dysregulation vs SARS-CoV-2 CAP patients with intermediate immune activation"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2B"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD8+,CD45+)"	"PR:000001020,PR:000001084,PR:000001006"	"natural killer cell (CD3+,CD8+,CD45+)"	"1"	"1"	"32320677_22_1012"
""	"natural killer cell (CD3+,CD8+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"12"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD8+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with macrophage-activation syndrome vs SARS-CoV-2 CAP patients with intermediate immune activation"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2B"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD8+,CD45+)"	"PR:000001020,PR:000001084,PR:000001006"	"natural killer cell (CD3+,CD8+,CD45+)"	"1"	"1"	"32320677_23_1013"
""	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"48.9"	"78.6"	"years"	"30"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD16+ CD56+ CD45+ lymphocytes"	""	"cell-type frequency"	"up"	"SARS-CoV-2 CAP patients with intermediate immune activation vs 2009 H1N1 CAP patients"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2D"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3-,CD16+,CD56+,CD45+)"	"PR:000001020,PR:000001483,PR:000001024,PR:000001006"	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"1"	"1"	"32320677_24_1014"
""	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"23"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD16+ CD56+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with immune dysregulation vs SARS-CoV-2 CAP patients with intermediate immune activation"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2D"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3-,CD16+,CD56+,CD45+)"	"PR:000001020,PR:000001483,PR:000001024,PR:000001006"	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"1"	"1"	"32320677_25_1015"
""	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"12"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD16+ CD56+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with macrophage-activation syndrome vs SARS-CoV-2 CAP patients with intermediate immune activation"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2D"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3-,CD16+,CD56+,CD45+)"	"PR:000001020,PR:000001483,PR:000001024,PR:000001006"	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"1"	"1"	"32320677_26_1016"
""	"natural killer cell (CD19+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"48.9"	"78.6"	"years"	"30"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD19+ CD45+ lymphocytes"	""	"cell-type frequency"	"up"	"SARS-CoV-2 CAP patients with intermediate immune activation vs 2009 H1N1 CAP patients"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2E"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD19+,CD45+)"	"PR:000001002,PR:000001006"	"natural killer cell (CD19+,CD45+)"	"1"	"1"	"32320677_27_1017"
""	"natural killer cell (CD19+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"12"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD19+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with macrophage-activation syndrome vs SARS-CoV-2 CAP patients with intermediate immune activation"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2E"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD19+,CD45+)"	"PR:000001002,PR:000001006"	"natural killer cell (CD19+,CD45+)"	"1"	"1"	"32320677_28_1018"
""	"natural killer cell (CD3+,CD4+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"57"	"78.6"	"years"	"21"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CD4+ CD45+ lymphocytes"	""	"cell-type frequency"	"down"	"SARS-CoV-2 CAP patients with severe respiratory failure vs 2009 H1N1 CAP patients with severe respiratory failure"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2F"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3+,CD4+,CD45+)"	"PR:000001020,PR:000001004,PR:000001006"	"natural killer cell (CD3+,CD4+,CD45+)"	"1"	"1"	"32320677_29_1019"
""	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"57"	"78.6"	"years"	"21"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD16+ CD56+ CD45+ lymphocytes"	""	"cell-type frequency"	"up"	"SARS-CoV-2 CAP patients with severe respiratory failure vs 2009 H1N1 CAP patients with severe respiratory failure"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2I"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD3-,CD16+,CD56+,CD45+)"	"PR:000001020,PR:000001483,PR:000001024,PR:000001006"	"natural killer cell (CD3-,CD16+,CD56+,CD45+)"	"1"	"1"	"32320677_30_1020"
""	"natural killer cell (CD19+,CD45+)"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by infection with either SARS-CoV-2 or 2009 H1N1 influenza (Athens, Greece)"	"57"	"78.6"	"years"	"21"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD19+ CD45+ lymphocytes"	""	"cell-type frequency"	"up"	"SARS-CoV-2 CAP patients with severe respiratory failure vs 2009 H1N1 CAP patients with severe respiratory failure"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 2J"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL_0000623"	"(CD19+,CD45+)"	"PR:000001002,PR:000001006"	"natural killer cell (CD19+,CD45+)"	"1"	"1"	"32320677_31_1021"
""	"lymphocyte"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"54"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	""	"lymphocyte"	""	"cell-type frequency"	"positively correlated"	"absolute number of mHLA-DR/CD14 monocytes"	"time of hospital admission"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 5B"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL:0000542"	""	""	"lymphocyte"	"1"	"1"	"32320677_32_1039"
""	"lymphocyte"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"immunomodulatory therapy w/ Tocilizumab"	"lymphocyte"	""	"cell-type frequency"	"up"	"24 hours post-treatment vs pre-treatment with immunomodulatory therapy Tocilizumab in SARS-CoV-2 patients w/ immune dysregulation"	"start of immunomodulatory therapy with Tocilizumab"	"24"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 5G"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL:0000542"	""	""	"lymphocyte"	"1"	"1"	"32320677_34_1044"
""	"lymphocyte"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"immunomodulatory therapy w/ Tocilizumab"	"lymphocyte"	""	"cell-type frequency"	"up"	"72h vs 24h after the start of immunomodulatory therapy with Tocilizumab in SARS-CoV-2 patients w/ immune dysregulation"	"start of immunomodulatory therapy with Tocilizumab"	"24 and 72"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 5G"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL:0000542"	""	""	"lymphocyte"	"1"	"1"	"32320677_35_1045"
""	"lymphocyte"	"2021-07-11"	"patients with community-acquired pneumonia (CAP) caused by SARS-CoV-2 infection (Athens, Greece)"	"48.9"	"78.6"	"years"	"6"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"immunomodulatory therapy w/ Tocilizumab"	"lymphocyte"	""	"cell-type frequency"	"up"	"72 hours post-treatment vs pre-treatment with immunomodulatory therapy Tocilizumab in SARS-CoV-2 patients w/ immune dysregulation"	"start of immunomodulatory therapy with Tocilizumab"	"72"	"hours"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32320677"	"2020-04-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172841/"	"Fig 5G"	"Significant changes were observed in the absolute number of the given cell(s)."	"CL:0000542"	""	""	"lymphocyte"	"1"	"1"	"32320677_36_1046"
""	"plasma cell (CD27++,CD38++)"	""	"ICU COVID-19 adult patients and healthy controls"	"42"	"91"	"years"	"13"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD27high CD38high B cells"	""	"cell-type frequency"	"up"	"severe COVID-19 patients vs healthy controls"	"time of ICU admission"	"3-31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33785765"	"2021-03-30"	"https://www.nature.com/articles/s41467-021-22210-3"	"Fig 1A"	"Significant changes were observed in the percentage of the given cell(s)."	"CL_0000786"	"(CD27++,CD38++)"	"PR:000001963,PR:000001408"	"plasma cell (CD27++,CD38++)"	"1"	"1"	"33785765_1_1047"
""	"plasma cell (CD27++,CD38++,IGA2+)"	""	"ICU COVID-19 adult patients and healthy controls"	"58"	"91"	"years"	"14"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ELISA; cytometric serology"	"IgA2+ CD27high CD38high B cells"	""	"cell-type frequency"	"up"	"severe COVID-19 patients with samples more than 7 days after ICU admission (Late) vs severe COVID-19 patients with samples within 7 days after ICU admission (1st week)"	"time of ICU admission"	"3-31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33785765"	"2021-03-30"	"https://www.nature.com/articles/s41467-021-22210-3"	"Fig 2B"	"Significant changes were observed in the percentage of the given cell(s)."	"CL_0000786"	"(CD27++,CD38++,IGA2+)"	"PR:000001963,PR:000001408,PR:000050180"	"plasma cell (CD27++,CD38++,IGA2+)"	"1"	"1"	"33785765_2_1048"
""	"plasmablast (IgA2+,CD27+,CD38+)"	""	"ICU COVID-19 adult patients and healthy controls"	"42"	"91"	"years"	"14"	"autopsied lung tissue"	"UBERON:0002048"	"MELC"	"IgA2+ CD27+ CD38+ plasmablasts"	""	"cell-type frequency"	"down"	"severe COVID-19 patients vs healthy controls"	"time of ICU admission"	"3-31"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33785765"	"2021-03-30"	"https://www.nature.com/articles/s41467-021-22210-3"	"Fig 6A-B"	"Significant changes were observed in the absolute numbers of the given cell(s) per image in 6A."	"CL_0000980"	"(IgA2+,CD27+,CD38+)"	"PR:000050180,PR:000001963,PR:000001408"	"plasmablast (IgA2+,CD27+,CD38+)"	"1"	"1"	"33785765_3_1050"
""	"CD8-positive, alpha-beta memory T cell"	""	"COVID-19 adult patients"	"22"	"82"	"years"	"39"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"memory CD8+ T cells"	""	"cell-type frequency"	"up"	"hospitalized patients with severe disease (N=22) vs non-hospitalized patients with mild disease (N=17)"	"time of symptom onset"	"2-47"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33478949"	"2021-01-21"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101257/"	"Fig 1B"	""	"CL_0000909"	""	""	"CD8-positive, alpha-beta memory T cell"	"1"	"1"	"33478949_1_1051"
""	"lymphocyte"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"lymphocytes"	""	"cell-type frequency"	"down"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32 (avg. 11)"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Suppl Fig 1"	""	"CL_0000542"	""	""	"lymphocyte"	"1"	"1"	"32650275_22_1052"
""	"lymphocyte"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"30"	"Whole Blood"	"UBERON:0000178"	""	"lymphocytes"	""	"cell-type frequency"	"down"	"severe disease vs mild disease"	"time of symptom onset"	"2-32 (avg. 11)"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Suppl Fig 1"	""	"CL_0000542"	""	""	"lymphocyte"	"1"	"1"	"32650275_23_1053"
""	"lymphocyte"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"lymphocytes"	""	"cell-type frequency"	"down"	"mild disease vs healthy control"	"time of symptom onset"	"2-32 (avg. 11)"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Suppl Fig 1"	""	"CL_0000542"	""	""	"lymphocyte"	"1"	"1"	"32650275_24_1054"
""	"b cell; natural killer cell; mature nk t cell; mature gamma-delta T cell; gamma-delta T cell (Vgamma9-); gamma-delta T cell (Vgamma9+); CD8-positive, alpha-beta T cell; CD4-positive, alpha-beta T cell; regulatory T cell"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"B cells; NK cells; NK T cells; TCRgammadelta+ cells; Vgamma9- cells; Vgamma9+ cells; CD8+ T cells; CD4+ T cells; regulatory T cells"	""	"cell-type frequency"	"down"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 1"	""	"CL_0000236; CL_0000623; CL_0000814; CL_0000800; CL_0000798; CL:0000625; CL:0000624; CL_0000815"	"; (Vgamma9-); (Vgamma9+)"	"; PR:Q99603"	"b cell; natural killer cell; mature nk t cell; mature gamma-delta T cell; gamma-delta T cell (Vgamma9-); gamma-delta T cell (Vgamma9+); CD8-positive, alpha-beta T cell; CD4-positive, alpha-beta T cell; regulatory T cell"	"9"	"9"	"32650275_25_1055"
""	"natural killer cell; mature nk t cell; mature gamma-delta T cell; CD8-positive, alpha-beta T cell"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"30"	"Whole Blood"	"UBERON:0000178"	""	"NK cells; NK T cells; TCRgammadelta+ cells; CD8+ T cells"	""	"cell-type frequency"	"down"	"severe disease vs mild disease"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 1"	""	"CL_0000623; CL_0000814; CL_0000800; CL:0000625"	""	""	"natural killer cell; mature nk t cell; mature gamma-delta T cell; CD8-positive, alpha-beta T cell"	"4"	"4"	"32650275_26_1056"
""	"b cell; regulatory T cell"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"B cells; regulatory T cells"	""	"cell-type frequency"	"down"	"mild disease vs healthy control"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 1"	""	"CL_0000236; CL_0000815"	""	""	"b cell; regulatory T cell"	"2"	"2"	"32650275_27_1057"
""	"effector memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L-)"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"effector/effector memory (CD45RA- CD62L-) CD4+ T cells"	""	"cell-type frequency"	"down"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2A, Suppl Fig 3A"	""	"CL_0000905"	"(CD45RA-,CD62L-)"	"PR:000001015,PR:000001318"	"effector memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L-)"	"1"	"1"	"32650275_28_1058"
""	"effector memory CD4-positive, alpha-beta T cell, terminally differentiated (CD45RA+,CD62L-)"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"terminally differentiated (CD45RA+ CD62L-) CD4+ T cells"	""	"cell-type frequency"	"up"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2A, Suppl Fig 3A"	""	"CL_0001087"	"(CD45RA+,CD62L-)"	"PR:000001015,PR:000001318"	"effector memory CD4-positive, alpha-beta T cell, terminally differentiated (CD45RA+,CD62L-)"	"1"	"1"	"32650275_29_1059"
""	"effector memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L-)"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"effector/effector memory (CD45RA- CD62L-) CD4+ T cells"	""	"cell-type frequency"	"down"	"mild disease vs healthy control"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2A, Suppl Fig 3A"	""	"CL_0000905"	"(CD45RA-,CD62L-)"	"PR:000001015,PR:000001318"	"effector memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L-)"	"1"	"1"	"32650275_30_1060"
""	"effector memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L-)"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"30"	"Whole Blood"	"UBERON:0000178"	""	"effector/effector memory (CD45RA- CD62L-) CD4+ T cells"	""	"cell-type frequency"	"down"	"severe disease vs mild disease"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2A, Suppl Fig 3A"	""	"CL_0000905"	"(CD45RA-,CD62L-)"	"PR:000001015,PR:000001318"	"effector memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L-)"	"1"	"1"	"32650275_31_1061"
""	"effector memory CD4-positive, alpha-beta T cell, terminally differentiated (CD45RA+,CD62L-); central memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L+)"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"terminally differentiated (CD45RA+ CD62L-) CD4+ T cells; central memory (CD45RA- CD62L+) CD4+ T cells"	""	"cell-type frequency"	"up"	"mild disease vs healthy control"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2A, Suppl Fig 3A"	""	"CL_0001087; CL_0000904"	"(CD45RA+,CD62L-); (CD45RA-,CD62L+)"	"PR:000001015,PR:000001318"	"effector memory CD4-positive, alpha-beta T cell, terminally differentiated (CD45RA+,CD62L-); central memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L+)"	"2"	"2"	"32650275_32_1062"
""	"naive thymus-derived CD8-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"CD8+ naive T cells; CD8+ effector/effector memory T cells"	""	"cell-type frequency"	"up"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2B"	""	"CL_0000900; CL_0000913"	""	""	"naive thymus-derived CD8-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell"	"2"	"2"	"32650275_33_1063"
""	"central memory CD8-positive, alpha-beta T cell"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"CD8+ central memory T cells"	""	"cell-type frequency"	"down"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2B, Suppl Fig 3B"	""	"CL_0000907"	""	""	"central memory CD8-positive, alpha-beta T cell"	"1"	"1"	"32650275_34_1064"
""	"effector memory CD8-positive, alpha-beta T cell, terminally differentiated"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"CD8+ terminally differentiated T cells"	""	"cell-type frequency"	"down"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2B"	""	"CL_0001062"	""	""	"effector memory CD8-positive, alpha-beta T cell, terminally differentiated"	"1"	"1"	"32650275_35_1065"
""	"effector memory CD8-positive, alpha-beta T cell, terminally differentiated"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"30"	"Whole Blood"	"UBERON:0000178"	""	"CD8+ terminally differentiated T cells"	""	"cell-type frequency"	"down"	"severe disease vs mild disease"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Suppl Fig 2B"	""	"CL_0001062"	""	""	"effector memory CD8-positive, alpha-beta T cell, terminally differentiated"	"1"	"1"	"32650275_36_1066"
""	"naive thymus-derived CD8-positive, alpha-beta T cell"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"CD8+ naive T cells"	""	"cell-type frequency"	"down"	"mild disease vs healthy control"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2B"	""	"CL_0000900"	""	""	"naive thymus-derived CD8-positive, alpha-beta T cell"	"1"	"1"	"32650275_37_1067"
""	"effector memory CD8-positive, alpha-beta T cell"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"CD8+ effector/effector memory T cells"	""	"cell-type frequency"	"up"	"mild disease vs healthy control"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2B, Suppl Fig 3B"	""	"CL_0000913"	""	""	"effector memory CD8-positive, alpha-beta T cell"	"1"	"1"	"32650275_38_1068"
""	"naive thymus-derived CD8-positive, alpha-beta T cell"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"30"	"Whole Blood"	"UBERON:0000178"	""	"CD8+ naive T cells"	""	"cell-type frequency"	"up"	"severe disease vs mild disease"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2B, Suppl Fig 3B"	""	"CL_0000900"	""	""	"naive thymus-derived CD8-positive, alpha-beta T cell"	"1"	"1"	"32650275_39_1069"
""	"effector memory CD8-positive, alpha-beta T cell"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"30"	"Whole Blood"	"UBERON:0000178"	""	"CD8+ effector/effector memory T cells"	""	"cell-type frequency"	"down"	"severe disease vs mild disease"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 2B, Suppl Fig 3B"	""	"CL_0000913"	""	""	"effector memory CD8-positive, alpha-beta T cell"	"1"	"1"	"32650275_40_1070"
""	"immature gamma-delta T cell (CD45RA+,CD62L+)"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"naive-like (CD45RA+ CD62L+) TCRgammadelta T cells"	""	"cell-type frequency"	"up"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 3A-B"	""	"CL_0000799"	"(CD45RA+,CD62L+)"	"PR:000001015,PR:000001318"	"immature gamma-delta T cell (CD45RA+,CD62L+)"	"1"	"1"	"32650275_41_1071"
""	"immature gamma-delta T cell (CD45RA+,CD62L+)"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"naive-like (CD45RA+ CD62L+) TCRgammadelta T cells"	""	"cell-type frequency"	"up"	"mild disease vs healthy control"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 3A-B"	""	"CL_0000799"	"(CD45RA+,CD62L+)"	"PR:000001015,PR:000001318"	"immature gamma-delta T cell (CD45RA+,CD62L+)"	"1"	"1"	"32650275_42_1072"
""	"mature gamma-delta T cell (CD45RA-,CD62L-)"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"effector/effector memory-like (CD45RA- CD62L-) TCRgammadelta T cells"	""	"cell-type frequency"	"down"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 3A-B"	""	"CL_0000800"	"(CD45RA-,CD62L-)"	"PR:000001015,PR:000001318"	"mature gamma-delta T cell (CD45RA-,CD62L-)"	"1"	"1"	"32650275_43_1073"
""	"mature gamma-delta T cell (CD45RA-,CD62L-)"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"effector/effector memory-like (CD45RA- CD62L-) TCRgammadelta T cells"	""	"cell-type frequency"	"down"	"mild disease vs healthy control"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 3A-B"	""	"CL_0000800"	"(CD45RA-,CD62L-)"	"PR:000001015,PR:000001318"	"mature gamma-delta T cell (CD45RA-,CD62L-)"	"1"	"1"	"32650275_44_1074"
""	"gamma-delta T cell (central memory-like  and CD45RA-,CD62L+)"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"central memory-like (CD45RA- CD62L+) TCRgammadelta T cells"	""	"cell-type frequency"	"down"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 3A-B"	""	"CL_0000798"	"(central memory-like  and CD45RA-,CD62L+)"	"PR:000001015,PR:000001318"	"gamma-delta T cell (central memory-like  and CD45RA-,CD62L+)"	"1"	"1"	"32650275_45_1075"
""	"gamma-delta T cell (terminally differentiated-like and CD45RA+,CD62L-)"	""	"COVID-19 adult patients and healthy controls (Hannover, Germany)"	"19"	"91"	"years"	"75"	"Whole Blood"	"UBERON:0000178"	""	"terminally differentiated-like (CD45RA+ CD62L-) TCRgammadelta T cells"	""	"cell-type frequency"	"down"	"severe disease vs healthy controls"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 3B"	""	"CL_0000798"	"(terminally differentiated-like and CD45RA+,CD62L-)"	"PR:000001015,PR:000001318"	"gamma-delta T cell (terminally differentiated-like and CD45RA+,CD62L-)"	"1"	"1"	"32650275_46_1076"
""	"gamma-delta T cell (central memory-like  and CD45RA-,CD62L+)"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"30"	"Whole Blood"	"UBERON:0000178"	""	"central memory-like (CD45RA- CD62L+) TCRgammadelta T cells"	""	"cell-type frequency"	"down"	"severe disease vs mild disease"	"time of symptom onset"	"2-32"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 3B"	""	"CL_0000798"	"(central memory-like  and CD45RA-,CD62L+)"	"PR:000001015,PR:000001318"	"gamma-delta T cell (central memory-like  and CD45RA-,CD62L+)"	"1"	"1"	"32650275_47_1077"
""	"naive thymus-derived CD4-positive, alpha-beta T cell (CD45RA+,CD62L+)"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"7"	"Whole Blood"	"UBERON:0000178"	""	"naive (CD45RA+ CD62L+) CD4+ T cells"	""	"cell-type frequency"	"down"	"convalescing vs baseline samples (for patients with both mild and severe disease)"	"time of symptom onset"	"4-25 (avg 13)"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 4A"	""	"CL_0000895"	"(CD45RA+,CD62L+)"	"PR:000001015,PR:000001318"	"naive thymus-derived CD4-positive, alpha-beta T cell (CD45RA+,CD62L+)"	"1"	"1"	"32650275_48_1078"
""	"effector memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L-); central memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L+)"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"7"	"Whole Blood"	"UBERON:0000178"	""	"effector/effector memory (CD45RA- CD62L-) CD4+ T cells; central memory (CD45RA- CD62L+) CD4+ T cells"	""	"cell-type frequency"	"up"	"convalescing vs baseline samples (for patients with both mild and severe disease)"	"time of symptom onset"	"4-25 (avg 13)"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 4A"	""	"CL_0000905; CL_0000904"	"(CD45RA-,CD62L-); (CD45RA-,CD62L+)"	"PR:000001015,PR:000001318"	"effector memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L-); central memory CD4-positive, alpha-beta T cell (CD45RA-,CD62L+)"	"2"	"2"	"32650275_49_1079"
""	"naive thymus-derived CD8-positive, alpha-beta T cell"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"7"	"Whole Blood"	"UBERON:0000178"	""	"CD8+ naive T cells"	""	"cell-type frequency"	"down"	"convalescing vs baseline samples (for patients with both mild and severe disease)"	"time of symptom onset"	"4-25 (avg 13)"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 4B"	""	"CL_0000900"	""	""	"naive thymus-derived CD8-positive, alpha-beta T cell"	"1"	"1"	"32650275_50_1080"
""	"effector memory CD8-positive, alpha-beta T cell; central memory CD8-positive, alpha-beta T cell"	""	"COVID-19 adult patients  (Hannover, Germany)"	"19"	"91"	"years"	"7"	"Whole Blood"	"UBERON:0000178"	""	"CD8+ effector/effector memory T cells; CD8+ central memory T cells"	""	"cell-type frequency"	"up"	"convalescing vs baseline samples (for patients with both mild and severe disease)"	"time of symptom onset"	"4-25 (avg 13)"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32650275"	"2020-07-07"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338277/"	"Fig 4B"	""	"CL_0000913; CL_0000907"	""	""	"effector memory CD8-positive, alpha-beta T cell; central memory CD8-positive, alpha-beta T cell"	"2"	"2"	"32650275_51_1081"
""	"lymphocyte"	"2021-06-19"	"Bronx, New York City"	"3.87"	"74.31"	"years"	"125"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"Complete blood count"	"lymphocytes"	""	"cell-type frequency"	"up"	"Age<24 w/ no mechanical ventilation (Group 1) vs Age<24 w/ MIS-C (Group 2)"	"time of hospital admission"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32958614"	"2020-10-07"	"https://pubmed.ncbi.nlm.nih.gov/32958614/"	"Fig 1A, Table 2"	""	"CL_0000542"	""	""	"lymphocyte"	"1"	"1"	"32958614_1_1086"
""	"CD4-positive, alpha-beta T cell (IFNG+)"	"2021-06-19"	"Bronx, New York City"	"52.99"	"73.09"	"years"	"3"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IFN-gamma+ CD4+ T cells"	""	"cell-type frequency"	"up"	"CD4+ T-cells in adults w/ mechanical or death (Group 4) before vs after in-vitro stimulation with spike protein"	"time of hospital admission"	"30.4-49.6"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32958614"	"2020-10-07"	"https://pubmed.ncbi.nlm.nih.gov/32958614/"	"Fig 3A&B"	""	"CL_0000624"	"(IFNG+)"	"PR:000000017"	"CD4-positive, alpha-beta T cell (IFNG+)"	"1"	"1"	"32958614_2_1097"
""	"CD4-positive, alpha-beta T cell (CD25+)"	"2021-06-19"	"Bronx, New York City"	"44.53"	"74.31"	"years"	"11"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD25+ CD4+ T cells"	""	"cell-type frequency"	"up"	"CD4+ T-cells in adults w/ no mechanical ventilation (Group 3) before vs after in-vitro stimulation with spike protein"	"time of hospital admission"	"30.4-49.6"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32958614"	"2020-10-07"	"https://pubmed.ncbi.nlm.nih.gov/32958614/"	"Fig 3C"	""	"CL_0000624"	"(CD25+)"	"PR:000001380"	"CD4-positive, alpha-beta T cell (CD25+)"	"1"	"1"	"32958614_3_1098"
""	"eosinophil; monocyte"	"2021-06-19"	"COVID-19 patients (Marseille, France)"	"49"	"75"	"years"	"26"	"Whole Blood"	"UBERON:0000178"	"laboratory data"	"Eosinophils; Monocytes"	""	"cell-type frequency"	"down"	"severe vs mild/moderate disease"	"time of symptom onset"	"5-20"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Table 2"	""	"CL_0000771; CL_0000576"	""	""	"eosinophil; monocyte"	"2"	"2"	"32941618_1_1103"
""	"granulocyte (high side scatter and CD15+); neutrophil (high side scatter and CD16+,CD15+); granulocyte (high side scatter and CD16+); natural killer cell (CD56+,CD3-,PD1+); natural killer cell (CD56+,CD3-,PDL1+); CD4-positive, alpha-beta T cell (CCR7+,PD1+)"	"2021-06-19"	"COVID-19 patients and healthy controls (Marseille, France)"	"31"	"74"	"years"	"51"	"Whole Blood"	"UBERON:0000178"	"flow cytometry"	"SS-hi CD15+ Granulocytes; SS-hi CD15+ CD16+ Granulocytes; SS-hi CD16+ Granulocytes; PD1+ CD56+ CD3- NK Cells; PD-L1+ CD56+ CD3- NK Cells; CD3+ CD4+ CCR7+ PD1+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=26) vs healthy controls (N=25)"	"time of infection"	"10"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Fig 1A"	""	"CL_0000094; CL_0000775; CL_0000623; CL_0000624"	"(high side scatter and CD15+); (high side scatter and CD16+,CD15+); (high side scatter and CD16+); (CD56+,CD3-,PD1+); (CD56+,CD3-,PDL1+); (CCR7+,PD1+)"	"PR:000001456; PR:000001483,PR:000001456; PR:000001483; PR:000001024,PR:000001020,PR:000001919; PR:000001024,PR:000001020,PR:000001543; PR:000001203,PR:000001919"	"granulocyte (high side scatter and CD15+); neutrophil (high side scatter and CD16+,CD15+); granulocyte (high side scatter and CD16+); natural killer cell (CD56+,CD3-,PD1+); natural killer cell (CD56+,CD3-,PDL1+); CD4-positive, alpha-beta T cell (CCR7+,PD1+)"	"6"	"6"	"32941618_2_1104"
""	"lymphocyte (CD3-,CD56-); basophil (low side scatter and CRTH2+); monocyte (medium side scatter and CD4+,CD14+); natural killer cell (NKG2D+,NKP46+)"	"2021-06-19"	"COVID-19 patients and healthy controls (Marseille, France)"	"31"	"74"	"years"	"51"	"Whole Blood"	"UBERON:0000178"	"flow cytometry"	"CD3- CD56- Lymphocytes; SS-low CRTH2+ Basophils; CD4+ SS-med CD14+ Monocytes; NKG2D+ NKp46+ NK Cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=26) vs healthy controls (N=25)"	"time of infection"	"10"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Fig 1A"	""	"CL_0000542; CL_0000767; CL_0000576; CL_0000623"	"(CD3-,CD56-); (low side scatter and CRTH2+); (medium side scatter and CD4+,CD14+); (NKG2D+,NKP46+)"	"PR:000001020,PR:000001024; PR:000001547; PR:000001004,PR:000001889; PR:000001828,PR:000001893"	"lymphocyte (CD3-,CD56-); basophil (low side scatter and CRTH2+); monocyte (medium side scatter and CD4+,CD14+); natural killer cell (NKG2D+,NKP46+)"	"4"	"4"	"32941618_3_1105"
""	"alpha-beta t cell (CD3+)"	"2021-06-19"	"COVID-19 patients and healthy controls (Marseille, France)"	"31"	"74"	"years"	"51"	"Whole Blood"	"UBERON:0000178"	"flow cytometry"	"CD3+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=26) vs healthy controls (N=25)"	"time of infection"	"10"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Fig 1A, Suppl Fig 2A"	""	"CL_0000789"	"(CD3+)"	"PR:000001020"	"alpha-beta t cell (CD3+)"	"1"	"1"	"32941618_4_1106"
""	"CD4-positive, alpha-beta T cell"	"2021-06-19"	"COVID-19 patients and healthy controls (Marseille, France)"	"31"	"74"	"years"	"51"	"Whole Blood"	"UBERON:0000178"	"flow cytometry"	"CD3+ CD4+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=26) vs healthy controls (N=25)"	"time of infection"	"10"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Fig 1A, Suppl Fig 2B"	""	"CL_0000624"	""	""	"CD4-positive, alpha-beta T cell"	"1"	"1"	"32941618_5_1107"
""	"plasmacytoid dendritic cell, human (CD11c-,HLADRA+,CD123+)"	"2021-06-19"	"COVID-19 patients and healthy controls (Marseille, France)"	"31"	"74"	"years"	"51"	"Whole Blood"	"UBERON:0000178"	"flow cytometry"	"lineage- CD11c- HLA-DR+ CD123+ pDCs"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=26) vs healthy controls (N=25)"	"time of infection"	"10"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Fig 1A, Suppl Fig 2C"	""	"CL_0001058"	"(CD11c-,HLADRA+,CD123+)"	"PR:000001013,PR:000002015,PR:000001865"	"plasmacytoid dendritic cell, human (CD11c-,HLADRA+,CD123+)"	"1"	"1"	"32941618_6_1108"
""	"CD8-positive, alpha-beta T cell"	"2021-06-19"	"COVID-19 patients and healthy controls (Marseille, France)"	"31"	"74"	"years"	"51"	"Whole Blood"	"UBERON:0000178"	"flow cytometry"	"CD3+ CD8+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=26) vs healthy controls (N=25)"	"time of infection"	"10"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Fig 1A, Suppl Fig 2D"	""	"CL_0000625"	""	""	"CD8-positive, alpha-beta T cell"	"1"	"1"	"32941618_7_1109"
""	"basophil"	"2021-06-19"	"COVID-19 patients and healthy controls (Marseille, France)"	"31"	"74"	"years"	"51"	"Whole Blood"	"UBERON:0000178"	"flow cytometry"	"Basophils"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=26) vs healthy controls (N=25)"	"time of hospital admission"	"on average, 11"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Fig 2A"	""	"CL_0000767"	""	""	"basophil"	"1"	"1"	"32941618_8_1121"
""	"plasmacytoid dendritic cell, human (CD11c-,HLADRA+,CD123+); monocyte (medium side scatter and CD4+,CD14+); lymphocyte; natural killer cell (NKG2D+,NKP46+); lymphocyte (CD3-,CD56-); natural killer cell (CD16+,CD56+,CD3+-); basophil (low side scatter and CRTH2+)"	"2021-06-19"	"COVID-19 patients (Marseille, France)"	"49"	"75"	"years"	"26"	"Serum"	"UBERON:0001977"	"flow cytometry"	"lineage- CD11c- HLA-DR+ CD123+ pDCs; CD4+ SS-med CD14+ Monocytes; CD3+ Lymphocytes; NKG2D+ NKp46+ NK Cells; CD3- CD56- Lymphocytes; CD16+ CD56+ CD3- NK Cells; SS-low CRTH2+ Basophils"	""	"cell-type frequency"	"down"	"severe vs mild/moderate disease"	"time of hospital admission"	"on average, 11"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Fig 3A"	""	"CL_0001058; CL_0000576; CL_0000542; CL_0000623; CL_0000767"	"(CD11c-,HLADRA+,CD123+); (medium side scatter and CD4+,CD14+); ; (NKG2D+,NKP46+); (CD3-,CD56-); (CD16+,CD56+,CD3+-); (low side scatter and CRTH2+)"	"PR:000001013,PR:000002015,PR:000001865; PR:000001004,PR:000001889; ; PR:000001828,PR:000001893; PR:000001020,PR:000001024; PR:000001483,PR:000001024,PR:000001020; PR:000001547"	"plasmacytoid dendritic cell, human (CD11c-,HLADRA+,CD123+); monocyte (medium side scatter and CD4+,CD14+); lymphocyte; natural killer cell (NKG2D+,NKP46+); lymphocyte (CD3-,CD56-); natural killer cell (CD16+,CD56+,CD3+-); basophil (low side scatter and CRTH2+)"	"7"	"7"	"32941618_10_1123"
""	"granulocyte (high side scatter and CD15+); basophil (low side scatter and CRTH2-,PDL1+); neutrophil (high side scatter and CD16+,CD15+); granulocyte (high side scatter and CD16+); natural killer cell (CD56+,CD3-,PDL1+)"	"2021-06-19"	"COVID-19 patients (Marseille, France)"	"49"	"75"	"years"	"26"	"Serum"	"UBERON:0001977"	"flow cytometry"	"SS-hi CD15+ Granulocytes; SS-low CRTH2- PD-L1+ Basophils; SS-hi CD15+ CD16+ Granulocytes; SS-hi CD16+ Granulocytes; PD-L1+ CD56+ CD3- NK Cells"	""	"cell-type frequency"	"up"	"severe vs mild/moderate disease"	"time of hospital admission"	"on average, 11"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Fig 3A"	""	"CL_0000094; CL_0000767; CL_0000775; CL_0000623"	"(high side scatter and CD15+); (low side scatter and CRTH2-,PDL1+); (high side scatter and CD16+,CD15+); (high side scatter and CD16+); (CD56+,CD3-,PDL1+)"	"PR:000001456; PR:000001547,PR:000001543; PR:000001483,PR:000001456; PR:000001483; PR:000001024,PR:000001020,PR:000001543"	"granulocyte (high side scatter and CD15+); basophil (low side scatter and CRTH2-,PDL1+); neutrophil (high side scatter and CD16+,CD15+); granulocyte (high side scatter and CD16+); natural killer cell (CD56+,CD3-,PDL1+)"	"6"	"5"	"32941618_11_1124"
""	"natural killer cell (PDL1+)"	"2021-06-19"	"COVID-19 patients (Marseille, France)"	"49"	"75"	"years"	"26"	"Serum"	"UBERON:0001977"	"flow cytometry"	"PDL1+ NK Cells"	""	"cell-type frequency"	"up"	"severe vs mild/moderate disease"	"time of hospital admission"	"on average, 11"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"32941618"	"2020-09-17"	"https://academic.oup.com/jid/article/222/12/1985/5907982"	"Suppl Fig 3A"	""	"CL_0000623"	"(PDL1+)"	"PR:000001543"	"natural killer cell (PDL1+)"	"1"	"1"	"32941618_12_1125"
""	"natural killer cell (CD3-,CD56+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000000"	"FACS"	"CD3- CD56+ NK cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 1A"	"Significant changes are seen in the absolute value of CD3-/CD56+ NK cells."	"CL_0000623"	"(CD3-,CD56+)"	"PR:000001020,PR:000001024"	"natural killer cell (CD3-,CD56+)"	"1"	"1"	"33060840_1_1144"
""	"immature natural killer cell (CD56++)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"immature CD56-bright NK cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 1B"	"Significant changes are seen in the percentage of immature CD56-bright NK cells."	"CL_0000823"	"(CD56++)"	"PR:000001024"	"immature natural killer cell (CD56++)"	"1"	"1"	"33060840_2_1145"
""	"immature natural killer cell (CD56++)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	"32"	"92"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"immature CD56-bright NK cells"	""	"cell-type frequency"	"down"	"COVID-19 deceased patients (N=15) vs COVID-19 surviving patients (N=17)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 1B"	"Significant changes are seen in the percentage of immature CD56-bright NK cells."	"CL_0000823"	"(CD56++)"	"PR:000001024"	"immature natural killer cell (CD56++)"	"1"	"1"	"33060840_3_1146"
""	"mature natural killer cell (CD57+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"mature CD57+ NK cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 1C"	"Significant changes are seen in the percentage of immature mature CD57+ NK cells."	"CL_0000824"	"(CD57+)"	"PR:000001440"	"mature natural killer cell (CD57+)"	"1"	"1"	"33060840_4_1147"
""	"mature natural killer cell (CD57+,CD56+-)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	"32"	"92"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"mature CD56-dim CD57+ NK cells"	""	"cell-type frequency"	"up"	"COVID-19 deceased patients (N=15) vs COVID-19 surviving patients (N=17)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 1C"	"Significant changes are seen in the percentage of mature CD56-dim CD57+ NK cells."	"CL_0000824"	"(CD57+,CD56+-)"	"PR:000001440,PR:000001024"	"mature natural killer cell (CD57+,CD56+-)"	"1"	"1"	"33060840_5_1148"
""	"natural killer cell"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	"32"	"92"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"FCepsilonRly- CD56+ CD57+ NK cells"	""	"cell-type frequency"	"up"	"COVID-19 deceased patients (N=15) vs COVID-19 surviving patients (N=17)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 1D"	"Significant changes are seen in the percentage of FCepsilonRIÎ³- CD56+ CD57+ NK cells."	"CL_0000623"	""	""	"natural killer cell"	"1"	"1"	"33060840_6_1149"
""	"natural killer cell (CD69+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD69+ NK cells"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 2A"	"Significant changes are seen in the percentage of the given cell."	"CL_0000623"	"(CD69+)"	"PR:000001343"	"natural killer cell (CD69+)"	"1"	"1"	"33060840_7_1150"
""	"natural killer cell (TIM3+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"TIM-3+ NK cells"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 2B"	"Significant changes are seen in the percentage of the given cell."	"CL_0000623"	"(TIM3+)"	"PR:000008454"	"natural killer cell (TIM3+)"	"1"	"1"	"33060840_8_1151"
""	"natural killer cell (PD1+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"PD1+ NK cells"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 2C"	"Significant changes are seen in the percentage of the given cell."	"CL_0000623"	"(PD1+)"	"PR:000001919"	"natural killer cell (PD1+)"	"1"	"1"	"33060840_9_1152"
""	"natural killer cell (NKG2D+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"NKG2D+ NK cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 2D"	"Significant changes are seen in the percentage of the given cell."	"CL_0000623"	"(NKG2D+)"	"PR:000001828"	"natural killer cell (NKG2D+)"	"1"	"1"	"33060840_10_1153"
""	"natural killer cell (SIGLEC7+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"Siglec-7+ NK cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 2E"	"Significant changes are seen in the percentage of the given cell."	"CL_0000623"	"(SIGLEC7+)"	"PR:000001929"	"natural killer cell (SIGLEC7+)"	"1"	"1"	"33060840_11_1154"
""	"natural killer cell (DNAM1+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"DNAM-1+ NK cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 2F"	"Significant changes are seen in the percentage of the given cell."	"CL_0000623"	"(DNAM1+)"	"PR:000001302"	"natural killer cell (DNAM1+)"	"1"	"1"	"33060840_12_1155"
""	"natural killer cell (CXCR6+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CXCR6+ NK cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 2G"	"Significant changes are seen in the percentage of the given cell."	"CL_0000623"	"(CXCR6+)"	"PR:000001210"	"natural killer cell (CXCR6+)"	"1"	"1"	"33060840_13_1156"
""	"natural killer cell (IFNG+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS & in-vitro stimulation w/ SW480"	"IFNgamma+ NK cells"	""	"cell-type frequency"	"down"	"SW480-stimulated cells from COVID-19 patients vs SW480-stimulated cells from healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 3A"	"IFNg+ NK cells after in-vitro stimulation with SW480 target cell. Significant changes are seen in the percentage of the given cell."	"CL_0000623"	"(IFNG+)"	"PR:000000017"	"natural killer cell (IFNG+)"	"1"	"1"	"33060840_14_1158"
""	"natural killer cell (IFNG+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS & in-vitro stimulation w/ K562"	"IFNgamma+ NK cells"	""	"cell-type frequency"	"down"	"K562-stimulated cells from COVID-19 patients vs K562-stimulated cells from healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 3B"	"IFNg+ NK cells after in-vitro stimulation with K562 target cell. Significant changes are seen in the percentage of the given cell."	"CL_0000623"	"(IFNG+)"	"PR:000000017"	"natural killer cell (IFNG+)"	"1"	"1"	"33060840_15_1159"
""	"natural killer cell (CD56++,CD107a+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS & in-vitro stimulation w/ K562"	"CD56-bright CD107a+ NK cells"	""	"cell-type frequency"	"down"	"K562-stimulated cells from COVID-19 patients vs K562-stimulated cells from healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 3C"	"CD56-bright CD107a+ cells after in-vitro stimulation with K562 target cell. Significant changes are seen in the percentage of the given cell."	"CL_0000623"	"(CD56++,CD107a+)"	"PR:000001024,PR:000002060"	"natural killer cell (CD56++,CD107a+)"	"1"	"1"	"33060840_16_1160"
""	"natural killer cell (CD56-++,IFNG+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS & in-vitro stimulation w/ K562"	"CD56-bright IFNgamma+ NK cells"	""	"cell-type frequency"	"down"	"K562-stimulated cells from COVID-19 patients vs K562-stimulated cells from healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 3C"	"CD56-bright IFNg+ cells after in-vitro stimulation with K562 target cell. Significant changes are seen in the percentage of the given cell"	"CL_0000623"	"(CD56-++,IFNG+)"	"PR:000001024,PR:000000017"	"natural killer cell (CD56-++,IFNG+)"	"1"	"1"	"33060840_17_1161"
""	"natural killer cell; natural killer cell (IFNG+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	""	"CD107a+ NK cells; IFNgamma+ NK cells"	""	"cell-type frequency"	"negatively correlated"	"C-reactive protein value in all patients"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 3D"	"C-reactive protein was negatively correlated to the percentage of CD107a+ NK cells, IFNg+ NK cells."	"CL_0000623"	"; (IFNG+)"	"; PR:000000017"	"natural killer cell; natural killer cell (IFNG+)"	"2"	"2"	"33060840_18_1162"
""	"CD4-positive, alpha-beta memory T cell (CD3-)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD3- CD4+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 4A"	"Significant changes are seen in the percentage and absolute number of the given cell(s)."	"CL_0000897"	"(CD3-)"	"PR:000001020"	"CD4-positive, alpha-beta memory T cell (CD3-)"	"1"	"1"	"33060840_19_1163"
""	"CD8-positive, alpha-beta T cell (CD3-)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD3- CD8+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 4B"	"Significant changes are seen in the percentage and absolute number of the given cell(s)."	"CL_0000625"	"(CD3-)"	"PR:000001020"	"CD8-positive, alpha-beta T cell (CD3-)"	"1"	"1"	"33060840_20_1164"
""	"CD8-positive, alpha-beta T cell (CD3-)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	"32"	"92"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD3- CD8+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 deceased patients (N=15) vs COVID-19 surviving patients (N=17)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 4B"	"Significant changes are seen in the percentage and absolute number of the given cell(s)."	"CL_0000625"	"(CD3-)"	"PR:000001020"	"CD8-positive, alpha-beta T cell (CD3-)"	"1"	"1"	"33060840_21_1165"
""	"activated CD8-positive, alpha-beta T cell (CD69+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD69+ CD8+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 4C"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0000906"	"(CD69+)"	"PR:000001343"	"activated CD8-positive, alpha-beta T cell (CD69+)"	"1"	"1"	"33060840_22_1166"
""	"activated CD8-positive, alpha-beta T cell (CD69+)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	"32"	"92"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD69+ CD8+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 deceased patients (N=15) vs COVID-19 surviving patients (N=17)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 4C"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0000906"	"(CD69+)"	"PR:000001343"	"activated CD8-positive, alpha-beta T cell (CD69+)"	"1"	"1"	"33060840_23_1167"
""	"activated CD4-positive, alpha-beta T cell (CD69+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD69+ CD4+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 4D"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0000896"	"(CD69+)"	"PR:000001343"	"activated CD4-positive, alpha-beta T cell (CD69+)"	"1"	"1"	"33060840_24_1168"
""	"activated CD4-positive, alpha-beta T cell (CD69+)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	"32"	"92"	"years"	"32"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD69+ CD4+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 deceased patients (N=15) vs COVID-19 surviving patients (N=17)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 4D"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0000896"	"(CD69+)"	"PR:000001343"	"activated CD4-positive, alpha-beta T cell (CD69+)"	"1"	"1"	"33060840_25_1169"
""	"exhausted T cell (CD8+,TIM3+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"TIM-3+ CD8+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 4E"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0011025"	"(CD8+,TIM3+)"	"PR:000001084,PR:000008454"	"exhausted T cell (CD8+,TIM3+)"	"1"	"1"	"33060840_26_1170"
""	"exhausted T cell (TIM3+,CD4+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"TIM-3+ CD4+ T cells"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 4F"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0011025"	"(TIM3+,CD4+)"	"PR:000008454,PR:000001004"	"exhausted T cell (TIM3+,CD4+)"	"1"	"1"	"33060840_27_1171"
""	"CD8-positive, alpha-beta T cell (CXCR6+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	"32"	"92"	"years"	"57"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CXCR6+ CD8+ T cells"	""	"cell-type frequency"	"down"	"COVID-19 patients (N=32) vs healthy controls (N=25)"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 4G"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0000625"	"(CXCR6+)"	"PR:000001210"	"CD8-positive, alpha-beta T cell (CXCR6+)"	"1"	"1"	"33060840_28_1172"
""	"CD8-positive, alpha-beta T cell"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	""	""	""	"7"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD3+ CD8+ T cells"	""	"cell-type frequency"	"up"	"convalescing (30-45 days after hospital discharge) vs acute disease phase"	""	""	""	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 5A"	"Significant changes are seen in the percentage and absolute number of the given cell(s)."	"CL_0000625"	""	""	"CD8-positive, alpha-beta T cell"	"1"	"1"	"33060840_29_1174"
""	"natural killer cell (TIM3+)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	""	""	""	"7"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"TIM-3+ NK cells"	""	"cell-type frequency"	"down"	"convalescing (30-45 days after hospital discharge) vs acute disease phase"	""	""	""	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 5B"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0000623"	"(TIM3+)"	"PR:000008454"	"natural killer cell (TIM3+)"	"1"	"1"	"33060840_30_1175"
""	"exhausted T cell (CD8+,TIM3+)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	""	""	""	"7"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"TIM-3+ CD8+ T cells"	""	"cell-type frequency"	"down"	"convalescing (30-45 days after hospital discharge) vs acute disease phase"	""	""	""	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 5C"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0011025"	"(CD8+,TIM3+)"	"PR:000001084,PR:000008454"	"exhausted T cell (CD8+,TIM3+)"	"1"	"1"	"33060840_31_1177"
""	"natural killer cell (CD69+)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	""	""	""	"7"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD69+ NK cells"	""	"cell-type frequency"	"down"	"convalescing (30-45 days after hospital discharge) vs acute disease phase"	""	""	""	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 5D"	""	"CL_0000623"	"(CD69+)"	"PR:000001343"	"natural killer cell (CD69+)"	"1"	"1"	"33060840_32_1178"
""	"activated CD8-positive, alpha-beta T cell (CD69+)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	""	""	""	"7"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD69+ CD8+ T cells"	""	"cell-type frequency"	"down"	"convalescing (30-45 days after hospital discharge) vs acute disease phase"	""	""	""	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 5E"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0000906"	"(CD69+)"	"PR:000001343"	"activated CD8-positive, alpha-beta T cell (CD69+)"	"1"	"1"	"33060840_33_1180"
""	"activated CD4-positive, alpha-beta T cell (CD69+)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	""	""	""	"7"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"FACS"	"CD69+ CD4+ T cells"	""	"cell-type frequency"	"down"	"convalescing (30-45 days after hospital discharge) vs acute disease phase"	""	""	""	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 5F"	"Significant changes are seen in the percentage of the given cell(s)."	"CL_0000896"	"(CD69+)"	"PR:000001343"	"activated CD4-positive, alpha-beta T cell (CD69+)"	"1"	"1"	"33060840_34_1181"
""	"monocyte (IL6+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-6+ CD14+ monocytes"	""	"cell-type frequency"	"up"	"convalescing (30-45 days after hospital discharge) patients vs healthy controls"	"time of hospital discharge"	"30-45"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 7A"	"ex vivo stimulation of freshly isolated monocytes"	"CL_0000576"	"(IL6+)"	"PR:000001393"	"monocyte (IL6+)"	"1"	"1"	"33060840_35_1194"
""	"monocyte (IL6+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-6+ CD14+ monocytes"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 7A"	"ex vivo stimulation of freshly isolated monocytes"	"CL_0000576"	"(IL6+)"	"PR:000001393"	"monocyte (IL6+)"	"1"	"1"	"33060840_36_1195"
""	"monocyte (IL8+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-8+ CD14+ monocytes"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 7B"	"ex vivo stimulation of freshly isolated monocytes"	"CL_0000576"	"(IL8+)"	"PR:000001395"	"monocyte (IL8+)"	"1"	"1"	"33060840_37_1196"
""	"monocyte (IL1B+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-1beta+ CD14+ monocytes"	""	"cell-type frequency"	"up"	"COVID-19 patients vs healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Fig 7C"	"ex vivo stimulation of freshly isolated monocytes"	"CL_0000576"	"(IL1B+)"	"PR:000001136"	"monocyte (IL1B+)"	"1"	"1"	"33060840_38_1197"
""	"classical monocyte (IL6+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-6+ classical monocytes"	""	"cell-type frequency"	"up"	"convalescing (30-45 days after hospital discharge) patients vs healthy controls"	"time of hospital discharge"	"30-45"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Suppl Fig 4A"	"ex vivo stimulation of freshly isolated monocytes. Significant changes were seen in the percentage of the given cell(s)."	"CL_0000860"	"(IL6+)"	"PR:000001393"	"classical monocyte (IL6+)"	"1"	"1"	"33060840_39_1198"
""	"classical monocyte (IL6+); non-classical monocyte (IL6+)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	""	""	""	"20"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-6+ classical monocytes; IL-6+ non-classical monocytes"	""	"cell-type frequency"	"up"	"hospitalized COVID-19 patients vs convalescing (30-45 days after hospital discharge) patients"	""	""	""	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Suppl Fig 4A"	"ex vivo stimulation of freshly isolated monocytes. Significant changes were seen in the percentage of the given cell(s)."	"CL_0000860; CL_0000875"	"(IL6+)"	"PR:000001393"	"classical monocyte (IL6+); non-classical monocyte (IL6+)"	"2"	"2"	"33060840_40_1199"
""	"classical monocyte (IL6+); intermediate monocyte (IL6+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-6+ classical monocytes; IL-6+ intermediate monocytes"	""	"cell-type frequency"	"up"	"hospitalized COVID-19 patients vs healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Suppl Fig 4A"	"ex vivo stimulation of freshly isolated monocytes. Significant changes were seen in the percentage of the given cell(s)."	"CL_0000860; CL_0002393"	"(IL6+)"	"PR:000001393"	"classical monocyte (IL6+); intermediate monocyte (IL6+)"	"2"	"2"	"33060840_41_1200"
""	"non-classical monocyte (IL6+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-6+ non-classical monocytes"	""	"cell-type frequency"	"down"	"convalescing (30-45 days after hospital discharge) patients vs healthy controls"	"time of hospital discharge"	"30-45"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Suppl Fig 4A"	"ex vivo stimulation of freshly isolated monocytes. Significant changes were seen in the percentage of the given cell(s)."	"CL_0000875"	"(IL6+)"	"PR:000001393"	"non-classical monocyte (IL6+)"	"1"	"1"	"33060840_42_1201"
""	"classical monocyte (IL8+); non-classical monocyte (IL8+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-8+ classical monocytes; IL-8+ non-classical monocytes"	""	"cell-type frequency"	"up"	"hospitalized COVID-19 patients vs healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Suppl Fig 4B"	"ex vivo stimulation of freshly isolated monocytes. Significant changes were seen in the percentage of the given cell(s)."	"CL_0000860; CL_0000875"	"(IL8+)"	"PR:000001395"	"classical monocyte (IL8+); non-classical monocyte (IL8+)"	"2"	"2"	"33060840_43_1202"
""	"intermediate monocyte (IL8+); non-classical monocyte (IL8+)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	""	""	""	"20"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-8+ intermediate monocytes; IL-8+ non-classical monocytes"	""	"cell-type frequency"	"up"	"hospitalized COVID-19 patients vs convalescing (30-45 days after hospital discharge) patients"	""	""	""	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Suppl Fig 4B"	"ex vivo stimulation of freshly isolated monocytes. Significant changes were seen in the percentage of the given cell(s)."	"CL_0002393; CL_0000875"	"(IL8+)"	"PR:000001395"	"intermediate monocyte (IL8+); non-classical monocyte (IL8+)"	"2"	"2"	"33060840_44_1203"
""	"intermediate monocyte (IL8+); non-classical monocyte (IL8+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-8+ intermediate monocytes; IL-8+ non-classical monocytes"	""	"cell-type frequency"	"down"	"convalescing (30-45 days after hospital discharge) patients vs healthy controls"	"time of hospital discharge"	"30-45"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Suppl Fig 4B"	"ex vivo stimulation of freshly isolated monocytes. Significant changes were seen in the percentage of the given cell(s)."	"CL_0002393; CL_0000875"	"(IL8+)"	"PR:000001395"	"intermediate monocyte (IL8+); non-classical monocyte (IL8+)"	"2"	"2"	"33060840_45_1204"
""	"classical monocyte (IL1B+); intermediate monocyte (IL1B+); non-classical monocyte (IL1B+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-1beta+ classical monocytes; IL-1beta+ intermediate monocytes; IL-1beta+ non-classical monocytes"	""	"cell-type frequency"	"up"	"hospitalized COVID-19 patients vs healthy controls"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Suppl Fig 4C"	"ex vivo stimulation of freshly isolated monocytes. Significant changes were seen in the percentage of the given cell(s)."	"CL_0000860; CL_0002393; CL_0000875"	"(IL1B+)"	"PR:000001136"	"classical monocyte (IL1B+); intermediate monocyte (IL1B+); non-classical monocyte (IL1B+)"	"3"	"3"	"33060840_46_1205"
""	"intermediate monocyte (IL1B+)"	"2021-06-19"	"severe COVID-19 adult patients and healthy controls (Pavia, Italy)"	""	""	""	"22"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-1beta+ intermediate monocytes"	""	"cell-type frequency"	"up"	"convalescing (30-45 days after hospital discharge) patients vs healthy controls"	"time of hospital discharge"	"30-45"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Suppl Fig 4C"	"ex vivo stimulation of freshly isolated monocytes. Significant changes were seen in the percentage of the given cell(s)."	"CL_0002393"	"(IL1B+)"	"PR:000001136"	"intermediate monocyte (IL1B+)"	"1"	"1"	"33060840_47_1206"
""	"non-classical monocyte (IL1B+)"	"2021-06-19"	"severe COVID-19 adult patients (Pavia, Italy)"	""	""	""	"20"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"ex-vivo stimulation"	"IL-1beta+ non-classical monocytes"	""	"cell-type frequency"	"up"	"baseline vs convalescing sample (30-45 days after hospital discharge) in hospitalized SARS-CoV-2 patients"	"time of first examination"	"1-2"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute & post-infection"	"33060840"	"2020-10-15"	"https://www.nature.com/articles/s41423-020-00557-9"	"Suppl Fig 4C"	"ex vivo stimulation of freshly isolated monocytes. Significant changes were seen in the percentage of the given cell(s)."	"CL_0000875"	"(IL1B+)"	"PR:000001136"	"non-classical monocyte (IL1B+)"	"1"	"1"	"33060840_48_1207"
""	"peripheral blood mononuclear cell"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"22"	"81"	"years"	"55"	"Whole Blood"	"UBERON:0000178"	""	"peripheral blood mononuclear cells"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=19) vs healthy controls (N=36)"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Extended Data Fig 1A"	""	"CL_2000001"	""	""	"peripheral blood mononuclear cell"	"1"	"1"	"33028979_1_1208"
""	"b cell"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"22"	"81"	"years"	"55"	"CD45+ cell"	"CL:0000236"	""	"CD19+ CD45+ B cell"	""	"cell-type frequency"	"up"	"COVID-19 patients (N=19) vs healthy controls (N=36)"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Extended Data Fig 1B"	""	"CL_0000236"	""	""	"b cell"	"1"	"1"	"33028979_2_1209"
""	"antibody secreting cell (CD138+)"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"34"	"81"	"years"	"10"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD138+ antibody-secreting cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU vs outpatients"	"time of symptom onset"	"7"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 1B"	""	"CL_0000946"	"(CD138+)"	"PR:000001935"	"antibody secreting cell (CD138+)"	"1"	"1"	"33028979_3_1210"
""	"transitional stage b cell (CD21+-)"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"26"	"44"	"years"	"7"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD21-low transitional B cell"	""	"cell-type frequency"	"up"	"COVID-19 outpatients vs COVID-19 ICU patients"	"time of symptom onset"	"4"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 1C"	""	"CL_0000818"	"(CD21+-)"	"PR:000001338"	"transitional stage b cell (CD21+-)"	"1"	"1"	"33028979_4_1211"
""	"double negative memory b cell (CXCR5-,CD21-)"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"34"	"81"	"years"	"10"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"DN2 B cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs COVID-19 outpatients"	"time of symptom onset"	"7"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 1D"	""	"CL_0000981"	"(CXCR5-,CD21-)"	"PR:000001209,PR:000001338"	"double negative memory b cell (CXCR5-,CD21-)"	"1"	"1"	"33028979_5_1212"
""	"unswitched memory b cell"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"34"	"81"	"years"	"10"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"usM B cells"	""	"cell-type frequency"	"down"	"COVID-19 ICU patients vs COVID-19 outpatients"	"time of symptom onset"	"7"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 1F"	""	"CL_0000970"	""	""	"unswitched memory b cell"	"1"	"1"	"33028979_6_1213"
""	"naive b cell (activated)"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"22"	"61"	"years"	"27"	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"aN naive B cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs healthy controls"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3C"	""	"CL_0000788"	"(activated)"	""	"naive b cell (activated)"	"1"	"1"	"33028979_7_1214"
""	"naive b cell (activated)"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	"17"	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"aN naive B cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs COVID-19 outpatients"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3C"	""	"CL_0000788"	"(activated)"	""	"naive b cell (activated)"	"1"	"1"	"33028979_8_1215"
""	"double negative memory b cell (CXCR5-,CD21-)"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"22"	"61"	"years"	"27"	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"DN2 B cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs healthy controls"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3D"	""	"CL_0000981"	"(CXCR5-,CD21-)"	"PR:000001209,PR:000001338"	"double negative memory b cell (CXCR5-,CD21-)"	"1"	"1"	"33028979_9_1216"
""	"double negative memory b cell (CXCR5-,CD21-)"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	"17"	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"DN2 B cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs COVID-19 outpatients"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3D"	""	"CL_0000981"	"(CXCR5-,CD21-)"	"PR:000001209,PR:000001338"	"double negative memory b cell (CXCR5-,CD21-)"	"1"	"1"	"33028979_10_1217"
""	"antibody secreting cell"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"22"	"61"	"years"	"22"	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"antibody-secreting cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs healthy controls"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3G"	""	"CL_0000946"	""	""	"antibody secreting cell"	"1"	"1"	"33028979_11_1220"
""	"antibody secreting cell"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	"17"	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"antibody-secreting cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs COVID-19 outpatients"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3G"	""	"CL_0000946"	""	""	"antibody secreting cell"	"1"	"1"	"33028979_12_1221"
""	"antibody secreting cell (CD138+)"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"22"	"61"	"years"	"22"	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"CD138+ antibody-secreting cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs healthy controls"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3H"	""	"CL_0000946"	"(CD138+)"	"PR:000001935"	"antibody secreting cell (CD138+)"	"1"	"1"	"33028979_13_1222"
""	"antibody secreting cell (CD138+)"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	"17"	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"CD138+ antibody-secreting cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs COVID-19 outpatients"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3H"	""	"CL_0000946"	"(CD138+)"	"PR:000001935"	"antibody secreting cell (CD138+)"	"1"	"1"	"33028979_14_1223"
""	"antibody secreting cell (CD138+)"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"22"	"61"	"years"	"22"	"antibody-secreting cell"	"CL:0000946"	"flow cytometry"	"CD138+ antibody-secreting cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs healthy controls"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3I"	""	"CL_0000946"	"(CD138+)"	"PR:000001935"	"antibody secreting cell (CD138+)"	"1"	"1"	"33028979_15_1224"
""	"antibody secreting cell (CD138+)"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	"17"	"antibody-secreting cell"	"CL:0000946"	"flow cytometry"	"CD138+ antibody-secreting cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs COVID-19 outpatients"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3I"	""	"CL_0000946"	"(CD138+)"	"PR:000001935"	"antibody secreting cell (CD138+)"	"1"	"1"	"33028979_16_1225"
""	"transitional stage b cell"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"22"	"61"	"years"	""	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"transitional B cell"	""	"cell-type frequency"	"up"	"COVID-19 outpatients vs healthy controls"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3J"	""	"CL_0000818"	""	""	"transitional stage b cell"	"1"	"1"	"33028979_17_1226"
""	"transitional stage b cell"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	""	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"transitional B cell"	""	"cell-type frequency"	"down"	"COVID-19 ICU patients vs COVID-19 outpatients"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3J"	""	"CL_0000818"	""	""	"transitional stage b cell"	"1"	"1"	"33028979_18_1227"
""	"transitional stage b cell (CD21+-)"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"22"	"61"	"years"	""	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"CD21-low transitional B cell"	""	"cell-type frequency"	"up"	"COVID-19 outpatients vs healthy controls"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3K"	""	"CL_0000818"	"(CD21+-)"	"PR:000001338"	"transitional stage b cell (CD21+-)"	"1"	"1"	"33028979_19_1228"
""	"transitional stage b cell (CD21+-)"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	""	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"CD21-low transitional B cell"	""	"cell-type frequency"	"down"	"COVID-19 ICU patients vs COVID-19 outpatients"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 3K"	""	"CL_0000818"	"(CD21+-)"	"PR:000001338"	"transitional stage b cell (CD21+-)"	"1"	"1"	"33028979_20_1229"
""	"double negative memory b cell (CD21-,CD11C-)"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	""	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"DN3 B cell"	""	"cell-type frequency"	"up"	"COVID-19 ICU patients vs COVID-19 outpatients"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Extended Data Fig 2B"	""	"CL_0000981"	"(CD21-,CD11C-)"	"PR:000001338,PR:000001013"	"double negative memory b cell (CD21-,CD11C-)"	"1"	"1"	"33028979_21_1233"
""	"double negative memory b cell (CD21+,CD11C-)"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	"17"	"double negative memory b cell"	"CL_0000981"	"flow cytometry"	"DN1 B cell"	""	"cell-type frequency"	"down"	"patients with extrafollicular pathway activation high vs low"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 4D"	""	"CL_0000981"	"(CD21+,CD11C-)"	"PR:000001338,PR:000001013"	"double negative memory b cell (CD21+,CD11C-)"	"1"	"1"	"33028979_22_1234"
""	"double negative memory b cell (CXCR5-,CD21-)"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	"17"	"double negative memory b cell"	"CL_0000981"	"flow cytometry"	"DN2 B cell"	""	"cell-type frequency"	"up"	"patients with extrafollicular pathway activation high vs low"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 4D"	""	"CL_0000981"	"(CXCR5-,CD21-)"	"PR:000001209,PR:000001338"	"double negative memory b cell (CXCR5-,CD21-)"	"1"	"1"	"33028979_23_1235"
""	"unswitched memory b cell"	""	"COVID-19 patients and healthy controls (Atlanta, USA)"	"22"	"81"	"years"	"26"	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"usM B cells"	""	"cell-type frequency"	"down"	"patients with extrafollicular pathway activation high vs healthy controls"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 4G"	""	"CL_0000970"	""	""	"unswitched memory b cell"	"1"	"1"	"33028979_27_1239"
""	"unswitched memory b cell"	""	"COVID-19 patients (Atlanta, USA)"	"26"	"81"	"years"	"17"	"CD19+ B cell"	"CL:0001201"	"flow cytometry"	"usM B cells"	""	"cell-type frequency"	"down"	"patients with extrafollicular pathway activation high vs low"	"time of symptom onset"	"several"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33028979"	"2020-10-07"	"https://www.nature.com/articles/s41590-020-00814-z"	"Fig 4G"	""	"CL_0000970"	""	""	"unswitched memory b cell"	"1"	"1"	"33028979_28_1240"
""	"natural killer cell (low forward scatter A and CD3-,CD7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"26"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7+ FSC-Alow NK cells of CD3- cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 1E"	""	"CL_0000623"	"(low forward scatter A and CD3-,CD7+)"	"PR:000001020,PR:000001836"	"natural killer cell (low forward scatter A and CD3-,CD7+)"	"1"	"1"	"33391280_4_1262"
""	"monocyte (high forward scatter A and CD3-,CD7-)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"26"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7- FSC-Ahigh monocytes of CD3- cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 1E"	""	"CL_0000576"	"(high forward scatter A and CD3-,CD7-)"	"PR:000001020,PR:000001836"	"monocyte (high forward scatter A and CD3-,CD7-)"	"2"	"1"	"33391280_5_1263"
""	"natural killer cell (low forward scatter A and CD3-,CD7+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7+ FSC-Alow NK cells of CD3- cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 1E"	""	"CL_0000623"	"(low forward scatter A and CD3-,CD7+)"	"PR:000001020,PR:000001836"	"natural killer cell (low forward scatter A and CD3-,CD7+)"	"1"	"1"	"33391280_6_1264"
""	"monocyte (high forward scatter A and CD3-,CD7-)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7- FSC-Ahigh monocytes of CD3- cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 1E"	""	"CL_0000576"	"(high forward scatter A and CD3-,CD7-)"	"PR:000001020,PR:000001836"	"monocyte (high forward scatter A and CD3-,CD7-)"	"2"	"1"	"33391280_7_1265"
""	"natural killer cell (low forward scatter A and CD3-,CD7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7+ FSC-Alow NK cells of CD3- cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 1E"	""	"CL_0000623"	"(low forward scatter A and CD3-,CD7+)"	"PR:000001020,PR:000001836"	"natural killer cell (low forward scatter A and CD3-,CD7+)"	"1"	"1"	"33391280_8_1266"
""	"monocyte (high forward scatter A and CD3-,CD7-)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7- FSC-Ahigh monocytes of CD3- cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 1E"	""	"CL_0000576"	"(high forward scatter A and CD3-,CD7-)"	"PR:000001020,PR:000001836"	"monocyte (high forward scatter A and CD3-,CD7-)"	"2"	"1"	"33391280_9_1267"
""	"natural killer cell (low forward scatter A and CD3-,CD7+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7+ FSC-Alow NK cells of CD3- cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 1E"	""	"CL_0000623"	"(low forward scatter A and CD3-,CD7+)"	"PR:000001020,PR:000001836"	"natural killer cell (low forward scatter A and CD3-,CD7+)"	"1"	"1"	"33391280_10_1268"
""	"monocyte (high forward scatter A and CD3-,CD7-)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7- FSC-Ahigh monocytes of CD3- cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 1E"	""	"CL_0000576"	"(high forward scatter A and CD3-,CD7-)"	"PR:000001020,PR:000001836"	"monocyte (high forward scatter A and CD3-,CD7-)"	"2"	"1"	"33391280_11_1269"
""	"monocyte (high forward scatter A and CD3-,CD7-)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7- FSC-Ahigh monocytes of CD3- cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 1E"	""	"CL_0000576"	"(high forward scatter A and CD3-,CD7-)"	"PR:000001020,PR:000001836"	"monocyte (high forward scatter A and CD3-,CD7-)"	"2"	"1"	"33391280_12_1270"
""	"natural killer cell (low forward scatter A and CD3-,CD7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7+ FSC-Alow NK cells of CD3- cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2A"	""	"CL_0000623"	"(low forward scatter A and CD3-,CD7+)"	"PR:000001020,PR:000001836"	"natural killer cell (low forward scatter A and CD3-,CD7+)"	"1"	"1"	"33391280_13_1271"
""	"monocyte (high forward scatter A and CD3-,CD7-)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7- FSC-Ahigh monocytes of CD3- cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2A"	""	"CL_0000576"	"(high forward scatter A and CD3-,CD7-)"	"PR:000001020,PR:000001836"	"monocyte (high forward scatter A and CD3-,CD7-)"	"2"	"1"	"33391280_14_1272"
""	"natural killer cell (low forward scatter A and CD3-,CD7+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7+ FSC-Alow NK cells of CD3- cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2A"	""	"CL_0000623"	"(low forward scatter A and CD3-,CD7+)"	"PR:000001020,PR:000001836"	"natural killer cell (low forward scatter A and CD3-,CD7+)"	"1"	"1"	"33391280_15_1273"
""	"monocyte (high forward scatter A and CD3-,CD7-)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7- FSC-Ahigh monocytes of CD3- cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2A"	""	"CL_0000576"	"(high forward scatter A and CD3-,CD7-)"	"PR:000001020,PR:000001836"	"monocyte (high forward scatter A and CD3-,CD7-)"	"2"	"1"	"33391280_16_1274"
""	"natural killer cell (low forward scatter A and CD3-,CD7+)"	""	"COVID-19 cases (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7+ FSC-Alow NK cells of CD3- cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2A"	""	"CL_0000623"	"(low forward scatter A and CD3-,CD7+)"	"PR:000001020,PR:000001836"	"natural killer cell (low forward scatter A and CD3-,CD7+)"	"1"	"1"	"33391280_17_1275"
""	"monocyte (high forward scatter A and CD3-,CD7-)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7- FSC-Ahigh monocytes of CD3- cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2A"	""	"CL_0000576"	"(high forward scatter A and CD3-,CD7-)"	"PR:000001020,PR:000001836"	"monocyte (high forward scatter A and CD3-,CD7-)"	"2"	"1"	"33391280_18_1276"
""	"natural killer cell (low forward scatter A and CD3-,CD7+)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7+ FSC-Alow NK cells of CD3- cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2A"	""	"CL_0000623"	"(low forward scatter A and CD3-,CD7+)"	"PR:000001020,PR:000001836"	"natural killer cell (low forward scatter A and CD3-,CD7+)"	"1"	"1"	"33391280_19_1277"
""	"monocyte (high forward scatter A and CD3-,CD7-)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7- FSC-Ahigh monocytes of CD3- cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2A"	""	"CL_0000576"	"(high forward scatter A and CD3-,CD7-)"	"PR:000001020,PR:000001836"	"monocyte (high forward scatter A and CD3-,CD7-)"	"2"	"1"	"33391280_20_1278"
""	"natural killer cell (low forward scatter A and CD3-,CD7+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7+ FSC-Alow NK cells of CD3- cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2A"	""	"CL_0000623"	"(low forward scatter A and CD3-,CD7+)"	"PR:000001020,PR:000001836"	"natural killer cell (low forward scatter A and CD3-,CD7+)"	"1"	"1"	"33391280_21_1279"
""	"monocyte (high forward scatter A and CD3-,CD7-)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7- FSC-Ahigh monocytes of CD3- cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2A"	""	"CL_0000576"	"(high forward scatter A and CD3-,CD7-)"	"PR:000001020,PR:000001836"	"monocyte (high forward scatter A and CD3-,CD7-)"	"2"	"1"	"33391280_22_1280"
""	"natural killer cell (low forward scatter A and CD3-,CD7+)"	""	"severe COVID-19 cases (Rome, Italy)"	"47"	"76"	"years"	"77"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3- CD7+ FSC-Alow NK cells of CD3- cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 ICU vs SARS CoV-2 non-ICU"	"time of diagnosis"	"unspecified"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 2C"	""	"CL_0000623"	"(low forward scatter A and CD3-,CD7+)"	"PR:000001020,PR:000001836"	"natural killer cell (low forward scatter A and CD3-,CD7+)"	"1"	"1"	"33391280_23_1281"
""	"cd14-positive, cd16-positive monocyte"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD14+ CD16++ non-classical monocytes"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 3B"	""	"CL_0002397"	""	""	"cd14-positive, cd16-positive monocyte"	"1"	"1"	"33391280_24_1282"
""	"cd14-positive, cd16-positive monocyte"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD14+ CD16++ non-classical monocytes"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 3B"	""	"CL_0002397"	""	""	"cd14-positive, cd16-positive monocyte"	"1"	"1"	"33391280_25_1283"
""	"cd14-positive, cd16-positive monocyte"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD14+ CD16++ non-classical monocytes"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 3B"	""	"CL_0002397"	""	""	"cd14-positive, cd16-positive monocyte"	"1"	"1"	"33391280_26_1284"
""	"t cell"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ T cells of lymphocytes"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4A, Fig S2A"	""	"CL_0000084"	""	""	"t cell"	"1"	"1"	"33391280_27_1287"
""	"t cell"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ T cells of lymphocytes"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2A"	""	"CL_0000084"	""	""	"t cell"	"1"	"1"	"33391280_28_1288"
""	"t cell"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ T cells of lymphocytes"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2A"	""	"CL_0000084"	""	""	"t cell"	"1"	"1"	"33391280_29_1289"
""	"t cell"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"48.5"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ T cells of lymphocytes"	""	"cell-type frequency"	"down"	"SARS CoV-2 asymptomatic vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2A"	""	"CL_0000084"	""	""	"t cell"	"1"	"1"	"33391280_30_1290"
""	"t cell"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ T cells of lymphocytes"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4A"	""	"CL_0000084"	""	""	"t cell"	"1"	"1"	"33391280_31_1291"
""	"cd4-positive, alpha-beta t cell"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ T cells of CD3+ cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2A"	""	"CL_0000624"	""	""	"cd4-positive, alpha-beta t cell"	"1"	"1"	"33391280_32_1292"
""	"cd8-positive, alpha-beta t cell"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ T cells of CD3+ cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2A"	""	"CL_0000625"	""	""	"cd8-positive, alpha-beta t cell"	"1"	"1"	"33391280_33_1293"
""	"cd4-positive, alpha-beta t cell"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ T cells of CD3+ cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2A"	""	"CL_0000624"	""	""	"cd4-positive, alpha-beta t cell"	"1"	"1"	"33391280_34_1294"
""	"cd8-positive, alpha-beta t cell"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"48.5"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ T cells of CD3+ cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 asymptomatic vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2A"	""	"CL_0000625"	""	""	"cd8-positive, alpha-beta t cell"	"1"	"1"	"33391280_35_1295"
""	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ HLADR+ T cells of CD4+ T cells; CD8+ HLADR+ T cells of CD8+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4B, Fig S2B"	""	"CL_0000896"	"(HLADRA+)"	"PR:000002015"	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	"2"	"2"	"33391280_36_1296"
""	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD4+ HLADR+ T cells of CD4+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4B, Fig S2B"	""	"CL_0000896"	"(HLADRA+)"	"PR:000002015"	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	"1"	"1"	"33391280_37_1297"
""	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ HLADR+ T cells of CD8+ T cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2B"	""	"CL_0000896"	"(HLADRA+)"	"PR:000002015"	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	"1"	"1"	"33391280_38_1298"
""	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"48.5"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ HLADR+ T cells of CD8+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 asymptomatic vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2B"	""	"CL_0000896"	"(HLADRA+)"	"PR:000002015"	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	"1"	"1"	"33391280_39_1299"
""	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ HLADR+ T cells of CD8+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4B, Fig S2B"	""	"CL_0000896"	"(HLADRA+)"	"PR:000002015"	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	"1"	"1"	"33391280_40_1300"
""	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD8+ HLADR+ T cells of CD8+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4B, Fig S2B"	""	"CL_0000896"	"(HLADRA+)"	"PR:000002015"	"activated cd4-positive, alpha-beta t cell (HLADRA+)"	"1"	"1"	"33391280_41_1301"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"48.5"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31+ CD45RA+ CCR7+ CD4+ T cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4C, Fig S2C"	""	"CL_0000895"	"(CD31+,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	"1"	"1"	"33391280_42_1302"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"48.5"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31- CD45RA+ CCR7+ CD4+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4C, Fig S2C"	""	"CL_0000895"	"(CD31-,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	"1"	"1"	"33391280_43_1303"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+); naive thymus-derived cd8-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31+ CD45RA+ CCR7+ CD4+ T cells; CD31+ CD45RA+ CCR7+ CD8+ T cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4C, Fig S2C"	""	"CL_0000895; CL_0000900"	"(CD31+,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+); naive thymus-derived cd8-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	"2"	"2"	"33391280_44_1304"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31- CD45RA+ CCR7+ CD4+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4C, Fig S2C"	""	"CL_0000895"	"(CD31-,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	"1"	"1"	"33391280_45_1305"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31+ CD45RA+ CCR7+ CD4+ T cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4C, Fig S2C"	""	"CL_0000895"	"(CD31+,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	"1"	"1"	"33391280_46_1306"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31- CD45RA+ CCR7+ CD4+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4C, Fig S2C"	""	"CL_0000895"	"(CD31-,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	"1"	"1"	"33391280_47_1307"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+); naive thymus-derived cd8-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31+ CD45RA+ CCR7+ CD4+ T cells; CD31+ CD45RA+ CCR7+ CD8+ T cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4C, Fig S2C"	""	"CL_0000895; CL_0000900"	"(CD31+,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+); naive thymus-derived cd8-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	"2"	"2"	"33391280_48_1308"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31+ CD45RA+ CCR7+ CD4+ T cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2C"	""	"CL_0000895"	"(CD31+,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	"1"	"1"	"33391280_49_1309"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31+ CD45RA+ CCR7+ CD4+ T cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2C"	""	"CL_0000895"	"(CD31+,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	"1"	"1"	"33391280_50_1310"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31- CD45RA+ CCR7+ CD4+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2C"	""	"CL_0000895"	"(CD31-,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	"1"	"1"	"33391280_51_1311"
""	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31- CD45RA+ CCR7+ CD4+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2C"	""	"CL_0000895"	"(CD31-,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd4-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	"1"	"1"	"33391280_52_1312"
""	"naive thymus-derived cd8-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31+ CD45RA+ CCR7+ CD8+ T cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2C"	""	"CL_0000900"	"(CD31+,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd8-positive, alpha-beta t cell (CD31+,CD45RA+,CCR7+)"	"1"	"1"	"33391280_53_1313"
""	"naive thymus-derived cd8-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31- CD45RA+ CCR7+ CD8+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2C"	""	"CL_0000900"	"(CD31-,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd8-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	"1"	"1"	"33391280_54_1314"
""	"naive thymus-derived cd8-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31- CD45RA+ CCR7+ CD8+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2C"	""	"CL_0000900"	"(CD31-,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd8-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	"1"	"1"	"33391280_55_1315"
""	"naive thymus-derived cd8-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD31- CD45RA+ CCR7+ CD8+ T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2C"	""	"CL_0000900"	"(CD31-,CD45RA+,CCR7+)"	"PR:000001904,PR:000001015,PR:000001203"	"naive thymus-derived cd8-positive, alpha-beta t cell (CD31-,CD45RA+,CCR7+)"	"1"	"1"	"33391280_56_1316"
""	"effector memory cd4-positive, alpha-beta t cell, terminally differentiated (CD45RA+,CCR7-)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"48.5"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CCR7- CD45RA+ CD4+ (TEMRA) T cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 asymptomatic vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2D"	""	"CL_0001087"	"(CD45RA+,CCR7-)"	"PR:000001015,PR:000001203"	"effector memory cd4-positive, alpha-beta t cell, terminally differentiated (CD45RA+,CCR7-)"	"1"	"1"	"33391280_57_1317"
""	"effector memory cd8-positive, alpha-beta t cell, terminally differentiated (CD45RA+,CCR7-)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CCR7- CD45RA+ CD8+ (TEMRA) T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2D"	""	"CL_0001062"	"(CD45RA+,CCR7-)"	"PR:000001015,PR:000001203"	"effector memory cd8-positive, alpha-beta t cell, terminally differentiated (CD45RA+,CCR7-)"	"1"	"1"	"33391280_58_1318"
""	"effector memory cd8-positive, alpha-beta t cell, terminally differentiated (CD45RA+,CCR7-)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CCR7- CD45RA+ CD8+ (TEMRA) T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S2D"	""	"CL_0001062"	"(CD45RA+,CCR7-)"	"PR:000001015,PR:000001203"	"effector memory cd8-positive, alpha-beta t cell, terminally differentiated (CD45RA+,CCR7-)"	"1"	"1"	"33391280_59_1319"
""	"effector memory cd8-positive, alpha-beta t cell, terminally differentiated (CD45RA+,CCR7-)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CCR7- CD45RA+ CD8+ (TEMRA) T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4D"	""	"CL_0001062"	"(CD45RA+,CCR7-)"	"PR:000001015,PR:000001203"	"effector memory cd8-positive, alpha-beta t cell, terminally differentiated (CD45RA+,CCR7-)"	"1"	"1"	"33391280_60_1320"
""	"effector memory cd8-positive, alpha-beta t cell, terminally differentiated (CD45RA+,CCR7-)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD3+ CCR7- CD45RA+ CD8+ (TEMRA) T cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 4D"	""	"CL_0001062"	"(CD45RA+,CCR7-)"	"PR:000001015,PR:000001203"	"effector memory cd8-positive, alpha-beta t cell, terminally differentiated (CD45RA+,CCR7-)"	"1"	"1"	"33391280_61_1321"
""	"b cell"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"B cells of lymphocytes"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5B, Fig S4B"	""	"CL_0000236"	""	""	"b cell"	"1"	"1"	"33391280_62_1322"
""	"plasmablast (CD27++,CD38++,CD24-)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD24- CD27++ CD38++ plasmablasts of B cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S4B"	""	"CL_0000980"	"(CD27++,CD38++,CD24-)"	"PR:000001963,PR:000001408,PR:000001932"	"plasmablast (CD27++,CD38++,CD24-)"	"1"	"1"	"33391280_63_1323"
""	"b cell"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"48.5"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"B cells of lymphocytes"	""	"cell-type frequency"	"up"	"SARS CoV-2 asymptomatic vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5B, Fig S4B"	""	"CL_0000236"	""	""	"b cell"	"1"	"1"	"33391280_64_1324"
""	"b cell"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"B cells of lymphocytes"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5B, Fig S4B"	""	"CL_0000236"	""	""	"b cell"	"1"	"1"	"33391280_65_1325"
""	"memory b cell"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"memory B cells of B cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S4B"	""	"CL_0000787"	""	""	"memory b cell"	"1"	"1"	"33391280_66_1326"
""	"memory b cell"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"memory B cells of B cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S4B"	""	"CL_0000787"	""	""	"memory b cell"	"1"	"1"	"33391280_67_1327"
""	"memory b cell"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"48.5"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"memory B cells of B cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 asymptomatic vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S4B"	""	"CL_0000787"	""	""	"memory b cell"	"1"	"1"	"33391280_68_1328"
""	"plasmablast (CD27++,CD38++,CD24-)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD24- CD27++ CD38++ plasmablasts of B cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5B, Fig S4B"	""	"CL_0000980"	"(CD27++,CD38++,CD24-)"	"PR:000001963,PR:000001408,PR:000001932"	"plasmablast (CD27++,CD38++,CD24-)"	"1"	"1"	"33391280_69_1329"
""	"plasmablast (CD27++,CD38++,CD24-)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"CD24- CD27++ CD38++ plasmablasts of B cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5B, Fig S4B"	""	"CL_0000980"	"(CD27++,CD38++,CD24-)"	"PR:000001963,PR:000001408,PR:000001932"	"plasmablast (CD27++,CD38++,CD24-)"	"1"	"1"	"33391280_70_1330"
""	"unswitched memory b cell (CD27+,IGM+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgM+ cells of CD27+ memory B cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5C"	""	"CL_0000970"	"(CD27+,IGM+)"	"PR:000001963,PR:000050257"	"unswitched memory b cell (CD27+,IGM+)"	"1"	"1"	"33391280_71_1331"
""	"unswitched memory b cell (CD27+,IGM+)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgM+ cells of CD27+ memory B cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0"	"days"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5C"	""	"CL_0000970"	"(CD27+,IGM+)"	"PR:000001963,PR:000050257"	"unswitched memory b cell (CD27+,IGM+)"	"1"	"1"	"33391280_72_1332"
""	"class switched memory b cell (CD27+,IGM-)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgM- (switched) cells of CD27+ memory B cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5C, Fig S4C"	""	"CL_0000972"	"(CD27+,IGM-)"	"PR:000001963,PR:000050257"	"class switched memory b cell (CD27+,IGM-)"	"1"	"1"	"33391280_73_1333"
""	"unswitched memory b cell (CD27+,IGM+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgM+ cells of CD27+ memory B cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5C, Fig S4C"	""	"CL_0000970"	"(CD27+,IGM+)"	"PR:000001963,PR:000050257"	"unswitched memory b cell (CD27+,IGM+)"	"1"	"1"	"33391280_74_1334"
""	"class switched memory b cell (CD27+,IGM-)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgM- (switched) cells of CD27+ memory B cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5C, Fig S4C"	""	"CL_0000972"	"(CD27+,IGM-)"	"PR:000001963,PR:000050257"	"class switched memory b cell (CD27+,IGM-)"	"1"	"1"	"33391280_75_1335"
""	"unswitched memory b cell (CD27+,IGM+)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgM+ cells of CD27+ memory B cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S4C"	""	"CL_0000970"	"(CD27+,IGM+)"	"PR:000001963,PR:000050257"	"unswitched memory b cell (CD27+,IGM+)"	"1"	"1"	"33391280_76_1336"
""	"unswitched memory b cell (CD27+,IGM+)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgM+ cells of CD27+ memory B cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S4C"	""	"CL_0000970"	"(CD27+,IGM+)"	"PR:000001963,PR:000050257"	"unswitched memory b cell (CD27+,IGM+)"	"1"	"1"	"33391280_77_1337"
""	"class switched memory b cell (CD27+,IGM-)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"63.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgM- (switched) cells of CD27+ memory B cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig S4C"	""	"CL_0000972"	"(CD27+,IGM-)"	"PR:000001963,PR:000050257"	"class switched memory b cell (CD27+,IGM-)"	"1"	"1"	"33391280_78_1338"
""	"class switched memory b cell (IGG+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"63.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgG+ cells of memory B cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 mild vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5D, Fig S4D"	""	"CL_0000972"	"(IGG+)"	"PR:000050252"	"class switched memory b cell (IGG+)"	"1"	"1"	"33391280_79_1339"
""	"class switched memory b cell (IGG+)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"48.5"	"years"	"48"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgG+ cells of memory B cells"	""	"cell-type frequency"	"down"	"SARS CoV-2 asymptomatic vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5D, Fig S4D"	""	"CL_0000972"	"(IGG+)"	"PR:000050252"	"class switched memory b cell (IGG+)"	"1"	"1"	"33391280_80_1340"
""	"class switched memory b cell (IGM-,IGG-)"	""	"COVID-19 cases and SARS-CoV-2-negative contacts (Rome, Italy)"	"32"	"82.5"	"years"	"36"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgG- IgM- cells of memory B cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 contacts"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5D, Fig S4D"	""	"CL_0000972"	"(IGM-,IGG-)"	"PR:000050257,PR:000050252"	"class switched memory b cell (IGM-,IGG-)"	"1"	"1"	"33391280_81_1341"
""	"class switched memory b cell (IGM-,IGG-)"	""	"COVID-19 cases (Rome, Italy)"	"34.3"	"82.5"	"years"	"28"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgG- IgM- cells of memory B cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 asymptomatic"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5D, Fig S4D"	""	"CL_0000972"	"(IGM-,IGG-)"	"PR:000050257,PR:000050252"	"class switched memory b cell (IGM-,IGG-)"	"1"	"1"	"33391280_82_1342"
""	"class switched memory b cell (IGM-,IGG-)"	""	"COVID-19 cases (Rome, Italy)"	"48"	"82.5"	"years"	"16"	"Peripheral Blood Mononuclear Cells"	"CL:2000001"	"flow cytometry"	"IgG- IgM- cells of memory B cells"	""	"cell-type frequency"	"up"	"SARS CoV-2 severe vs SARS CoV-2 mild"	"time of diagnosis"	"0,1,2,3,4,5,6"	"weeks"	"2697049"	"Occurrence of infectious disease"	"COVID-19"	"acute"	"33391280"	"2020-12-16"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772470/"	"Fig 5D, Fig S4D"	""	"CL_0000972"	"(IGM-,IGG-)"	"PR:000050257,PR:000050252"	"class switched memory b cell (IGM-,IGG-)"	"1"	"1"	"33391280_83_1343"
